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ABSTRACT	
This	thesis	is	an	empirical	investigation	of	epigenetics	and	policy.	This	research	first	focused	on	mapping	the	impact	of	epigenetics	in	health	care	and	exploring	the	challenges	 it	poses	 for	health	care	policy.	The	 thesis	developes	a	combined	qualitative-quantitative	 strategy	 to	 identify	 the	most	 active	 areas	 of	 epigenetic	research,	clinical	applications	and	clinical	outputs,	as	well	as	to	track	the	number	of	 publications	 on	 epigenetics.	 Moreover,	 the	 thesis	 finds	 that	 the	 science	 of	epigenomics	 goes	 ‘beyond	 the	 genome’	 insofar	 as	 what	 lies	 beyond	 can	 be	conceptualised	 through	 and	 converted	 into	 genome-friendly,	 code-compatible	digital	 representations.	The	 research	 further	 focused	on	 the	 case	of	Glasgow,	a	city	characterized	by	stark	health	and	social	inequalities,	where	epigenetics	has	been	employed	 in	an	 interdisciplinary	project	 to	measure	and	instruct	relevant	social	programs	to	target	these	inequalities.	This	thesis	thus	contributes	a	critical	insight	 into	 how	 epigenetics	 is	 currently	 employed	 –	 in	 collaboration	 between	actors	of	diverse	backgrounds;	and	in	policy	efforts	and	action	upon	health.	The	thesis	 finds	 that	 within	 this	 project	 epigenetics	 is	 conceptualised	 as	instrumentally	 effective,	 policy-approprate	 evidentiary	 resource	 that	 could	foster	socio-political	change	 in	a	non-distant	 future.	Accordingly,	 it	 is	 thanks	to	its	molecularization	of	the	environment	and	therefore	its	purported	objectivity,	that	 epigenetics	 is	 bestowed	 the	 potential	 for	 actionable	 public	 health	knowledge.	 Additionally,	 the	 thesis	 finds	 that	 it	 is	 the	 solidary	 practice	 that	governs	this	interdisciplinary	collaborative	endeavour	in	Glasgow.			
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CHAPTER	ONE	-	INTRODUCTION	
	This	thesis	is	an	empirical	investigation	of	epigenetics	and	policy.	This	research	first	focused	on	mapping	the	impact	of	epigenetics	in	health	care	and	exploring	the	challenges	it	poses	for	health	care	policy.	The	research	further	focused	on	a	particular	 project	 in	 Glasgow,	 in	 which	 epigenetics	 was	 employed	 in	 research	with	the	aim	to	foster	political	action	upon	health	called	the	psychological,	social	and	 biological	 determinants	 of	 ill	 health	 (pSoBid)	 project.	 Drawing	 on	 the	empirical	data	on	Glasgow	case,	 the	 thesis	 finds	 that	epigenetics	 represents	an	instrumentally	 effective,	 policy-apprpriate	 evidentiary	 resource,	 that	 could	foster	socio-political	change	by	virtue	of	its	purported	‘objectivity’,	conferred	by	its	‘molecularization	of	the	environment,	biography	and	milieu	(Landecker	2011;	Niewöhner	 2011).	 Additionally,	 the	 thesis	 finds	 that	 the	 research	 and	 action	upon	health	in	Glasgow	is	governed	by	communal	solidarity,	i.e.	solidary	practice	(Prainsack	and	Buyx	2012).			
INTRODUCTION	
Epigenetics	is	an	emerging	science	that	studies	changes	in	gene	expression	that	do	 not	 involve	 changes	 to	 the	 underlying	 DNA	 sequence.	 Ever	 since	 the	completion	of	the	reference	sequence	of	the	human	genome,	most	efforts	of	the	scientific	 community	 have	 been	 directed	 to	 understanding	 how	 the	 linear	nucleotide	 sequence	 of	 DNA	 is	 employed	 in	 cellular	 activities	 in	 development	and	pathological	conditions.	In	the	words	of	the	Italian	Epigenetics	Consortium:		
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“Upon	 completion	 of	the	 Human	 Genome	 Project	 in	 2003,	 it	became	evident	 that	 the	 information	 for	 life	 is	 encoded	 not	 only	 in	 the	 DNA	sequence	 but	 also	 in	 the	 chemical	 modifications	 deposited	 by	 enzymes	both	 on	 DNA	 and	 its	 associated	 Histone	 proteins.	 These	 are	 known	 as	“epigenetic	 modifications”,	 which	 alter	 gene	 expression	 while	 the	 DNA	sequence	 remains	 unchanged.”	 (The	 Italian	 Epigenetics	 Consortium,	EPIGEN)		Much	of	today’s	epigenetic	science	means	studying	the	multiple	modifications	to	which	 DNA	 or	 histone	 proteins	 are	 subjected,	 and	 consequently	 how	 such	modifications	affect	overall	nucleosome	and	chromatin	structure	(Goldberg	et	al.	2007).	 The	 overwhelming	 technological	 development	 in	 recent	 years	 made	 it	possible	to	assay	such	modifications	at	the	level	of	a	single	gene	or	modification,	as	 well	 as	 to	 describe	 them	 across	 the	whole	 genome	 (Callinan	 and	 Feinberg	2006).	A	genome-wide	set	of	modifications	made	to	DNA	and	the	protein	scaffold	that	 supports	 it	 is	 called	 the	 ‘epigenome’	 and	 the	 science	 that	 studies	 it	‘epigenomics’.	 Epigenomics	 science	 thus	 consists	 of	 a	 “global,	 comprehensive	view	 of	 sequence-independent	 processes	 that	 modulate	 gene	 expression	patterns	in	a	cell”	(Rivera	and	Ren	2013,	39).		In	the	last	couple	of	years,	many	national	and	supranational	epigenomic	projects	and/or	consortia	were	initiated.	These	projects	aim	to	generate	freely	available,	high-resolution	reference	maps	of	epigenomes	‘for	normal	and	disease	cell	types’	in	 both	 humans	 and	 animal	 models.	 The	 Human	 International	 Epigenome	
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Consortium	 (IHEC1)	 states	 that	 these	 epigenome	 reference	maps	 ‘are	 likely	 to	have	 an	 immediate	 impact	 on	 the	 understanding	 of	 many	 diseases,	 and	 will	hopefully	lead	to	the	discovery	of	new	means	to	treat	and	manage	them’.	Among	the	diseases	that	have	been	linked	to	epigenetic	aberrations	are	cancer	(Esteller	2007;	Kulis	and	Esteller	2010;	Sandoval	and	Esteller	2012),	neurodegenerative	(Urdinguio	et	al.	2009)	and	autoimmune	diseases	(Brooks	et	al	2010),	as	well	as	cardiovascular	 (Ordovàs	 and	 Smith	 2010)	 and	 metabolic	 diseases	 (Schwenk,	Vogel	and	Schuermann	2013),	etc.		The	 World	 Health	 Organisation	 (WHO)	 marked	 these	 diseases	 as	 the	 major	contributors	 to	 the	 burden	 of	 disease	 in	 both	 ‘developed’	 and	 ‘developing’	countries	(WHO	2012).	The	WHO	links	the	development	of	 these	diseases	with	‘life	style	factors’	such	as	smoking,	physical	activity	and	diet,	and	alcohol	intake,	as	 well	 as	 with	 ‘social	 factors’	 like	 poverty	 (WHO	 2015).	 The	 associations	between	epigenetic	 changes	and	environmental	 factors	such	as	socio-economic	status	 (McGuinness	 et	 al	 2012),	 smoking	 (Shenker	 et	 al	 2013),	 air	 pollution	(Baccarelli	et	al	2009),	nutrition	(Heijmans	et	al	2008),	etc.	have	indeed	already	been	 reported	 in	 cohort	 studies.	 Speculations	 over	 epidemiological	 research	suggest	that	the	effects	of	diet	or	smoking	are	transmitted	into	next	generations	in	 virtue	 of	 yet	 unknown	 epigenetic	 mechanism	 (Pembrey	 2006).	 Findings	 in	animal	 studies	 suggest	 that	 some	 epigenetic	 changes	 can	 travel	 across	generations	(e.g.	Padmanabhan	et	al.	2013;	Lambrot	et	al.	2013;	Dias	and	Ressler	2014).	 However,	 this	 idea	 is	 highly	 disputed	 in	 the	 scientific	 community	 and	especially	controversial	when	extended	to	humans.		
																																																								1	Available	at:	http://ihec-epigenomes.org	(Last	accessed	on	12.12.2016)	2	Available	at	http://www.deutsches-epigenom-programm.de/epigenomics/	(Last	accessed	on	
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Epigenetics	research	outputs	have	already	made	it	 into	the	clinic	and	many	are	expected	 to	 do	 so	 in	 the	 near	 future.	 Investigations	 of	 epigenetics	 are	contributing	 to	 normative	 debates	 on	 responsibility	 for	 health	 (Wiener	 2010,	Hedlund	2011,	Chadwick	and	O’Connor	2013)	and	health	equity	(Loi	et	al	2013;	Stapleton	et	al	2012),	and	to	debates	about	the	biological	and	the	social,	 innate	and	 acquired	 (Landecker	 and	 Panosfky	 2013;	 Niewhoener	 2015;	 Lock	 2015;	Meloni	2015;).	In	short,	as	a	science	that	studies	what	lies	beyond	or	above	the	genome	and	examines	how	the	contingencies	of	 life	 (pollution,	 stress,	what	we	eat,	etc.)	affect	how	the	genes	operate,	epigenetics	has	potentially	paradigmatic	implications	for	the	biological	and	the	social	sciences,	as	well	as	for	policy.			
FRAMEWORK	OF	THE	PROJECT	AND	HOW	THIS	THESIS	DEVELOPED	
This	research	is	rooted	in	the	“EPIGEN:	Public	Engagement	and	Policy	Work	on	Epigenetics”	 (the	 EPIGEN	 project)	 which	 was	 initiated	 in	 2013	 to	 pursue	 the	EPIGEN	Consortium’s	commitment	to	integrate:	1)	the	study	of	Ethical,	Legal	and	Social	 Issues	within	its	research	activities;	and	2)	the	engagement	of	the	public	and	 policy	 makers	 on	 the	 implications	 of	 epigenomics	 more	 upstream	 in	 the	research	process.	As	the	EPIGEN	project	itself	stated:		 »This	 pioneering	 CNR-Flagship	 Project	 has	 recognized	 that	 the	 rise	 of	high-throughput	 epigenomics,	with	 its	 potential	 to	 revolutionize	 human	health	care,	needs	to	take	into	account	[the]	fundamental	changes	in	the	ways	 in	 which	 science	 is	 being	 made	 accountable	 and	 responsive	 to	societal	 needs	 and	 concerns.	 Therefore	 it	 has	 integrated	 the	 study	 of	
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Ethical	 Legal	 and	Social	 issues	 (ELSI)	 fully	within	 its	 research	activities,	thus	 fulfilling	 EU’s	 recommendation	 to	 consider	 ELSI	 as	 a	 critical	component	 in	 the	 evaluation	 of	 risk	 for	 new	 technologies.»	 	 (EPIGEN:	Public	Engagement	and	Policy	Work	on	Epigenetics)		To	 this	 end,	 the	 EPIGEN	 consortium	 established	 collaboration	 with	 the	 PhD	programme	of	Foundations	Of	The	Life	Sciences	And	Their	Ethical	Consequences	(FOLSATEC)	at	the	European	School	of	Molecular	Medicine	(SEMM)	in	Milan.	The	FOLSATEC	 PhD	 programme	 is	 opened	 to	 students	 with	 both	 scientific	 and	philosophical	 background	 as	 it	 aims	 to	 create	 interdisciplinary	 scholars.	 The	research	projects	of	FOLSATEC	students	are	developed	during	the	course	of	their	training	 and	 through	 their	 engagement	 with	 biomedicine	 and	 biomedical	researchers	 in	one	of	 the	 following	three	areas:	a)	philosophical	 foundations	of	biomedicine	 and	 biotechnology;	 b)	 ethical	 implications	 of	 biomedicine	 and	biotechnology;	 and	 c)	biomedicine	 and	 society.	 In	 this	 respect,	 the	programme	represents	an	experimental	and	unique	approach	to	the	studies	of	biomedicine.	Two	FOLSATEC	students	were	assigned	to	work	on	the	EPIGEN	project	together	with	the	principle	investigator	of	the	EPIGEN	project,	Prof.	Testa:	a	student	with	a	 scientific	 background	 –	myself,	who	 had	 just	 enrolled	 in	 the	 FOLSATEC	 PhD	programme;	 and	 Luca	 Chiapperino,	 a	 senior	 FOLSATEC	 student	 with	 a	philosophical	background.				This	 PhD	 project	 has	 thus	 been	 developed	 within	 the	 framework	 of	 the	interdisciplinary	 PhD	 programme	 (FOLSATEC)	 and	 within	 the	 activities	 the	EPIGEN	Consortium’s	special	Dissemination	programme	(EPIGEN	project).	This	
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study	draws	on	 ideas	 from	the	 fields	of	philosophy	of	science,	bioethics,	public	health,	science	and	technology	studies	(STS)	and	political	philosophy.	It	aims	to	deliver	 an	 empirically	 grounded	 interdisciplinary	 reflection	 upon	 epigenetics	and	its	societal	implications.			
RESEARCH	DESIGN	AND	METHODS		
The	initial	aim	of	this	project	was	to	map	the	impact	of	epigenetics	in	health	care	and	 investigate	 the	 challenges	 of	 epigenetics	 for	 health	 care	 policy.	 The	objectives	of	this	research	were:		1)	 To	 identify	 the	 most	 active	 types	 of	 epigenetics	 research	 –	 basic,	translational,	clinical	research	2)	 To	 identify	 the	 most	 actively	 studied	 disease	 areas	 in	 each	 type	 of	research		3)	To	identify	the	most	active	areas	of	application	within	clinical	research		4)	To	identify	the	clinical	outputs		The	 methods	 used	 in	 this	 part	 of	 the	 research	 project	 included	 systematic	literature	 review,	 qualitative	 reading	 of	 literature,	 systematic	 review	 and	qualitative	reading	of	literature,	and	bibliometric	analysis	to	track	the	record	of	publications	on	epigenetics/epigenomics.	In	order	to	position	the	results	of	this	research	 in	 the	 broader	 picture	 of	 health	 care	 in	 Europe,	 the	 European	 Union	(EU)	Together	for	Health	Strategy	was	used	to	identify	the	interests	and	goals	in	health	management	 in	the	EU	for	that	period	(2008-2013).	These	 interests	and	goals	 were	 further	 investigated	 in	 reports	 published	 by	 the	 World	 Health	Organisation.		
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	The	succeeding	objectives	of	this	project	were	initially	set	as:	1) To	investigate	the	onset	of	epigenomics	by	asking	to	what	extent	and	how	is	 the	 establishment	 of	 this	 health	 enterprise	 influenced	 by,	 on	 the	 one	hand,	developments	in	the	life	sciences	to	address	complex	diseases,	and	political	 commitments	 to	 tackle	 health	 inequities	 on	 the	 other.	 This	objective	 was	 to	 be	 pursued	 within	 the	 framework	 of	 coproduction	(Jasanoff,	2004)	and	by	employing	the	concepts	of	boundary	object	(Star	and	Griesemer,	1989)	and	boundary	work	(Gieryn,	1983),	to	address	how	actors	 coming	 from	 different	 social	 worlds	 co-operate	 in	 a	 pursuit	 of	 a	common	 goal,	 and	 create	 new	 and/or	 reinforce	 old	 divisions	 between	fields	of	knowledge	in	pursuing	their	own	research	interests.	2) To	develop	a	political	framework	for	epigenetics-informed	policy-making,	by	asking	which	values	and	goals	 should	underlie	our	healthcare	policy.		This	 objective	 was	 to	 build	 upon	 Richard	 Rorty’s	 ideas	 of	 postmodern	pragmatism	 (Rorty	 1983)	 to	 integrate	 different	 theoretical	 concepts	which,	 in	 political	 philosophy,	 belong	 to	 different	 and	 often	 conflicting	
theoretical	 perspectives,	 but	 which	 could	 complement	 each	 other	 in	
practice	 to	produce	better	policy-outcomes.	The	 STS	 foundations	of	 this	framework	would	be	grounded	on	Charles	Thorpe’s	 idea	 that	STS	offers	tools	 and	 resources	 at	 the	basis	 of	which	 competing	normative	political	visions	of	science	and	technology	can	be	clarified,	analysed	and	criticised	–	an	idea	which	he	himself	referred	to	as	‘STS	as	political	theory’	(Thorpe	2008).	The	descriptive	 framework	would	 thus	build	upon	 the	 analytical	tools	 and	 resources	 offered	 by	 STS,	 and	 would	 in	 turn	 give	 normative	
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power	to	the	analyses	conducted	and	the	results	obtained	by	using	such	tools.				Two	key	developments	changed	the	shape	of	the	research	and	this	thesis.	First,	it	became	 evident	 that	 the	 uptake	 of	 epigenetics	 in	 the	 broader	 discourse	 on	inequalities	in	health	is	too	sporadic	and	slow.	It	was	noticeable	in	certain	cohort	studies	and	in	several	emerging	projects	and	initiatives,	but	this	was	insufficient	for	 a	 systematic	 data	 collection	 and	 analysis	 that	was	 required	 of	 this	 project.	The	idea	of	looking	in	parallel	at	the	life	sciences	and	public	health	as	fields	was	therefore	changed	into	interviewing	actors	in	these	fields:	the	scientists	a	the	IEO	and	 within	 the	 EPIGEN	 consortium;	 and	 representatives	 of	 the	 World	 Health	Organization	(WHO)	and	the	WHO	for	the	European	Region	(WHO/Europe),	who	were	invited	to	be	speakers	at	the	EPIGEN	International	Conference	in	Milan	in	December	 2014.	 However,	 second	 and	 in	 relation	 to	 this	 new	 idea,	 the	representatives	of	 the	WHO	and	 the	WHO/Europe	declined	 their	 invitations	 to	come	to	Milan	and	speak	at	the	EPIGEN	Conference.	For	this	reason,	the	research	further	focused	on	one	project	that	combined	the	life	sciences	and	epidemiology	in	 its	 approach	 to	 research	 and	 policy	 efforts	 for	 action	 upon	 health	 –	 the	Glasgow-based	 psychological	 social	 and	 biological	 determinants	 of	 ill	 health	(pSoBid)	 project.	 The	 pSoBid	 study	 report	 was	 at	 that	 moment	 the	 only	document	 released	 by	 a	 health	 organisation	 (Glasgow	 Centre	 for	 Population	Health)	that	contained	a	reference	to	epigenetic	data.	This	therefore	provided	a	unique	opportunity	to	investigate	not	only	how	epigenetics	is	conceptualised	by	actors	 in	 different	 disciplines,	 but	 also	 how	 it	 is	 actually	 employed	 in	 health	
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policy.	However,	scaling	down	from	the	general	to	the	local	level	reflected	itself	to	the	objectives	that	the	project	can	pursue	and	research	questions	it	can	ask.	Thus,	 the	 succeeding	 aim	 of	 this	 project	 was	 to	 explore	 how	 epigenetics	 is	mobilised	 across	 domains	 by	 exploring	 how	 it	 is	 conceptualised	 by	 different	actors	 in	 research	 and	 action	 upon	 health	 within	 one	 such	 interdisciplinary	project.	The	research	questions	that	the	thesis	asks	include:		1)	How	is	epigenetics	mobilised	and	used	 in	an	 interdisciplinary	project	that	combines	biological	and	social	approaches	to	health?		2)	 How	 do	 different	 actors	 conceptualise	 and	 use	 epigenetics	 within	 a	collaborative	 health	 endeavour	 aimed	 to	 bring	 about	 policy	 and	 action	upon	health?	The	methods	used	in	this	part	of	research	include	qualitative	reading	of	selected	literature	and	semi-structured	interviews	with	experts	from	the	pSoBid	project,	complemented	 by	 observational	 studies.	 The	 study	 draws	 on	 ideas	 of	molecularisation	 of	 the	 environment,	 biography	 and	 milieu	 (Landecker	 2011;	Niewöhner	 2011);	 analogi-digital	 convertor	 (Meloni	 and	 Testa	 2014);	 local	biologies	 (Lock	 2015;	 Niewöhner	 2015)	 and	 solidarity	 (Prainsack	 and	 Buyx	2011;	Prainsack	and	Buyx	2012;	Rorty	1989).		Finally,	 scaling	down	 from	 the	general	 to	 the	 local	 level	 reflected	 itself	 also	on	the	second	initial	objective,	as	the	intended	descriptive	framework	should	have	been	 located	 at	 the	 general	 level,	 not	 at	 the	 locally	 situated	 case	 of	 Glasgow.	 I	attempted	to	correct	for	this	by	resorting	back	to	a	combination	of	quantitative	and	qualitative	methods	in	examining	values	and	concepts	that	inform	normative	discussions	 of	 societal	 implications	 of	 epigenetics.	 But	 this	 approach	 did	 not	
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yield	 results	 of	 sufficient	 quality	 to	 serve	 the	 original	 idea	 of	 the	 descriptive	political	 framework,	 which	 would	 be	 used	 to	 ‘compare,	 clarify	 and	 analyse’	competing	visions	of	health	policy.	 Instead,	 the	 thesis	opted	 to	 consider	values	and	 principles	 that	 were	 at	 play	 in	 the	 initiation	 and	 implementation	 of	 the	collaborative	approach	to	health	and	policy	action	in	Glasgow.			
A	BRIEF	OVERVIEW	OF	CHAPTERS		
Following	this	introduction	chapter,	the	thesis	is	first	concerned	with	the	review	
of	 literature	 upon	 which	 this	 project	 built.	 Chapter	 2	 thus	 first	 outlines	 the	science	 of	 epigenetics;	 it	 then	 moves	 to	 consider	 the	 societal	 implications	 of	epigenetics;	 current	 governance	 of	 research;	 public	 health	 strategies	 and	epigenetics;	 STS	 considerations	 of	 epigenetics;	 and	 finishes	 by	 outlining	public	representations	of	epigenetics.	The	review	finds	that	empirical	investigations	of	epigenetics	 in	 the	 current	 literature	 still	 occupy	 a	 much	 smaller	 corner	 than	those	of	critical	reflections	upon	epigenetics.	This	thesis	therefore	set	to	deliver	an	 empirically	 grounded	 contribution	 to	 explorations	 of	 epigenetics	 and	 its	societal	implications.	
Chapter	 3	 then	 moves	 on	 to	 describe	 research	 design	 and	 methods	 through	which	 the	data	 informing	 the	conclusions	of	 this	 thesis	was	gathered.	The	 first	section	of	this	chapter	describes	a	combined	qualitative-quantitative	srategy	that	was	developed	within	this	project	to	map	the	impact	of	epigenetics	in	health	care	and	to	track	the	number	of	publications	on	epigenetics.	The	second	section	then	focuses	 on	 methods	 used	 to	 explore	 how	 epigenetics	 is	 mobilised	 and	conceptualised	 by	 actors	 of	 diverse	 backgrounds	 in	 research	 and	 action	 upon	
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health.	 It	 describes	 how	 the	 field	 research	 in	 Glasgow	 with	 semi-structured	interviews	and	observational	studies	was	designed	and	conducted.	
Chapter	 4	 draws	 on	 empirical	 data	 gathered	 through	 combined	 qualitative-quantitative	 strategy	 developed	within	 this	 project	 to	 present	 the	most	 active	areas	of	epigenetic	research,	clinical	application	and	clinical	outputs;	and	to	track	the	 number	 of	 publications	 on	 epigenetics.	 It	 also	 presents	 data	 on	 how	‘environment’	 is	 conceptualised/addressed	 in	 epigenomic	 practice;	 and	 on	environmental	epigenetics	research	and	its	commercial	application.	The	chapter	finds	that	epigenetics	goes	‘beyond	the	genome’	insofar	as	what	lies	beyond	can	be	 converted	 into	 genome-friendly,	 code-compatible	 digital	 representations	(Meloni	and	Testa	2014).			
Chapter	5	draws	on	empirical	data	collected	through	semi-structured	interviews	and	 observational	 studies	 to	 discuss	 how	molecularisation	 of	 the	 environment	(Landecker	2011;	Niewhoener	2011)	is	employed	in	research	and	health	policy.	It	 discusses	 collaboration	 among	 actors	 of	 diverse	 backgrounds	 in	 the	 pSoBid	study;	epigenetic	data	as	‘evidence’	in	research	and	policy	action;	and	communal	identity	 and	 membership	 as	 the	 driving	 engine	 behind	 the	 pSoBid	 collective	endeavour.	 The	 chapter	 finds	 that	 it	 is	 thanks	 to	 its	 molecularization	 of	 the	environment	 and	 therefore	 its	 purported	 objectivity,	 that	 epigenetics	 is	bestowed	 the	potential	 for	actionable	public	health	knowledge	 in	 the	Glasgow-based	pSoBid	project.		Finally,	 Chapter	 6	 concludes	 this	 thesis	 by	 summarizing	 the	 findings	 and	specifying	 the	 contribution	 of	 this	 research	 to	 the	 discussions	 on	molecularisation	of	the	environment,	as	well	as	on	governance	of	research.	The	chapter	 and	 thesis	 finish	 with	 proposals	 for	 further	 research	 that	 include	
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exploring	 the	 epistemic	 and	 normative	 tensions	 and	 junstures	 that	 arise	 from	understanding	of	 the	body	as	both	universal	and	 locally	embedded	by	 focusing	on	 a	 regional	 (instead	 of	 local)	 network	 of	 researchers	 and	 institutions	 across	the	UK	and	Europe	 called	EpiStressNet;	 employing	gender	analysis	 in	 research	design	and	interdisciplinary	dialogue	in	science	and	public	debate;	and	exploring	conceptual	issues	in	epigenetic	data	collection	and	analysis	in	population	studies,	and	their	social	dimensions.			
A	STATEMENT	OF	CONTRIBUTION		
The	 four-year	 project	 (in	 further	 text,	 the	 PhD	project)	 on	which	 this	 thesis	 is	based	 was	 partially	 funded	 by	 the	 Italian	 Epigenetics	 Consortium	 (EPIGEN	Consortium).	Such	funding	arrangement	required	a	two-year	collaboration	on	a	related	but	distinct	project	(the	EPIGEN	project).	This	section	therefore	explains	the	nature	and	outputs	of	collaborations	that	took	place	throughout	this	PhD.			
• The	 aim	 and	 objectives	 of	 the	 EPIGEN	 project	 have	 been	 set	 by	 its	Principal	Investigator	(PI)	Prof.	Testa.		
• The	strategy	 for	 investigating	the	ethical,	 legal,	and	societal	 implications	of	 epigenetics	 has	 been	 jointly	 devised	 by	 myself,	 a	 senior	 FOLSATEC	colleague	Luca	Chiapperino,	and	our	PhD	supervisor	Prof.	Testa.	
• All	 the	 empirical	 studies	 –	 for	 the	 EPIGEN	 project,	 and	 the	 PhD	 project	that	 has	 been	 grounded	 in	 it	 –	 were	 deigned	 and	 conducted	 solely	 by	myself.	The	results	of	these	empirical	studies	have	been	shared	with	other	members	 of	 the	 EPIGEN	 team.	 All	 work	 on	 the	 EPIGEN	 project	 was	collectively	 presented	 in	 a	White	 paper	 “EPIGENomics	 and	 Health	 Care	
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Policy:	Challenges	and	Opportunities”.	This	White	paper	was	presented	at	the	 “EPIGEN	 International	 conference	 on	EPIGENomics	 and	Health	 Care	Policy:	Challenges	and	Opportunities”	 in	December	2014,	which	was	co-organised	 by	 myself,	 Luca	 Chiapperino,	 Prof.	 Testa,	 and	 Prof.	 Maccino	(director	of	the	EPIGEN	Consortium).	
• Due	to	my	employment	by	the	EPIGEN	consortium	to	work	on	the	EPIGEN	project,	 this	 PhD	 project	 has	 been	 framed	 as	 ‘epigenetics	 and	 policy’.	Apart	 from	 this	 initial	 framing,	 this	 thesis	 has	been	 composed	 solely	by	myself.	
• The	 empirical	 study	 on	 Glasgow	 has	 been	 selected,	 designed	 and	conducted	solely	by	myself.	Correspondingly,	the	data	collected	have	also	been	 analysed	 solely	 by	 myself.	 This	 can	 be	 verified	 with	 a	 report	submitted	 to	 the	 funding	 body	 –	 the	 COST	 Action	 IS1001	 –	 and	 its	representatives	 –	 Andrew	 Webster	 and	 Bettina	 Bock	 Weulfingen	 –	 on	November	28,	2014	–	four	weeks	after	my	return	from	Glasgow;	as	well	as	 with	 a	 ‘Third	 year	 report’	 submitted	 to	 the	 PhD	 Graduate	 office	 in	October,	 2015,	 which	 was	 approved	 by	 my	 external	 advisor	 Barbara	Prainsack..	 The	 results	 of	 this	 empirical	 study	 have	 been	 shared	 with	other	members	of	the	EPIGEN	team.		
• I	am	grateful	 to	Kathryn	Bouskill	 from	Emory	University	who	suggested	me	 to	 have	 a	 look	 at	Margaret	 Lock’s	work,	 after	 she	 heard	my	 talk	 on	“Gender	 and	 Epigenetics”	 at	 the	 Symposium	 “Body	 Discourse/Body	Politics	and	Agency”	February	6	2015	in	Vienna	(the	paper	was	produced	in	 collaboration	 with	 Anna	 Lydia	 Svalastog).	 The	 idea	 to	 explore	 the	context	 of	 Glasgow	 through	 the	 concept	 of	 ‘local	 biology’	 was	 later	
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discussed	with	Luca	Chiapperino	in	a	collegial	exchange	of	opinions.	This	exchange	resulted	in	a	paper,	co-authored	by	the	EPIGEN	team	members.	This	 co-authored	 paper	 awaits	 submission	 to	 the	 special	 issue	 on	empirical	studies	of	epigenetics	of	the	journal	Biosocieties	under	the	title	
The	 ‘Glasgow	 effect’:	 the	 political	 laboratory	 of	 localised	 biologies	 by	Damjanovicova,	 Chiapperino	 and	 Testa.	 Draft	 of	 this	 co-authored	 paper	was	 presented	 at	 the	 4S	 conference	 in	 Barcelona,	 September	 2016.	Additionally,	the	Glasgow	study	was	presented	at	the	ISHPSSB	Conference	in	 Montreal,	 July	 2015	 under	 the	 title	 From	 Ants’	 Colonies	 to	 Working	
Classes:	 Molecular	 Epigenomics	 and	 the	 Digitization	 of	 Social	 Status	 by	Prof.	Testa	
	 The	publications	that	resulted	from	this	PhD	include:	
• Damjanovicova,	M.	2016.	Incidental	findings.	In:	Boniolo	G.	-	Sanchini	V.	 (eds),	Ethical	counseling	and	medical	decision-making	in	the	era	of	
personalized	 medicine.	 A	 practice-oriented	 guide,	 Springer	International	Publishing.	
• Svalastog	 A.	 and	 Damjanovicova	 M.	 2015.	 Epigenetics,	 society	 and	bio-objects.	 Croat	 Med	 J.	 2015;	 56:166-8	 doi:	10.3325/cmj.2015.56.166		
• Damjanovicova	M.	2014.	Review	of	Boniolo,	G.	and	Maugeri,	P.	(eds.):	2014,	Etica	 alle	frontiere	 della	 biomedicina.	 Med	 Health	 Care	 and	
Philos	2014;	DOI	10.1007/s11019-014-9599-0			
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CHAPTER	TWO	–	LITERATURE	REVIEW	
	
INTRODUCTION	
This	chapter	on	literature	review	first	outlines	the	science	of	epigenetics;	it	then	moves	to	consider	the	societal	implications	of	epigenetics;	current	governance	of	research;	 public	 health	 strategies	 and	 epigenetics;	 STS	 considerations	 of	epigenetics;	and	finishes	by	outlining	public	representations	of	epigenetics.		
THE	SCIENCE	OF	EPIGENETICS	
Epigenetics	 is	an	emerging	science	 that	studies	changes	 in	gene	expression	 that	do	 not	 involve	 changes	 to	 the	 underlying	DNA	 sequence.	 The	 term	 epigenetics	was	coined	by	Conrad	Waddington	to	define	studies	of	the	complex	processes	of	how	development	of	an	organism	is	controlled	by	multiple	genes:		 »Between	genotype	 and	phenotype,	 and	 connecting	 them	 to	 each	other,	there	lies	a	whole	complex	of	developmental	processes.	It	is	convenient	to	have	a	name	for	this	complex:	‘epigenotype’»		(Waddington	1942).			David	 Nanney	 later	 defined	 ‘epigenetic	 control	 system’	 as	 what	 determines	which	subsets	of	genetic	specificities	are	 to	be	expressed	 in	a	particular	cell	 as	epigenetic	 (Nanney	 1958).	 	 Nanney’s	 concept	 of	 ‘epigenetic	 control’	 has	 been	then	 applied	 in	 explaining	 cellular	 inheritance	 (Ephrussi	 1958),	 somatic	mutations	 in	 cancer	 (Luria	 1960)	 and	 cellular	 differentiation	 (Abercrombie	
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1967).	 Epigenetics	 has	 thus	 developed	 two	 distinct	 ‘traditions’.	 The	Waddingtonian	‘tradition’	was	concerned	with	causal	processes	by	which	genetic	systems	 interact	 with	 the	 environment	 to	 bring	 about	 development	 and	phenotypic	 plasticity.	 The	 Nanneyan	 ‘tradition’	 was	 concerned	 with	distinguishing	 between	 genetic	 and	 epigenetic	 causes	 of	 changes	 in	 cellular	phenotype,	 including	the	transformation	of	somatic	cells	 into	cancer	cells	being	(Haig	 2012).	 The	 two	 ‘traditions’	 have	 brought	 about	 a	 ‘hybrid	 recombinant	offspring’	in	recent	years	(cf.	Haig	2012;	Jablonka	and	Lamm	1989).	Despite	this	‘hybridization	of	traditions’,	the	multifarious	origin	of	its	meaning	seem	to	have	brought	about	a	multitude	of	co-existing	in-use	definitions	of	epigenetics.	Some	of	these	definitions	of	epigenetics	include:	-	The	study	of	»the	mechanisms	of	temporal	and	spatial	control	of	gene	activity	during	the	development	of	complex	organisms»	(Holliday	1990,	329);	-	The	study	of	 the	relationship	between	non-sequence-specific	modifications	of	the	genome	and	gene	expression	(Riddihough	and	Zahn	2010);	-	The	study	of	«any	 long-term	change	 in	gene	 function	that	persists	even	when	the	initial	trigger	is	long	gone	that	does	not	involve	a	change	in	gene	sequence	or	structure»	(McGowan	and	Szyf	2010,	67);	-	 The	 study	 of	 any	 «phenotypic	 variation	 that	 is	 not	 attributable	 to	 genetic	variation»	(Champagne	2010,	300);	-	The	 study	of	 »how	signals	 from	 the	environment	 trigger	molecular	biological	changes	(Powledge	2011,	588).	-	The	study	of	molecular	changes	«labile	 to	environmental	 influence,	which	are	important	in	regulating	gene	transcription	and	translation,	and	that	create	a	self-
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perpetuating,	 heritable,	 and	 reversible	 set	 of	 marks	 that	 determine	 how	 the	genome	in	any	given	cell	is	expressed»	(Landecker	and	Panofsky	2013,	337);	-	 The	 study	 of	 »mitotically	 and	meiotically	 heritable	 changes	 in	 gene	 function	that	cannot	be	explained	by	changes	in	genetic	sequence»	(Allis	et	al.	2007,	16).	Most	 of	 these	 definitions	 are	 not	 subject	 of	 scientific	 debate,	 nor	 source	 of	disagreement.	 The	 common	 use	 of	 the	 word	 ‘epigenetics’	 in	 the	 current	experimental	 practice	 relates	 mostly	 to	 the	 definitions	 proposed	 by	 Holliday	(1990)	 and	 Riddihough	 and	 Zahn	 (2010),	 while	 the	 one	 of	 Landecker	 and	Panofsky	 came	 to	 be	 endorsed	 in	 the	 fields	 of	 social,	 behavioural	 and	environmental	 epigenetic	 studies.	 The	 last	 definition	 on	 the	 list,	 however,	 is	disputed	 within	 the	 field.	 The	 problematic	 aspect	 of	 this	 formulation	 of	epigenetics	 comes	 from	 its	 inclusion	 of	 ‘meiotically	 heritable	 changes	 in	 gene	expression’,	the	existence	of	which	polarises	the	field	(e.g.	see	Iqbal	et	al.	2015;	Guerrero-Bosagna	 2016;	 Iqbal	 et	 al.	 2016).	 The	 dominant	 opinion	 holds	 that	epigenetic	marks	carried	by	the	egg	and	sperm	are	erased	after	the	fertilisation	process,	 only	 to	 be	 established	 de	 novo	 in	 the	 embryo	 that	 is	 formed.	 Hence,	epigenetics	entails	only	mitotically	heritable	changes	in	gene	expression,	that	is	to	 say,	 within	 one	 generation.	 However,	 several	 studies	 demonstrated	intergenerational	 (from	parents	 to	 children)	 and	 transgenerational	 inheritance	of	 epigenetic	marks	 (from	grandparents,	 and	even	before	 in	 the	 family	 tree,	 to	grandchildren),	 which	 implies	 that	 these	 marks	 might,	 in	 fact,	 be	 meiotically	heritable	 (e.g.	Padmanabhan	et	al.	 2013;	Lambrot	et	al.	 2013;	Dias	and	Ressler	2014;	Gapp	et	al.	2014a;	2014b).		Epigenetic	mechanisms	of	gene	regulation	operate	on	different	 levels	of	nuclear	organisation	 that	 include	DNA	sequence,	histone	proteins	and	nucleosome	(the	
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basic	unit	of	DNA	packaging),	and	chromatin	(the	highest	structure	of	the	DNA-protein	 complex).	 In	 addition,	 non-coding	 RNAs	 also	 represent	 an	 epigenetic	mechanism	of	gene	regulation.	The	approximately	147	base-pair	 long	strand	of	DNA	 is	 wrapped	 around	 a	 globular	 octameric	 core	 of	 four	 types	 of	 histone	proteins	 (called	H2A,	H2B,	H3,	 and	H4;	 each	of	 them	 comes	 in	 pair)	 to	 form	a	nucleosome	–	the	basic	unit	of	DNA	packaging	(Luger	et	al.	1997).	Nucleosomes	are	 connected	 between	 each	 other	 by	 another	 histone	 protein	 (H1,	 the	 linker	histone),	 which	 results	 in	 formation	 of	 chromatin	 (Bernstein	 et	 al.	 2007).	 The	condensation	 of	 DNA	 in	 chromatin	 can	 very	 from	 loose	 –	 which	 makes	 the	underlying	 DNA	 sequence	 available	 to	 transcription	 machinery	 –	 through	intermediate	levels	of	condensations	that	result	in	differential	gene	expression	–	to	 hypercondensation,	 which	 denies	 access	 to	 the	 underlying	 sequences	 and	results	in	switching	off	of	the	underlying	genes.	Today’s	science	of	epigenetics	is	in	 large	 part	 concerned	with	 studying	modifications	 to	 which	 DNA	 or	 histone	proteins	 are	 subjected,	 and	 the	 effects	 of	 those	 modifications	 on	 nucleosome,	chromatin	structure	and,	consequently,	gene	expression	(Goldberg	et	al.	2007).	The	 most	 characterized	 covalent	 (non-transient)	 modifications	 that	 can	 affect	chromatin	 function	 include	 DNA	 methylation	 and	 post-translational	 histone	modifications	(Callinan	and	Feinberg	2006).	DNA	methylation	occurs	on	the	fifth	position	 of	 the	 base	 cytosine	 (5mc)	 which	 is	 coupled	 with	 guanine	 (as	 CpG	dinucleotides)	and	can	be	 found	 in	 islands	 (1000-base	pair	 long	DNA	stretches	that	are	rich	in	CpG	dinucleaotide	and	called	CpG	islands),	transcription	starting	sites,	 gene	 bodies,	 as	 well	 as	 in	 other	 regulatory	 sites	 like	 enhancers	 or	insulators.	 The	 discovery	 of	 5-hydroxymethylcytosine	 (5hmC)	 as	 an	intermediate	of	demethylation	of	5mC	to	cytosine	(Kriaucionis	and	Heintz,	2009;	
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Tahiliani	et	al.,	2009)	suggested	DNA	methyltion	mark	to	be	much	more	dynamic	than	 previously	 thought.	 Instead	 of	 being	 quite	 a	 stable	 epigenetic	 mark	 as	previously	 thought,	 DNA	 methylation	 seems	 to	 vary	 with	 context	 –	 the	relationship	between	DNA	methylation	and	transcription	is	more	nuanced	than	was	at	 first	realized	at	 first	and	 its	 function	thus	seems	to	vary	with	context.	A	picture	 of	 DNA	 methylation	 as	 being	 diverse	 (in	 terms	 of	 its	 location	 and	function)	 and	 dynamic	 (in	 terms	 its	 deposition	 and	 removal)	 emerged	mainly	thanks	 to	 the	 improvement	 of	 genome-scale	 mapping	 of	 methylation	 (Jones	2012;	Rivera	and	Ren	2013).	The	three	main	ways	to	assay	DNA	methylation	are	digestion	 of	 genomic	 DNA	 with	 methyl-sensitive	 restriction	 enzymes;	 affinity-based	 enrichment	 of	 methylated	 DNA	 fragments	 (an	 antibody-capture	 based	technique);	and	chemical	conversion	methods	(Bock,	2012;	Laird,	2010);	each	of	which	has	its	advantages	and	limitations	(Rivera	and	Ren	2013).		Histone	proteins	are	substrate	of	more	than	130	covalent	modifications	that	can	be	 found	 on	 their	 tails	 and	 their	 globular	 domains.	 Histone	 modifications	 are	involved	 in	 both	 activation	 and	 silencing	 of	 genomic	 regions,	 and	 can	 serve	 as	binding	 substrates	 for	 recruitment	 or	 exclusion	 of	 proteins	 and	 protein	complexes	 that	 serve	 different	 functions	 in	 different	 cell	 types	 	 (ibid.).	 Well-studied	 post-translational	 histone	 modifications	 (PTM)	 include	 acetylation,	methylation,	 phosphorylation,	 ribosylation,	 ubiquitylation	 and	 sumoylation	(Karlic	 et	 al.	 2010)	 and	 are	mostly	 found	 on	 amino	 acids	 lysine	 and	 arginine.	Many	 novel	 histone	 PTMs	 are	 being	 unveiled	 by	 mass-spectrometry-based	proteomic	 technologies	 (Tian	et	al.	2012).	The	role	of	 these	modifications	 is	 to	change	surface	charge	of	histones,	which	in	turn	changes	the	overall	strength	of	histone-histone	and	histone-DNA	interactions.	The	main	technique	for	mapping	
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the	 genome-wide	 binding	 pattern	 of	 chromatin-associated	 proteins,	 including	modified	 histones,	 is	 chromatine	 immunoprecipitation	 (ChiP-seq),	 while	mapping	 of	 chromatin	 structures	 is	 done	 by	 techniques	 that	map	 nucleosome	positioning	and	chromatin	accessibility	(Rivera	and	Ren	2013).	RNA-mediated	 mechanisms	 of	 gene	 expression	 have	 become	 regarded	 as	epigenetic	mechanisms,	although	some	researchers	have	argued	that	they	should	not	be	considered	as	being	epi-genetic	since	they	do	not	regulate	the	expression	of	the	genome,	but	rather	affect	processes	of	protein	translation	(Bernstein	and	Allis	2005).	Noncoding	RNAs	were	included	among	epigenetic	mechanisms	after	their	 role	 in	 formation	 of	 “active”	 (euchromatic)	 or	 “silent”	 (heterochromatic)	chromatin	domains	was	discovered	(Goldberg	et	al.	2007).	The	molecular	basis	of	the	crosstalk	between	RNA	and	chromatin,	however,	remains	thus	far	unclear.		
	The	last	few	years	have	been	characterised	by	an	overwhelming	development	in	sequencing-based	 technologies:	 from	 whole	 genome	 sequencing,	 exome	(messinger	RNAs)	and	transcriptome	(all	RNAs)	sequencing,	to	protein	analysis	and	 techniques	 for	 mapping	 various	 DNA	 and	 chromatin	 modification	 (e.g.	ChiPseq,	 Ox-Bs-seq,	 MethylC-seq),	 as	 well	 as	 techniques	 for	 mapping	 the	chromatin	 structure	 (e.g.	 DNase-seq,	 Hi-C).	 This	 overwhelming	 technological	development	made	it	possible	to	assay	epigenetic	modifications	at	the	level	of	a	
single	gene	or	modification,	as	well	as	to	describe	them	across	the	whole	genome	(Callinan	and	Feinberg	2006).	A	genome-wide	set	of	modifications	made	to	DNA	and	the	protein	scaffold	that	supports	it	is	called	the	‘epigenome’	and	the	science	that	 studies	 it	 ‘epigenomics’.	 The	 science	 of	 epigenomics	 thus	 represents	 a	«global,	 comprehensive	 view	 of	 sequence-independent	 processes	 [the	
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‘epigenome’]	that	modulate	gene	expression	patterns	in	a	cell»	(Rivera	and	Ren	2013,	39).	Accordingly,	 the	national	and	supranational	project	 that	aim	to	map	these	processes	 and	produce	 ‘high	 resolution’	 reference	epigenome	maps	have	been	established	in	recent	years:	the	NIH	Roadmap	Epigenomics	Project	in	2010;	EpiGeneSys,	 Blueprint	 Epigenome	 in	 2011;	 IHEC,	 EPIGEN	 and	 DEEP	 in	 2012.	These	projects	and	consortia	refer	to	the	decoding	of	the	human	genome,	and	the	subsequent	acknowledgment	that	‘genes	are	not	the	only	factors	to	regulate	the	many	different	 functions	 of	 the	 human	body’2,	 as	 causing	 a	 shift	 in	 biomedical	research	towards	the	role	that	epigenetics	has	in	this	regulation.	Results	of	one	such	consortium	–	the	NIH	Roadmap	Epigenomics	–	were	collectively	published	in	 across	 Nature	 Publishing	 Group	 journals	 in	 February	 2015	 (Roadmap	Epigenomics	Consortium	2015)			
SOCIETAL	IMPLICATIONS	OF	EPIGENETICS	
The	ethical,	legal	and	societal	implications	of	epigenetics	have	first	been	outlined	by	 Rothstein,	 Cai	 and	 Merchant	 (2009).	 In	 this	 article,	 the	 legal	 issues	 of	epigenetic	 findings	 were	 analyzed	 with	 respect	 to	 environmental	 regulation;	food	and	drug	 regulation;	 litigation	 regarding	harmful	 effects	 of	 chemicals	 and	other	 environmental	 agents;	 occupational	 safety	 and	 health	 regulation;	 and	discrimination	in	employment	and	health	insurance.	The	ethical	 implications	of	epigenetics	 were	 discussed	 in	 relation	 to	 environmental	 justice,	 privacy	 and	confidentiality,	access	to	health	care,	intergenerational	equity,	and	eugenics.	The	study	concluded	that	‘numerous	legal	and	ethical	issues	are	raised	by	epigenetic’																																																									2	Available	at	http://www.deutsches-epigenom-programm.de/epigenomics/	(Last	accessed	on	12.12.2016.)	
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(ibid.).	 In	 a	 later	 paper,	 however,	 one	of	 the	 authors	 claimed	 that	 even	 though	some	 aspects	 of	 epigenetics	 raise	 interesting	 and	 challenging	 issues	 for	 ethics	and	law,	“there	is	nothing	inherently	unique	about	the	science	of	epigenetics	that	it	demands	an	entirely	new	ethical	paradigm	and	legal	regime”	(Rothstein	2013).		Even	 without	 requiring	 an	 entirely	 new	 ethical	 and	 legal	 framework,	investigations	 of	 epigenetics	 are	 contributing	 to	 normative	 debates	 on	responsibility	 for	health	(Wiener	2010,	Hedlund	2011,	Chadwick	and	O’Connor	2013)	 and	 health	 equity	 (Loi	 et	 al	 2013;	 Stapleton	 et	 al	 2012).	 Moreover,	 its	investigations	 may	 add	 to	 normative	 debates	 about	 the	 data	 management	 in	biomedical	 research.	 Publicly	 available	 genomic	 databases	 have	 already	 been	shown	to	put	individual	privacy	at	risk	by	allowing	identifiability	of	the	sample	donor,	 and	 thus	 a	 potential	 exposure	 of	 some	 delicate	 personal	 information	contained	 in	 the	 identified	donor's	sample	 (Gymrek	et	al	2013).	The	shift	 from	single-gene	towards	the	genome-wide	approach	has	raised	issues	regarding	the	nature	 and	 scope	 of	 information	 that	 should	 be	 returned	 to	 research	participants,	as	it	makes	possible	to	detect	susceptibilities	to	certain	conditions	that	 may	 or	 may	 not	 ever	 develop	 into	 diseases	 (McEwen	 et	 al	 2013;	Damjanovicova	2016).		The	epigenome-wide	analyses	probe	samples	from	multiple	tissues	of	any	given	individual	and	are	coupled	with	genetic	sequencing	to	determine	the	underlying	genomic	 position	 of	 epigenetic	marks	 in	 question	 (Pauline	 and	 Feinberg	 2006,	Marx	 2012,	 Rivera	 and	 Ren	 2013).	 In	 this	 respect,	 the	 issues	 of	 privacy	 and	incidental	 findings	 may	 be	 further	 ignited	 because	 epigenomic	 information	constitutes	a	further	set	of	data	from	which	genomic	information	can	be	drawn.	However,	the	nature	of	epigenetic	information	may	actually	make	a	difference	in	
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degree	 of	 the	 relevance	 of	 addressing	 potential	 issues	 related	 to	 privacy	 and	incidental	findings.	Repositories	of	epigenetic	information	may	reveal	some	very	sensitive	data,	which	would	add	up	to	sensitive	genomic	ones,	like	information	of	one’s	 lifestyle	 and	 of	 health-related	 behaviours	 (Relton	 and	 Smith	 2010).	 Such	data	 enhance	 the	 richness	 of	 sole	 genomic	 information	 and	have	 therefore	 the	potential	 to	 make	 privacy	 breaches	 more	 detrimental	 (Rodenhiser	 and	 Mann	2006,	Van	Vliet	et	al.	2007).	Moreover,	 the	current	clinical	significance	of	some	epigenetic	modifications	 can	 often	 be	 uncertain	 and	 transient	 (Bernstein	 et	 al.	2010),	making	 thus	 disclosure	 of	 this	 information	 questionable	 for	 its	 analytic	and	clinical	utility.			The	possibility	to	read	the	marks	of	environmental	influences	on	one's	body	has	the	 potential	 to	 make	 visible,	 in	 a	 molecular	 language,	 links	 between	environmental	exposures	and	health	outcomes	(Godfrey	et	al	2010;	Gronniger	et	al	 2010;	 Breitling	 et	 al	 2011;	 Feil,	 and	 Fraga,	 2011;	 Joubert	 et	 al.	 2012;	McGuinness	 et	 al	 2012;	Borghol	 et	 al	 2012).	 The	nature	of	 this	 knowledge	has	important	implications	for	epidemiological	approaches	to	population	health	(Mill	and	Heijmans	 2013;	 Relton	 and	 Smith	 2010;	 Smith	 2010;	Michels	 2012),	 as	 it	may	unravel	the	biological	mechanisms	through	which	the	health	prospects	of	a	population	are	affected	by	unequal	social	arrangements	(Loi	et	al	2013;	Dupras	et	 al	 2012;	 Stapleton	 et	 al	 2012).	 It	 has	 even	 been	 argued	 that	 epigenetics	provides	 proof	 of	 principle	 of	 the	 health	 effects	 of	 socio-economic	 structures	(Bateson	et	al	2004;	Heijmans	and	Mill	2012).	In	this	respect,	the	implication	for	health	of	both	personal	choices	and	collective	decisions	over	environmental	and	social	conditions	could	be	made	visible	and	knowledgeable	by	epigenetics.	This	
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recognition	may	have	some	implications	as	to	how	responsibility	for	epigenetic	changes	should	be	allocated	(Hedlund	2012;	Chadwick	and	O’Connor	2013).		Moreover,	 molecular	 approaches	 to	 diseases	 have	 lead	 to	 revisionist	 efforts	regarding	the	classification	of	diseases	(Mirnezami	et	al	2012)	and	controversies	over	patenting	and	ownership	of	biotechnologies	(Gostin	2013;	Lenk,	Hoppe	and	Andorno	2007),	as	well	as	regarding	strategies	for	the	validation	and	approval	of	new	therapies	(Mandrekar	and	Sargent	2009;	Mahalatchimy	et	al	2012;	Faulkner	2012).	Epigenome	modifying	compounds	(i.e.	epidrugs),	as	well	as	epigenetically	modified	 cells	 (Induced	 Pluripotent	 Stem	 Cells,	 iPSCs)	 for	 drug	 discovery	contribute	 to	 debates	 on	 what	 counts	 as	 a	 disease,	 and	 how	 to	 best	 treat	 it	(Brand	2001).		In	short,	the	societal	implications	of	epigenetics	are	to	be	regarded	with	respect	to	current	debates	about	privacy	and	confidentiality;	management	of	 incidental	findings;	 as	well	 as	 to	 normative	 questions	 regarding	 individual	 and	 collective	responsibility	for	health;	and	the	governance	of	biomedical	innovation.	The	bio-objectification	 framework	 (Vermeulen,	 Tamminen	 and	 Webster,	 eds.	 2012;	Melzer	 and	 Webster	 2011;	 Gajovic	 2014)	 and	 its	 employment	 in	 discussions	about	European	policy	and	economy	with	respect	to	the	value	of	bio-objects	and	the	new	bio-economies	they	produce	(Maeseel	et	al	2013;	Svalastog	2014)	have	been	 proposed	 as	 one	 direction	 in	 which	 the	 investigation	 of	 the	 societal	implications	 of	 epigenetics	 can	 be	 furthered	 (Svalastog	 and	 Damjanovicova	2015).			
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THE	GOVERNANCE	OF	RESEARCH	
The	European	Union	research	policy	has	recently	moved	away	from	the	study	of	ethical,	 legal	 and	 social	 issues	 (ELSI)	 of	 biomedicine	 as	 merely	 a	 critical	component	 in	 the	evaluation	 of	 the	 potential	 impact	 of	 scientific	 research.	 The	cutting-edge	approaches	to	science	policy	and	scholarly	research	on	the	ELSI	of	scientific	 innovation	 have	 shifted	 towards	 more	 inclusive	 approaches	 to	 the	governance	of	 science.	This	has	 led	 to	 rethinking	–	as	 stated	 in	 the	 framework	programme	 of	 Horizon	 2020	 –	 of	 the	 traditional	 linear	 model	 of	 innovation	where	the	“societal	challenges”	of	“excellent	science”	are	treated	as	a	second	and	separated	step	of	the	innovation	pathway	(European	Commission	2013).		In	anticipating	this,	the	European	Commission	Directorate	General	for	Research	(DG-RTD)	 has	 in	 2005	 commissioned	 an	 inquiry	 on	 science	 and	 governance,	focusing	on:	1)	how	to	 respond	 to	 the	widely-recognized	problem	of	European	public	 unease	 with	 science,	 especially	 in	 relation	 to	 new	 science-based	technologies;	 2)	 how	 to	 further	 the	 stated	 EU	 commitment	 to	 improve	 the	involvement	of	diverse	elements	of	democratic	civil	society	in	European	science	and	governance;	and	3)	how	at	the	same	time	to	address	urgent	European	policy	challenges	that	are	often	taken	as	strongly	scientific	in	nature	–	including	climate	change,	sustainability,	environment	and	development.		The	 result	 of	 this	 inquiry	 was	 a	 report	 “Taking	 European	 Knowledge	 Society	Seriously”	 (European	 Commission	 2007)	 which	 traced	 the	 evolution	 of	 EU	Science	 policy	 and	 emphasized	 the	 transition	 from	 paradigm	 of	 Public	Understanding	 of	 Science	 (PUS)	 to	 Public	 Engagement	 with	 Science	 (PES).	Traditional	PUS	efforts	assumed	that	public	unease	with	science	was	largely	the	
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result	of	a	deficit	in	understanding	on	the	side	of	the	public	(deficit	model)	and	could	thus	be	solved	simply	by	enhancing	scientific	literacy.	Yet,	as	documented	in	 the	 report,	 ample	 evidence	 from	 empirical	 research,	 including	 ‘rather	unchanged	 outcomes	 of	 public	 surveys	 despite	 strong	 information/education	campaigns’,	have	prompted	the	policy	and	scientific	communities	to	question	the	validity	 of	 the	 deficit	model	 and	 endorse	 instead	 the	 paradigm	 of	 PES.	 In	 PES	publics,	 including	 research	 participants,	 stakeholders	 and	 the	 potential	consumers	 of	 new	biomedical	 technologies,	 are	not	 seen	 as	 downstream	users	who	 are	 simply	 in	 need	 of	 education,	 but	 rather	 as	 active	 citizens	 who	 can	contribute	to	the	production	of	new	knowledge	and	have	a	legitimate	interest	in	the	 modalities	 of	 its	 application.	 The	 rising	 involvement	 of	 stakeholders	 not	simply	 in	 the	 funding	 of	 biomedical	 research	 but	 also	 in	 the	 shaping	 of	 its	priorities	 and	 the	 distribution	 of	 its	 outcomes	 is	 an	 example	 of	 this	 new	relationship	 between	 science	 and	 society	 in	 which	 ‘interactions	 between	scientists	 and	 lay	 persons	 build	 trust	 and	 mutual	 learning’	 and	 ‘knowledge	created	 in	 the	 laboratories	 is	 nourished	 by	 actions	 from	 citizens	 and	 mutual	enrichment’	(European	Commission	2007).		From	the	sociology	of	scientific	knowledge	(SSK)	towards	Jasanoff’s	idiom	of	co-production,	STS	scholarship	had	been	repeatedly	signified	that	the	production	of	knowledge	 and	 technology	 is	 a	 historical	 phenomenon,	 and	 that	 conceiving	 of	alternatives	within	the	routes	of	development	of	a	given	technology	is	feasible,	as	is	acting	politically	to	change	the	course	of	its	development.	In	the	words	of	Andy	Stirling:		
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«The	form	and	orientation	taken	by	science	and	technology	are	no	longer	seen	 as	 inevitable,	 unitary,	 and	 awaiting	 discovery	 in	 Nature[;]	 instead	they	 are	 increasingly	 recognized	 to	 be	 open	 to	 individual	 creativity,	collective	 ingenuity,	 economic	 priorities,	 cultural	 values,	 institutional	interests,	 stakeholder	 negotiation,	 and	 the	 exercise	 of	 power»	 (Stirling	2008,	263).		The	 basis	 of	 technical	 decision-making	 thus	 can	 and	 should	 be	 opened	 up	‘beyond	 the	 core	 of	 certified	 experts’	 (Collins	 and	 R.	 Evans	 2002,	 237).	 ‘The	‘democratization	of	expertise’	was	referred	to	as	‘the	order	of	the	day	in	national	governments	 and	 supra-national	 bodies	 such	 as	 the	EU	 (Maasen	 and	Weingart	2005,	2).		In	 analysing	 participatory	 programme	 of	 the	 British	 science	 policy,	 Thorpe	suggested	 that	 such	 program	 ‘has	 been	 explicitly	 oriented	 toward	 producing	forms	of	social	consciousness	and	activity	seen	as	essential	to	a	viable	knowledge	economy	and	consumer	society’	(Thorpe	2010)	and	argued	that	‘STS	arguments	for	 public	 engagement	 in	 science	 have	 gained	 influence	 insofar	 as	 they	 have	intersected	with	the	Third	Way	politics	of	post-Fordism’	(Thorpe	2010;	Thorpe	and	 Gregory	 2010).	 In	 following	 STS	 critiques	 of	 the	 liberal	 assumptions	 of	science,	 Thorpe	 suggested	 that	 such	 critiques	 could	 be	 read	 from	 diverse	perspectives:	 from	 communitarian	 and	 conservative	 philosophy,	 through	Marxism	 and	 critical	 theory,	 to	 feminism	 and	multiculturalism	 (Thorpe	 2007).	Accordingly,	 preoccupation	 in	 STS	 with	 questions	 of	 public	 participation	 and	engagement	in	science	were	suggested	to	represent	‘a	turn	toward	participatory	democratic	 and	 republican	 ideals	 of	 active	 citizenship’	 (Thorpe	 2007).	 It	 has	been	 argued,	 in	 fact,	 that	 democratic	 institutions	 should	 be	 grounded	 in	 a	
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conception	 of	 scientific	 and	 political	 representation	 instead	 of	 the	 prevailing	‘liberal-rationalist’	model	(Brown	2009).	In	tracing	the	linkages	between	STS	and	political	thought,	Thorpe	argued	for	a	conception	of	STS	as	political	theory:			 »	STS	as	political	theory	offers	a	set	of	intellectual	resources	and	models	on	the	basis	of	which	competing	normative	political	visions	of	science	and	technology	 can	 be	 clarified,	 analyzed,	 and	 criticized»	 (Thorpe	 2007,	 64;	original	emphasis)		How	 such	 a	 conception	 could	 be	 put	 to	 work,	 however,	 remained	 opened	 to	further	 exploration.	 Within	 political	 philosophy,	 Richard	 Rorty	 articulated	 the	pragmatist	 position	 of	 John	 Dewey	 into	 what	 he	 called	 a	 ‘postmodern	pragmatism’	whereby	there	are	practical	measures	to	be	taken	to	accomplish	a	practical	 goal	 of	 bringing	 together	 concepts	 that	 are	 incommensurable	 at	 the	level	 of	 theory	 (Rorty,	 1983;	 1989).	 In	 the	 article	 Postmodernist	 Bourgeois	
Liberalism,	Rorty	suggested	that	we	should	give	up	an	account	of	rationality	and	morality	 as	 transcultural	 and	 ahistorical,	 while	 preserving	 our	 institutions	(Rorty	1983).	As	there	are	no	ahistorical	underpinnings	to	these	institutions,	we	can	modify	 them	 to	make	 them	 suit	 better	 this	 particular	 time	 in	 history.	 The	most	suitable	concept	upon	which	these	institutions	would	then	rest	is	suggested	to	be	solidarity	(ibid;	Rorty	1989).		Solidarity	 has	 recently	 gained	 attention	 in	 writings	 on	 the	 governance	 of	biomedicine.	The	Nuffield	 council	 on	Bioethics	 commissioned	an	 inquiry	 about	solidarity	as	an	emerging	concept	in	bioethics.	The	report	“Solidarity:	reflections	on	 an	 emerging	 concept	 in	 bioethics”	 (Prainsack	 and	 Buyx	 2011)	 traced	 the	
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concept	 of	 solidarity	 from	 traditional	 approaches,	 like	 Roman	 Law,	 Christian	wirings,	 or	 Marxist	 theories;	 to	 the	 more	 recent	 approaches	 of	communitarianism,	 feminism,	 or	 contractarianism;	 and	 finally	 to	 recent	bioethical	literature.	The	authors	offered	a	new	approach	to	solidarity	whereby	solidarity	signifies	shared	practices	that	reflect	a	collective	commitment	to	carry	‘costs’	 (financial,	 social,	 emotional	 or	 otherwise)	 to	 assist	 others.	 Being	understood	 as	 ‘a	 practice’,	 solidarity	 therefore	 requires	 action	 (ibid.).	Furthermore,	 solidarity	 is	 enacted	 at	 three-levels:	 personal,	 communal	 and	contractual/legal	(Prainsack	and	Buyx	2012).	Accordingly,	crises	of	solidarity	are	explained	 as	 occurring	when	 inter-personal	 and	 communal	 levels	 of	 solidarity	practices	have	‘broken	away’	while	formal	solidaristic	arrangements	continue	to	exist,	as	exemplified	with	welfare	state	arrangements	(ibid.).	In	recent	literature,	solidarity	has	been	discussed,	for	example,	as	an	approach	to	the	governance	of	biobanks	(Prainsack	and	Buyx	2013)	and	in	relation	to	lifestyle-related	diseases	and	individual	responsibility	(Buyx	and	Prainsack	2012).			
PUBLIC	HEALTH	STRATEGIES	AND	EPIGENETICS	
One	of	the	three	core	objectives	set	out	by	the	first	European	Health	Strategy	was	to	 ‘Foster	 good	 Health	 in	 an	 Aging	 Europe’	 through	 Solidarity	 (EC	 2007).	 In	pursuing	 this	 objective,	 the	 Strategy	 advocated	 for	 prevention	 of	 health	problems	and	disabilities	from	an	early	age	through	health	promotion	activities;	and	 for	 tackling	 inequities	 in	 health	 linked	 to	 social,	 economic	 and	environmental	 factors.	 The	 core	 principle	 on	 which	 such	 strategy	 is	 to	 be	grounded	 is	 ‘Health	 in	All	Policies’	 (HIAP).	HiAP	was	 initially	used	to	designate	
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the	main	 health	 theme	 of	 the	 Finnish	 Presidency	 in	 the	 European	 Union	 (EU)		(Ståhl,	 Wismar,	 Ollila,	 Lehtinen	 and	 Leppo,	 eds.	 2006),	 and	 has	 since	 been	endorsed	by	many	public	health	initiatives,	both	global	and	local,	as	an	approach	to,	a	strategy	of,	as	well	as	a	principle	in	health	policy-making.	The	principle	puts	emphasis	 on	 the	 necessity	 for	 collaboration	 across	 different	 sectors	 that	influence	health,	 especially	 since	greater	 socioeconomic	 inequality	 in	 society	 is	associated	 with	 poorer	 average	 health3	(cf.	 Ståhl,	Wismar,	 Ollila,	 Lehtinen	 and	Leppo,	eds.	2006).	The	recently	established	European	Partnership	for	improving	health,	 equity	 and	wellbeing	 –	 the	 EuroHealthNet4	endorsed	HiAP	 as	 its	 policy	strategy5	and	set	up	a	European	portal	for	Action	on	Health	Inequalities6	within	the	Equity	Action	Project7.	A	global	recognition	of	the	HiAP	approach	came	with	the	World	Health	Organisation’s	 “Adelaide	 Statement	 on	Health	 in	All	 Policies:	moving	towards	a	shared	governance	for	health	and	well-being”	(WHO	2010).		Because	 of	 its	 emphasis	 on	 the	 relationship	 between	 the	 social	 and	 health	gradient,	 the	 WHO	 Regional	 Office	 for	 Europe	 (WHO/Europe)	 introduces	 the	HiAP	 principle	 and	 its	 Report	 in	 its	 ‘social	 determinants	 of	 health	 section’8.	There,	poverty	 is	 indicated	as	a	key	 factor	 in	explaining	poorer	 levels	of	health	between	the	most	and	least	well-off	countries	and	population	groups	within	the	
																																																								3	The	papers	cited	include:	Marmot	M,	Wilkinson	R.	Psychosocial	and	material	pathways	in	the	relation	between	income	and	health:	a	response	to	Lynch	et	al.	British	Medical	Journal,	2001,322:1233–1236;	Wilkinson	R,	Pickett	K.	Income	inequality	and	population	health:	a	review	and	explanation	of	evidence.	Social	Science	and	Medicine,	2006,	62:1768–1784;	and	Wilkinson	R.	Unhealthy	societies:	the	affliction	of	inequality.	London,	Routledge,	1996.	4	Available	at:	http://eurohealthnet.eu	(Last	accessed	12.12.2016.)	5	Available	at:	http://www.health-inequalities.eu/HEALTHEQUITY/EN/policies/health_in_all_policies/	(Last	accessed	12.12.2016.)	6	Available	at:	http://www.health-inequalities.eu/HEALTHEQUITY/EN/home/	(Last	accessed	12.12.2016.)	7	Available	at:	http://www.equityaction-project.eu	(Last	accessed	12.12.2016.)	8	Available	at:	http://www.euro.who.int/en/health-topics/health-determinants/social-determinants/publications/pre-2007/health-in-all-policies-prospects-and-potentials	(Last	accessed	12.12.2016.)	
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same	country.	Accordingly,	the	uneven	distribution	of	social	determinants	leads	to	unfair	and	avoidable	differences	in	health	status	across	groups	in	society,	i.e.	to	social	inequities	in	health	9.	 ‘Inequalities	in	health’	on	the	other	hand,	had	its	formal	recognition	as	early	as	in	1978	with	the	Declaration	of	Alma	Ata:		 «The	 existing	 gross	 inequality	 in	 the	 health	 status	 of	 the	 people	particularly	 between	 developed	 and	 developing	 countries	 as	 well	 as	within	countries	is	politically,	socially	and	economically	unacceptable	and	is,	therefore,	of	common	concern	to	all	countries»	(WHO	1978)		Highlighting	inequalities	in	health	paved	the	way	for	the	endorsement	of	‘health	for	 all’	 principle	 of	 in	 the	 WHO	 Ottawa	 Charter	 for	 Health	 Promotion	 (WHO	1986).	Accordingly,	the	WHO	established	a	Commission	on	Social	Determinants	of	Health	in	2005,	to	support	national	and	global	efforts	in	addressing	the	social	factors	 leading	 to	 ill	 health	 and	 health	 inequities	 and	 creating	 better	 social	conditions	 for	 health,	 particularly	 among	 the	 most	 vulnerable	 people.10	A	 few	years	later,	the	commission	delivered	a	report	“Closing	the	gap	in	a	generation:	Health	equity	through	action	on	the	social	determinants	of	health”	(WHO	2008).	In	 this	 report,	 the	 city	 of	 Glasgow	 was	 highlighted	 as	 a	 region	 with	 both	 the	healthiest	and	the	least	healthy	population	–	its	affluent	citizens	were	at	the	top	of	the	health	list,	while	the	socially	deprived	residents	were	at	the	bottom	of	this	list,	much	behind	 all	 other	 regions	 including	 India	 and	 the	black	population	 in	
																																																								9	Available	at:	http://www.euro.who.int/en/health-topics/health-determinants/social-determinants/social-determinants	(Last	accessed	12.12.2016.)	10	Available	at:	http://www.who.int/social_determinants/thecommission/en/	(Last	accessed	12.12.2016.)	
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Washington	 DC.	 In	 the	 words	 of	 Sir	 Michael	 Marmot,	 chair	 of	 the	 WHO	Commission	on	Social	factors	that	determine	health:		 	«A	boy	 in	 the	deprived	area	of	Calton	had	an	average	 life	expectancy	of	54	years	compared	with	a	boy	 from	affluent	Lenzie,	12	km	away	 in	East	Dunbartonshire,	who	could	expect	to	live	to	82»	(WHO	2011).			Such	 epidemiologically	 severe	 urban	 profile	 of	 the	 city	 of	 Glasgow	 is	 not	 fully	explained	 by	 conventional	 risk	 factors	 for	 disease	 as	 other	 equally	 deprived,	former	 industrial	 cities	 of	 the	 UK	 (such	 as	 Liverpool,	 Manchester	 and	Birmingham),	 which	 have	 faced	 similar	 effects	 of	 de-industrialization	 like	Glasgow,	have	higher	average	life	expectancies.	These	figures	“earned”	the	city	of	Glasgow	the	reputation	of	‘the	sick	man	of	Europe’,	and	led	to	the	naming	of	this	phenomenon:	the	Glasgow	effect	(ibid.).		The	Report	of	the	WHO	Commission	on	Social	Determinants	of	Health,	however,	concluded	that	it	is	possible	to	achieve	health	equity	within	one	generation;	that	it	is	the	right	thing	to	do;	and	that	now	is	the	right	time	to	do	it.	Accordingly,	the	Commission	called	for	the	WHO	and	all	governments	to	lead	the	global	action	on	social	 determinants	 of	 health	 for	 achieving	 health	 equity.	 These	 calls	 of	 the	Commission	have	recently	been	formalised	into	a	Political	Declaration	on	Social	Determinants	of	Health	while	the	WHO	Secretariat	also	devised	a	Global	Plan	of	Action	on	Social	Determinants	of	Health	by11:			
																																																								11	Available	at:	http://www.who.int/social_determinants/action_sdh/en/	(Last	accessed	12.12.2016.)	
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«The	 declaration	 expresses	 global	 political	 commitment	 for	 the	implementation	 of	 a	 social	 determinants	 of	 health	 approach	 to	 reduce	health	inequities	and	to	achieve	other	global	priorities»12	(WHO	2011)		Two	recent	publications	by	the	WHO	Regional	Office	for	Europe	(WHO/Europe)	resonate	with	these	future	commitments:	the	report	on	social	determinants	and	the	health	divide	in	the	European	Region	(WHO	2013a)	and	the	follow-up	of	the	first	 EU	 health	 strategy	 –	 the	 Health	 2020	 EU	 strategy	 for	 the	 twenty-first	century	 (WHO	2013b).	Both	of	 these	documents	 refer	 to	 the	 ‘ample	amount	of	evidence’	 collected	on	 social	determinants	of	health	 to	 recommend	policies	 for	reducing	health	inequalities.	Director	of	the	WHO/Europe,	in	fact,	portrayed	the	Review	 as	 a	 ‘wake-up’	 call	 to	 action	 among	 political	 and	 professional	 leaders	(WHO	2013a,	p.	v).	The	EU	Health	2020	strategy,	on	 the	other	hand,	 adds	 that	improving	 health	 for	 all	 and	 reducing	 health	 inequalities	 will	 be	 achieved	‘through	 improved	 leadership	 and	 governance	 for	 health’	 	 (WHO	 2013b).	Likewise,	 as	 a	 reaction	 to	 the	 grim	 health	 figures	 reported	 in	 their	 city	 of	Glasgow,	 the	 National	 Health	 Service	 Greater	 Glasgow	 and	 Clyde,	 the	 Glasgow	City	 Council	 and	 the	 University	 of	 Glasgow,	 with	 the	 support	 from	 Scottish	Government,	established	the	Glasgow	Centre	 for	Population	Health	(GCPH)13	to	conduct	 research	 and	 propose	 policy	 actions	 to	 tackle	 health	 inequalities	 in	Glasgow.		The	(inverse)	association	between	socio-economic	circumstances	and	mortality	from	a	wide	range	of	diseases	was	first	reported	by	the	1967	Whitehall	study	of	
																																																								12	Available	at:	http://www.who.int/sdhconference/declaration/en/	(Last	accessed	12.12.2016.)	
13 Available	at: http://www.gcph.co.uk (Last accessed: 12.12.2016.). 
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the	British	civil	servants.	Twenty	years	later,	another	cohort	of	civil	servants,	the	Whitehall	II	study,	was	assembled	in	order	to	investigate	the	causes	of	the	social	gradient	in	morbidity	(Marmot	et	al.	1991).	The	data	from	the	Whitehall	studies	represent	 first	 pieces	 of	 empirical	 evidence	 on	 the	 existence	 of	 health	inequalities	 and	 socioeconomic	 gradient	 in	 noncommunicable	 diseases.	 These	studies	paved	the	way	for	the	establishment	of	social	epidemiology	–	a	discipline	that	 systematically	 investigates	 the	 social	 determinants	 of	 health	 and	 disease	(Chauvel	 and	 Leist	 2015).	 Social	 epidemiology	 has	 recently	 started	 to	 include	collection	 of	 the	 data	 also	 on	 epigenetic	 level.	 The	 life-course	 approach	 in	population	studies	projects	has	particularly	endorsed	this	trend,	as	exemplified	by	 the	 LIFEPATH	 project	 (Lifepath:	 healthy	 aging	 for	 all,	 funded	 from	 the	European	Union’s	Horizon	2020	Research	 and	 Innovation	Programme)	 –	 a	 life	course	 population	 study	 that	 aims	 to	 investigate	 the	 biological	 pathways	 that	underlie	social	differences	in	healthy	ageing14.		The	 challenges	 and	 opportunities	 of	 the	 synergy	 between	 epigenetics	 and	epidemiology	 have	 first	 been	 highlighted	 by	 Karin	 Michels	 in	 Epigenetic	
Epidemiology	 (Michels,	 ed.	 2012)	 –	 a	 book	 welcomed	 as	 ‘a	 primer	 in	epidemiology	for	epigeneticists	and	an	epigenetics	reference	for	epidemiologists’	(Potter	and	Relton	2012).	The	 International	 Journal	of	Epidemiology	dedicated	an	entire	issue	to	epigenetics	in	January	2012.	Besides	epigenetic	epidemiology	papers,	 the	 special	 issue	 of	 the	 International	 Journal	 of	 Epidemiology	 included	reviews	 of	 epigenetics-related	 books	 and	 commentaries	 and	 opinions	 such	 as	
Epigenetics:	 the	 next	 big	 thing	 (Ebrahim	 2012);	 Is	 epidemiology	 ready	 for	
epigenetics?	 (Relton	 and	 Smith	 2012);	 and	 Commentary:	 The	 seven	 plagues	 of																																																									14	Available	at:	http://www.lifepathproject.eu	(Last	accessed	12.12.2016.)	
	 48	
epigenetic	epidemiology	(Mill	and	Heijmans	2012),	or	Epigenetics	for	the	masses:	
more	 than	 Audrey	 Hepburn	 and	 yellow	mice?	 (Davey	 Smith	 2012).	 Considered	together,	 these	 publications	 indicated	 that	 while	 many	 researchers	 embrace	epigenetics	 in	 epidemiology,	 others	 are	 highly	 skeptical	 of	 its	 significance	 and	utility.	Despite	such	opposing	perspectives,	this	type	of	research	is	experiencing	a	rapid	growth.	 	Some	popular	studies	 include	associations	between	epigenetic	markers	 and	 factors	 like	 socio-economic	 status	 (McGuinness	 et	 al	 2012),	smoking	 (Shenker	 et	 al	 2013),	 air	 pollution	 (Baccarelli	 et	 al	 2009),	 nutrition	(Heijmans	 et	 al	 2008),	 etc.	 reported	 in	 cohort	 studies	 like	 the	 Dutch	 Hunger	Winter	 Families	 Study	 (Lumey	 et	 al	 2007),	 the	 European	 Prospective	Investigation	 into	 Cancer	 and	 Nutrition	 (EPIC;	 Riboli	 et	 al	 2002),	 the	 Avon	Longitudinal	Study	of	Parents	and	Children	(ALSPAC;	Boyd	et	al.	2013;	Fraser	et	al.	 2013),	 or	 the	 psychological,	 biological	 and	 social	 determinants	 of	 ill	 health	(pSoBid;	Vellupilai	et	al	2008).		The	 pSoBid	 cohort	was	 initiated	 by	 the	GCPH	 as	 a	 cross-sectional,	 population-bases	study	which	sought	to	examine	population	groups	in	Glasgow	that	differed	in	 socioeconomic	 status	 and	 in	 their	 propensity	 to	 develop	 chronic	 disease	(Vellupilai	et	al.	2008).	The	pSoBid	cohort	 thus	recruited	participants	 from	the	most	 deprived	 and	 the	 most	 affluent	 Glaswegian	 communities.	 Results	 of	 the	pSoBid	study,	were	collectively	presented	in	a	document	Psychological,	social	and	
biological	 determinants	 of	 ill	 health	 (pSoBid)	 in	 Glasgow:	 a	 cross-sectional,	
population-based	study:	Final	study	report	which	its	proponents	have	thought	as	a	guide	for	Glasgow's	public	health	policies	in	the	upcoming	years	(GCPH	2013).	These	include	results	of	the	studies	on	telomere	attrition	rate	(Shiels	et	al	2011),	levels	 of	 25-Hydroxyvitamin	 D	 (Knox	 et	 al	 2012),	 N-acetyl	 aspartate	
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concentrations	 (McLean	 et	 al	 2012),	 the	 cerebellar	 grey	 matter	 volume	(Cavanagh	et	al	2013),	etc.	as	well	as	DNA	methylation	levels	(McGuinness	et	al	2012).	 The	 pSoBid	 study	 Final	 Report	 therefore	 represents	 the	 first	 document	published	by	a	health	organisation	that	refers	to	epigenetic	data.		On	 the	 other	 hand,	 factors	 such	 as	 unhealthy	 diet,	 physical	 inactivity,	 tobacco	use,	 the	 harmful	 use	 of	 alcohol,	 as	 well	 as	 ageing	 and	 rapid	 unplanned	urbanization,	 are	 all	 listed	 as	 the	 factors	 that	 drive	 the	 development	 of	noncommunicable	 diseases	 (WHO	 2015	 –	 Fact	 sheets).	 Noncommunicable	diseases	 are	 reported	 as	 the	 leading	 causes	 of	 death	 both	 in	 developed	 and	developing	 countries,	 representing	 thus	 the	major	 burden	 in	 terms	 of	 disease	contribution	 (WHO	 2012).	 Since	 2005	 and	 after	 initial	 ten	 years	 of	 data	collection,	 the	 WHO	 started	 with	 annual	 publication	 of	 the	 World	 Health	Statistics.	Its	‘health	forecast’	for	the	next	twenty-five	years	predicted	a	dramatic	shift	 in	 the	 distribution	 of	 deaths	 from	 younger	 to	 older	 ages	 and	 from	communicable	 to	 noncommunicable	 diseases	 (WHO	 2006).	 Noncommunicable	diseases	were	thus	highlighted	as	‘a	major	health	challenge	of	the	21st	century’,	with	 cardiovascular	 diseases	 and	 cancer	 representing	 48%	 and	 21%	 of	 those	deaths,	respectively	(WHO	2012).		Accordingly,	the	management	of	noncommunicable	diseases	(NDCs)	is	set	as	the	global	public	health	objective	–	 the	WHO	Global	Action	Plan	 for	 the	Prevention	and	 Control	 of	 NCDs	 2013-2020	 (resolution	WHA66.10)15	was	 adopted	 at	 the	66th	World	Health	Assembly.	Moreover,	 this	Global	Action	Plan	on	NCDs	came	after	 the	 United	 Nation	 (UN)	 Political	 Declaration	 on	 NCDs	 (resolution	
																																																								15	Available	at	http://www.who.int/nmh/events/ncd_action_plan/en/	(Last	accessed	12.12.2016.)	
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A/RES/66/2)16,	adopted	at	 the	UN	High-level	Meeting	on	NCDs.	The	only	other	health	 issue,	 on	 which	 the	 UN	 General	 Assembly	 previously	 met,	 is	 acquired	immune	 deficiency	 syndrome,	 AIDS).	 The	 strategy	 endorsed	 in	 addressing	 the	problem	of	noncommunicable	diseases	is,	accordingly,	the	HiAP	strategy:			 «To	 lessen	 the	 impact	 of	 NCDs	 on	 individuals	 and	 society,	 a	comprehensive	 approach	 is	 needed	 that	 requires	 all	 sectors,	 including	health,	 finance,	 foreign	 affairs,	 education,	 agriculture,	 planning	 and	others,	to	work	together	to	reduce	the	risks	associated	with	NCDs,	as	well	as	promote	the	interventions	to	prevent	and	control	them»	(WHO	2013).			
STS	CONSIDERATIONS	OF	EPIGENETICS	
The	 STS	 engagements	 with	 epigenetics	 focus	 mostly	 on	 the	 subfield	 of	epigenetics	called	environmental	epigenetics,	and	its	sociological	(Landecker	and	Panofsky	2013),	anthropological	(Niewöhner	2011)	and	biopolitical	implications	(Mansfield	2012;	Niewoener	2015).	In	biomedical	practice,	however,	a	variety	of	research	approaches	are	gaining	currency	under	the	lemma	of	‘epigenetics’.	The	lack	 of	 an	 agreed	 precise	 definition	 of	 epigenetics	 was,	 on	 the	 one	 hand,	suggested	as	enabling	scientists	from	different	disciplines	to	feel	they	are	at	the	cutting	 edge	 of	 science	 as	 their	 work	 is	 ‘epigenetic’	 (cf.	 Ebrahim	 2012).	 The	interviews	with	the	cutting	edge	epigeneticists	conducted	by	Martyn	Pickersgill	(2016)	confirm	such	attitudes	among	the	scientists,	as	epigenetics	is	considered	a	sexy	term	that	tends	to	get	people	excited	(Pickersgill	2016).	Along	the	similar																																																									16	Available	at	http://www.who.int/nmh/events/un_ncd_summit2011/en/	(Last	accessed	12.12.2016.)	
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line	 of	 reasoning,	 Meloni	 and	 Testa	 argued	 that	 the	 scientific	 success	 story	 of	epigenetics	 lies	 precisely	 in	 ‘the	 ambiguity	 of	 its	 very	 definition’	 (Meloni	 and	Testa	2014),	while	Niewöhner	evoked	 that	 the	 concept	of	 gene,	 too,	defied	 the	attempts	 of	 an	 ell-encompassing	 definition	 and	 ‘proved	 productive	 as	 an	epistemic	 object	 of	 exquisite	 versatility	 capturing	 structural,	 functional	 and	agential	 aspects	 of	 heredity,	 evolution	 and	 self-organization’	 (cf.	 Niewöhner	2011).			Environmental	 epigenetics	 research	 addresses	 the	 questions	 of	 ‘how	 signals	from	 the	 environment	 trigger	 molecular	 biological	 changes	 (Powledge	 2011,	588).	The	environment,	especially	at	early	stages	of	life	is	considered	as	having	a	‘long-lasting	 impact	 on	 mental	 and	 physical	 health	 trajectories	 via	 epigenetic	marking	 of	 specific	 genes’	 (McGowan	 and	 Szyf	 2010,	 71).	 Environmental	epigenetics	is	thus	part	of	a	wider	movement	in	the	life	sciences	to	incorporate	‘matters	social’	into	experimental,	functional	and	mechanistic	enquiry.	Focusing	on	a	particular	and	a	rather	small	corner	of	biomedical	endeavour	 is	argued	to	offer	 a	 grasp	 on	 ‘broader	 scientific	 and	 social	 transformations	 that	 might	otherwise	be	hard	to	fathom	or	narrate’	(Landecker	2011).		Drawing	on	ethnographic	analysis	of	 research	practices	of	a	particular	 lab	 that	studies	 the	 effects	 of	 context	 on	 gene	 expression,	 Niewoeher	 argued	 that	 this	style	 of	 doing	 epigenetic	 biology	 contributes	 to	 ‘molecularisation	 of	 biography	and	 milieu’;	 and	 suggested	 that	 such	 research	 practices	 produce	 a	 different	concept	 of	 the	 body:	 the	 embedded	 body	 (Niewöhner	 2011).	 Niewöhner’s	ethnography	was	 centred	 in	Moshe	 Szyf’s	 epigenetics	 laboratory	 at	 the	McGill	University,	Montreal	Canada,	which	spearheaded	the	environmental	epigenetics	
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(Weaver	et	al	2004).	Niewöhner	notes	that	although	the	practices,	technologies	and	 knowledge	 about	 cellular	 and	 molecular	 process	 in	 environmental	epigenetics	build	on	 the	dominant	epigenetic	genealogy,	 the	 theoretical	agenda	and	 experimental	 designs	 borrow	 from	 a	 much	 wider	 range	 of	 research	(Niewöhner	 2011).	 The	 environmental	 epigenetics	 is	 thus	 understood	 as	bringing	different	 levels	of	 context	 into	experimental	designs	of	molecular	 and	cellular	biology.	Contrary	to	the	statistical	significance	sought	in	cancer	research,	the	 significance	 of	 findings	 in	 environmental	 epigenetics	 involves	 considering	‘wider	biology	of	the	case	in	hand,	as	well	as	import	of	popular	social	theory	to	make	 plausible	 why	 certain	 instances	 of	 social	 change	 may	 lead	 to	 certain	somatic	 changes’	 (Niewöhner	 2011).	 The	 body	 that	 is	 being	 produced	 by	environmental	epigenetics	 is	 thus	“heavily	 impregnated	by	 its	own	past	and	by	the	social	and	material	environment	within	which	 it	dwells”	 (Niewöhner	2011,	11).	Such	understanding	of	socio-material	environments	and	people’s	life-spans	Niewöhner	 referred	 to	 as	 ‘molecularisation	 of	 biography	 and	 milieu’	 –	 an	extension	 of	 ‘molecularisation	 of	 the	 environment’	 thesis	 proposed	 by	Hannah	Landecker	(2011).		Focusing	on	the	experimental	formalisation	of	food,	Landecker	argued	that	such	practices	generate	concepts	of	 food	as	 ‘a	 form	of	molecular	exposure’	(ibid.).	 In	the	 ‘input-output’	 model	 of	 manipulation	 that	 dominates	 animal	 studies,	epigenetics	puts	the	focus	on	molecular	events	that	occur	between	them.	In	such	a	model,	food	enters	the	body	and	never	leaves	it	as	‘it	transforms	the	organism’s	being	as	much	as	the	organism	transforms	it’	(ibid.	177).	Nutritional	epigenetics	thus	proposes	a	specific	molecular	route	of	how	things	 from	the	outside	of	 the	body	 are	 transformed	 into	 the	 biology	 of	 the	 body.	 The	 experimental	
	 53	
formalisation	 of	 food	 in	 nutritional	 epigenetics,	 according	 to	 Landecker,	 thus	generates	 concepts	 of	 food	 as	 a	 form	 of	molecular	 exposure	 and	 constitutes	 a	molecular	 politics	 of	 eating	 (ibid.).	 The	 implication	 of	 ‘molecularisation	 of	 the	environment’	should	here	be	understood	as	a	rearrangement	of	interrelation	not	a	collapse	of	the	inside	and	the	outside.	The	divide	between	internal	(nature)	and	external	(nurture)	has	shaped	the	debate	in	health,	education,	and	social	policy	in	 the	 last	 century,	 and	 corresponds	 to	 a	 significant	 political	 fracture	 between	social	 conservatism	 and	 progressivism.	 	 In	 comparison	 with	 science	 wars	 on	sociobiology	and	the	excesses	of	genetic	determinism,	epigenetics	looks,	at	least	prima	 facie,	 a	more	 promising	 and	 productive	 terrain	 of	 cooperation	 between	biological	research	and	sociology	(Landecker	and	Panofsky	2013).		Accordingly,	there	is	an	ongoing	interest	in	employing	epigenetic	bio-dosimeters	(ibid;	 McGuinness	 2012)	 for	 measurement	 in	 the	 social	 sciences	 and	 social	epidemiology,	and	merging	social	sciences	with	epigenetics	driven	epidemiology	and	 biomedicine	 (Niewoehener	 2011;	 Meloni	 2015).	 The	 measurement	 of	 the	entire	 set	 of	 exposures	 –	 from	 environmental	 pollutants	 to	 work-related	exposures,	 and	 lifestyles	 –	 to	which	 individuals	 are	 subjected	 from	 conception	onwards,	throughout	their	lifespan,	is	in	epigenetic	epidemiology	referred	to	as	‘exposome’	 (Wild	 2005,	 2012;	 Vrijheid	 2014).	 On	 the	 other	 hand,	 it	 has	 been	argued	 that	 epigenetics	 promises	 to	 reduce	 the	 ‘analogical	 vastness	 of	 the	environmental	 signals’	 into	 ‘genome-friendly,	 code-compatible	 digital	representations’	(Meloni	and	Testa	2014).	In	the	words	of	Maurizio	Meloni	and	Giuseppe	Testa:			
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»Epigenomic	 profiles,	 in	 their	 expanding	 variety,	 provide	 a	 new	 place	holders	 to	 anchor	 the	 environment	 to	 the	 genome	 and	 enable	 the	attending	 analogic-digital	 translations,	 conceptually	 as	 much	 as	experimentally»	(Meloni	and	Testa	2014,	p.	6)		The	 evidentiary	 weight	 of	 molecular	 data	 has	 previously	 been	 shown	 with	regards	 to	 exceptional	 status	 of	 DNA	 evidence	 in	 the	 present	 day	 courtroom	(Lynch	2013)	and	the	greater	truth-governing	power	of	genomic	articulations	of	ancestry	 (Tall	 Bear	 2013;	 Kent	 2013).	 For	 example,	 in	 the	 course	 of	 the	Innocence	 Project,	 original	 verdicts	 of	 over	 250	 prisoners	 in	 the	 U.S.	 were	overturned	through	DNA	testing	or	retesting	from	the	bodily	evidence	collected	during	the	original	investigation	(Lynch	2013).	Similarly,	states	tend	to	privilege	genome	knowledge	claims	over,	for	example,	the	indigenous	peoples	knowledge	claims	when	these	are	in	conflict	(Tall	Bear	2013).	Moreover,	in	some	cases,	the	indigenous	people	were	forced	or	have	chosen	to	interact	with	genomic	science	for	 filing	 their	 claims,	 such	 as	 the	 case	with	 DNA	 testing	 for	 tribal	 enrollment	(Tall	Bear	2013)	or	in	disputed	territory	claims	(Kent	2013).	Critical	reflections	on	epigenetics	and	race	and	ethnicity	have	also	been	offered	(Kuzawa	and	Sweet	2008;	Meloni	2015;	Mansfield	2012;	Mansfield	and	Guthman	2015).		Molecularisation	 of	 the	 environment	 is	 part	 of	 a	 broader	 ‘molecularisation	 of	biology’	thesis	(Rose	2001)	and	further	extension	of	a	‘molecular	gaze’	of	the	life	sciences	 at	 different	 biological	 traits	 (Nowotny	 and	 Testa	 2011).	 	 While	 the	clinical	body	of	the	nineteenth	century	was	located	within	a	social	body	made	up	of	extra-corporeal	systems,	the	twentieth	century	genetic	body	is	conceived	on	a	different	scale,	as	biology	of	 the	1930s	came	to	consider	 life	phenomena	at	 the	
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submicroscopic	 region	 (Rose	 2001	 p.	 13).	 Molecularisation	 is	 therefore	understood	as	an	 irreversible	epistemological	and	a	significant	 technical	event.		In	the	words	of	Nikolas	Rose:		 »This	molecularisation	 was	 not	merely	 a	matter	 of	 the	 use	 of	 artefacts	fabricated	at	the	molecular	level.	It	was	a	reorganisation	of	the	gaze	of	the	life	 sciences,	 their	 institutions,	 procedures,	 instruments,	 spaces	 of	operation	and	forms	of	capitalisation»	(Rose	2001,	p.	13).			As	such	transformations	took	place	in	the	life	sciences,	biopolitics,	according	to	Rose,	 has	 become	 ‘molecular	 politics’	 (ibid).	 The	 advent	 of	 genetics	 and	molecular	 understanding	of	 life	were	 argued	 to	have	 caused	 a	mutation	 in	 the	way	 contemporary	 biopolitics	 operates.	 The	 target	 of	 biopolitics	 is	 no	 longer	populations	 and	 their	 ‘gross	 characteristics’	 such	 as	 race,	 but	 increasingly	 the	individuals.	 Accordingly,	 interventions	 upon	 health	 do	 not	 take	 the	 form	 of	‘normalisation’	anymore,	but	instead	take	the	form	of	‘optimisation’	of	one’s	own	corporeality	 and	 psychology	 (Rose	 and	 Rabinow	 2006).	 Epigenetics	 and	molecular	 understanding	 of	 the	 environment	 was,	 instead,	 used	 to	 argue	 that	contemporary	 biopolitics	 still	 targets	 the	 management	 of	 population,	 even	 if	indirectly,	 via	 interventions	 on	 its	 ‘gross	 characteristics’	 (Masfield	 2009).	 In	 a	paper	Race	and	the	new	epigenetic	biopolitics	of	environmental	health,	Mansfield	focused	on	methylmercury	contamination	in	fish	as	an	environmental	factor,	and	the	 efforts	 of	 regulatory	 agencies	 (Food	 and	 Drug	 Administration;	 and	 the	 US	Environmental	 Agency)	 to	 control	 fetal	 exposures	 by	 issuing	 fish	 consumption	advisories	 to	 women	 of	 childbearing	 age.	 According	 to	 Mansfield,	 these	
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advisories	 have	 greater	 impact	 on	 women	 of	 color	 due	 to	 existing	 racial	disparities	in	fish	consumption.	Moreover,	the	advisories	shift	the	problem	from	contamination	 itself	 to	 the	 inadequate	 diets	 of	 these	 women.	 The	 ‘failure’	 of	these	women	to	make	the	right	dietary	choice	is	therefore	understood	as	giving	rise	to	bodily	differences	in	people	of	allegedly	different	races.		In	the	words	of	Joerg	Niewöhner:			 »Environmental	epigenetic	knowledge	is	equally	readily	adopted	by	those	in	favor	of	increasing	social	welfare	spending	and	public	health	measures	to	 reduce	 social	 inequality	 as	 it	 is	 by	 those	 in	 favor	 of	 increasing	individualistic	 attention	 to	 early	 life	 development.	The	main	biopolitical	concern	must	therefore	lie	with	the	crude	naturalization	and	subsequent	reification	 of	 complex	material-semiotic	 configurations	 inherent	 in	 both	biopolitical	positions.»	(Niewöhner	2015,	p.	224).		The	 concept	 of	 ‘local	 biologies’	 has	 been	 suggested	 as	 a	 productive	 way	 to	explore	 the	 promissory	 and	 precautionary	 narratives	 of	 epigenetics,	 as	 both	 a	sociotechnical	phenomenon	and	an	interdisciplinary	academic	endeavour		(Lock	2015,	Niewöhner	2015).	 First	used	 to	describe	 the	entanglement	of	 subjective,	socio-political	and	biomedical	dimensions	of	menopause	(Lock	1993;	2001),	the	approach	 of	 ‘local	 biologies’	 showed	how	 “it	 is	 appropriate	 to	 think	 of	 biology	and	 culture	 as	 in	 a	 continuous	 feedback	 relationship	 of	 ongoing	 exchange,	 in	which	both	are	subject	to	variation”	(Lock	2001,	503;	original	emphasis).	Among	the	proponents	of	this	concept	as	analytical	tool	for	describing	the	social	uptake	of	 epigenetics,	 Jörg	 Niewöhner	 (2015)	 interpreted	 epigenetics	 as	 performing	
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subjectivities	 and	 social	 phenomena,	 as	well	 as	 new	materialisms	 and	 distinct	understandings	of	the	environment	in	its	connections	to	the	human	body.	Apart	from	 the	 idea	 of	 ‘temporary	 joint	 epistemic	 work’	 proposed	 to	 explain	 co-laboration	around	epigenetics	between	anthropologists	and	biologists	who	work	on	 their	 own	 projects	 (ibid),	 collaboration	 between	 people	 of	 different	backgrounds	within	one	project	working	towards	the	same	goal	has	been	shown	to	depend	on	development	of	‘analytic	concepts	of	those	scientific	objects	which	inhabit	 several	 intersecting	 social	 worlds	 and	 satisfy	 the	 informational	requirement	of	each	of	them’;	that	is	to	say,	‘	boundary	objects’,	which	are	‘both	plastic	enough	to	adapt	to	local	needs	and	the	constraints	of	the	several	parties	employing	them,	yet	robust	enough	to	maintain	a	common	identity	across	sites”	(Star	&	Griesemer,	1989;	emphasis	added)		
REPRESENTATIONS	OF	EPIGENETICS	IN	POPULAR	CULTURE	In	 January	 2010,	 the	 Time	magazine	 featured	 an	 article	 on	 epigenetics	with	 a	cover	“Why	your	DNA	is	not	your	destiny.	The	new	science	of	epigenetics	reveals	how	 the	 choices	 you	 make	 can	 change	 your	 genes	 –	 and	 those	 of	 your	 kids”	(Cloud	2010).	 In	 the	same	year,	 the	August	 cover	of	 the	German	magazine	Der	Spiegel	 read	 Victory	 over	 the	 gene	 –	 smarter,	 healthier,	 happier:	 how	 we	 can	
outsmart	our	genes	(der	Sieg	über	der	Gene	-	Klüger,	gesünder,	glücklicher:	Wie	wir	 unser	 Erbgut	 überlisten	 können),	 showing	 water	 wrapping	 around	 a	prancing	 woman	 in	 the	 form	 of	 DNA	 double	 helix 17 .	 Ever	 since,	 the	representations	 of	 epigenetics	 in	 popular	 culture	 have	 mostly	 consisted	 of	
																																																								17	Available	at:	http://www.spiegel.de/spiegel/print/d-73109479.html	(Last	accessed	on	12.12.2016.)	
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sensationalistic	 stories	 about	 politically	 controversial	 and	 socially	 sensitive	facets,	 as	 well	 as	 scientifically	 disputed	 research	 such	 as	 transgenerational	inheritance	in	humans.		One	 such	 example	 is	 the	 Överkalix	 study,	 which	 has	 become	 something	 like	 a	hallmark	 of	 epigenetic	 inheritance.	 In	 the	 section	 “Meet	 the	 Epigenome”,	 the	Time	magazine	article	stated	that	»scientists	have	known	about	epigenetic	marks	since	 at	 least	 the	 1970s.	 But	 until	 the	 late	 '90s,	 epigenetic	 phenomena	 were	regarded	 as	 a	 sideshow	 to	 the	 main	 event,	 DNA.	 ...	 More	 recently,	 however,	researchers	have	begun	to	realize	that	epigenetics	could	also	help	explain	certain	scientific	 mysteries	 that	 traditional	 genetics	 never	 could»	 (Cloud	 2010).	 The	‘mystery’	 considered	 in	 the	 Time	 Magazine	 article	 is	 data	 from	 the	 Överkalix	study	(Bygren	et	al	2001).	The	Överkalix	study	was	conducted	 in	the	county	of	Norrbotten	 in	 Northern	 Sweden.	 It	 results	 of	 apparently	 made	 its	 author	 (Dr.	Lars	Olov	Bygren,	now	at	Karolinska	Institute	in	Stockholm,	but	born	and	raised	in	 the	county	of	Norrbotten),	«wonder	whether	 ...	parents'	experiences	early	 in	their	 lives	 [could]	 somehow	 change	 the	 traits	 they	 passed	 to	 their	 offspring»	(ibid.).	The	TIME	Magazine	article	stated	with	confidence	that	«Bygren's	data	—	along	with	 those	of	many	other	 scientists	working	 separately	over	 the	past	20	years	—	have	given	birth	to	a	new	science	called	epigenetics”(ibid.)		In	addition	to	making	the	headlines,	the	Överkalix	study	has	been	discussed	on	many	blogs	and	forums,	as	well	as	in	on-line	educational	courses	on	epigenetics,	such	 as	 Coursera’s	Epigenetic	 control	 of	 gene	 expression18.	 A	 radio	 show	 called	
																																																								18	Available	at:	https://www.coursera.org/learn/epigenetics/lecture/7Y7Kz/5-5-human-epidemiological-studies-on-the-overkalix-cohort-grandparental-effects	(Last	accessed	12.12.2016.)	
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Radiolab19	featured	 a	 podcast	 episode	 on	 Inheritance20	featured	 an	 interview	with	Lars	Olav	Byrgen21	and	discussed	the	Överkalix	study	under	the	name	“You	are	what	your	grandpa	eats”.	The	other	two	inheritance	stories	discussed	in	this	podcast’s	 were	 “Leaving	 your	 Lamarck”	 –	 about	 the	 early	 20th	 century	experiments	 of	 Paul	 Kammerer	 with	 midwife	 toads	 to	 prove	 Lamarckian	inheritance,	 and	 the	 contemporary	 research	 of	 Michael	 Meanney	 and	 Frances	Champagne	 on	maternal	 care	 in	 rats22;	 and	 “What	 if	 there	was	 no	Destiny?”	 –	about	nature	vs.	nurture	debate	told	through	an	adoptive	vs.	biological	parents	story23.		With	 becoming	 the	 hallmark	 of	 epigenetic	 inheritance,	 or	 inheritance	 via	
epigenetic	 mechanisms,	 it	 would	 not	 be	 unreasonable	 to	 presume	 that	 some	epigenetic	data	must	have	been	collected	on	the	Överkalix	cohort.	But	 this	was	not	 the	 case	 as	 the	 study	 used	 agricultural	 data	 and	 historical	 records	 of	inhabitants	 in	 the	 nineteenth	 century.	 Unsurprisingly,	 biological	 samples	 from	people	 who	 lived	 in	 the	 nineteenth	 century	 are	 not	 available.	 The	 Överkalix	study,	however,	motivated	further	research	as	Dr.	Byrgen	joined	forces	with	one	of	 the	 prominent	 epigenetisists,	 Dr.	 Marcus	 Pembrey,	 involved	 in	 the	 Avon	Longitudinal	 Study	 of	 Parents	 and	 Children	 (ALSPAC).	 Together	 with	 several	other	 researchers,	 they	 published	 a	 paper	 on	 transgenerational	 inheritance	 in	humans	 (Pembrey	 2006),	 which	 the	 TIME	 Magazine	 article	 called	 ‘the	 most	compelling	 epigenetic	 study	 yet	written’	 (Cloud	2010).	However,	 not	 even	 this																																																									19	Available	at:	http://www.radiolab.org	(Last	accessed	on	12.12.2016.)	20	Available	at	http://www.radiolab.org/story/251876-inheritance/	(Last	accessed	on	12.12.2016.)	21	Available	at	http://www.radiolab.org/story/251885-you-are-what-your-grandpa-eats/	(Last	accessed	on	12.12.2016.)	22	Available	at	http://www.radiolab.org/story/251884-leaving-lamarck/	(Last	accessed	on	12.12.2016.)	23	Available	at	http://www.radiolab.org/story/251887-what-if-no-destiny/	(Last	accessed	on	12.12.2016.)	
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study	 actually	 conducted	 research	 on	 epigenetics,	 although	 biological	 samples	for	the	ALSPAC	cohort	are	available	(Boyd	et	al.	2013;	Fraser	et	al.	2013).		Another	study	that	has	become	a	hallmark	of	epigenetic	inheritance	is	the	study	on	 the	 effects	 of	 maternal	 behaviour	 on	 offspring	 (Weaver	 et	 al	 2004).	 The	Discover	Magazine	featured	an	article	about	this	study	“Grandma's	Experiences	Leave	a	Mark	on	Your	Genes”	(Hurley	2013).	Other	studies	on	transgenerational	epigenetic	inheritance	include	The	Economist	magazine	“Poisoned	inheritance”24	about	 a	diet-induced	 sperm	reprogramming	 in	mice	 (Lambrot	 et	 al.	 2013)	and	The	 Scientist	magazine	 “Upside	 of	 early	 life	 stress?”25	about	 early	 life	 stress	 in	fathers	inducing	behavioural	flexibility	in	their	offspring	(Gapp	et	al.	2014);	etc.			Inheritance	and	early-life	exposures	are	also	the	central	topic	of	popular	books	on	epigenetics.	Nessa	Carey’s	“The	Epigenetisc	Revolution:	How	Modern	Biology	is	 Rewriting	 Our	 Understanding	 of	 Genetics,	 Disease	 and	 Inheritance”	 (Carey	2011)	 was	 praised	 by	 her	 scientist	 colleagues	 as	 providing	 a	 great	 basic	introduction	to	the	topic	of	epigenetics,	as	well	as	a	sense	of	the	challenges	and	opportunities	it	presents.	Yet,	the	book	also	offered	an	epigenetic	account	of	life	of	 ‘a	 film	 and	 fashion	 icon’	 Audrey	Hepburn.	 Hepburn	was	 exposed	 to	 the	 so-called	 Dutch	 Hunger	Winter26	when	 she	 was	 a	 teenager,	 which	 in	 the	 book	 is	offered	as	an	explanation	of	Hepburn’s	‘fragile	health’	in	adulthood.	Some	studies	have	 investigated	 the	 links	 between	 effects	 of	 Dutch	Huger	Winter	 and	 health	
																																																								24	Available	at	http://www.economist.com/news/science-and-technology/21591547-lack-folate-diet-male-mice-reprograms-their-sperm-ways	(Last	accessed	on	12.12.2016.)	25	(Last	accessed	on	12.12.2016.)	http://www.the-scientist.com/?articles.view/articleNo/41465/title/Upside-of-Early-Life-Stress-/	(Last	accessed	on	12.12.2016.)	26	The	Dutch	Hunger	Winter	refers	to	the	period	during	the	WWII	in	which	the	Netherlands’	food	supply	was	blocked	by	the	Nazi’s,	causing	an	extreme	hunger		
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outcomes	 via	 epigenetics,	 like	 The	 Dutch	 Famine	 Birth	 cohort	 study27.	 These	studies	focus	on	the	effects	experienced	in	utero,	and	their	health	consequences	experienced	 in	 adulthood.	 Audrey	 Hepburn	 did	 not,	 and	 was	 not	 eligible	 to,	participate	 in	 such	 studies,	 as	 she	 was	 a	 teenager	 at	 the	 time	 when	 the	environmental	insults	occurred.		Other	 popular	 accounts	 on	 epigenetics	 by	 scientists,	 such	 as	 Spector’s	“Identically	Different:	Why	you	can	change	your	genes”	focus,	as	indicated	by	the	book’s	 title,	 on	 our	 ability	 to	 change	 our	 genes	 (Spector	 2012).	 Outside	 the	popularising	accounts	of	epigenetics	offered	by	scientists,	a	genre	of	 ‘biology	of	belief’	 or	 ‘biology	 of	 intention’	 is	 also	 increasingly	 engaging	 with	 epigenetics,	with	 “The	 Genie	 in	 Your	 Genes:	 Epigenetic	 Medicine	 and	 the	 New	 Biology	 of	Intention”	being	its	original	and	still	most	popular	example	(Church	2007).			
EPIGENETICS	AND	POLICY	–	THE	THESIS	
One	 of	 the	most	 intriguing	 features	 of	 epigenetics	 has	 been	 its	 capacity	 to	 be	mobilized	 in	 a	 variety	 of	 fields	 beyond	 biomedicine,	 most	 notably	 the	 social	sciences.	 It	 has	 been	 welcomed	 as	 a	 healthy	 opportunity	 for	 cooperation	between	 disciplines	 that	 in	 the	 past	 have	 animated	 cultural	 wars	 –	 with	 a	political	undertone	–	as	for	the	respective	place	of	innate	(nature)	and	acquired	(nurture)	 traits	 (Landecker	 and	 Panofsky	 2013).	 It	 constitutes	 an	 object	 of	inquiry	 for	 anthropology	 and	 social	 sciences,	 engaging	 them	with	 a	molecular	understanding	of	cultural	and	social	practices	(Landecker	2011,	Landecker	and	Panofsky	2013).	At	a	meta-disciplinary	level,	epigenetics	prompts	reflections	on																																																									27	Available	at:	http://www.dutchfamine.nl/index_files/study.htm	(Last	accessed	29.08.2016)	
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the	very	boundaries	between	social	and	natural	sciences,	and	the	opportunities	and	 challenges	 entailed	 in	 constructing	 mixed	 epistemic	 categories	 (Meloni	2015).	It	also	holds	the	potential	to	“both	propel	sociotechnical	change	and	(co-)produce	novel	 conceptualisations	of	biosocial	 entities”	 (Pickersgill	 et	 al.	 2013,	438).	The	transdisciplinary	success	of	epigenetics	seems	to	be	predicated	upon	the	intersection	of	its	theoretical	significance,	social	promises	and	amenability	to	inquiry.		Yet,	the	empirical	investigations	of	epigenetics	in	the	current	literature	occupy	a	much	smaller	corner	than	those	of	critical	reflections	upon	epigenetics.	This	PhD	project	 delivers	 an	 empirically	 grounded	 contribution	 to	 explorations	 of	epigenetics.	In	particular,	by	focusing	on	the	case	of	Glasgow,	a	city	characterized	by	stark	health	and	social	inequalities,	where	epigenetics	has	been	employed	in	a	interdisciplinary	 project	 to	 measure	 and	 instruct	 relevant	 social	 programs	 to	target	 these	 inequalities,	 this	 thesis	 contributes	 a	 critical	 insight	 into	 how	epigenetics	 is	 currently	 employed	–	 in	 collaboration	between	actors	 of	 diverse	backgrounds;	and	in	policy	efforts	and	action	upon	health.	Being	grounded	in	a	programme	 of	 interdisciplinary	 character,	 this	 thesis	 contributes	 a	 meta-disciplinary	reflection	on	epigenetics	and	its	societal	implications.			
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CHAPTER	THREE	–	RESEARCH	DESIGN	AND	METHODS	
	
INTRODUCTION	
This	 chapter	 describes	 the	 methods	 through	 which	 the	 data	 informing	 the	conclusions	of	this	project	was	gathered.	The	chapter	is	divided	into	two	sections	according	to	the	two	separate	aims	of	this	project.	Section	one	is	concerned	with	methods	employed	in	pursuing	the	aim	of	mapping	the	impact	of	epigenetics	in	health	care.	The	section	 first	describes	how	 the	 research	was	designed;	 it	 then	moves	 to	 the	 materials	 and	 methods	 used	 in	 collecting	 the	 data;	 the	 rational	behind	using	those	methods;	and	the	techniques	of	data	analyses	in	each	of	the	studies	that	were	conducted.	Section	two	is	concerned	with	methods	employed	in	pursuing	the	aim	of	exploring	how	epigenetics	is	conceptualised	by	actors	of	diverse	 backgrounds	 in	 research	 and	 action	 upon	 health.	 The	 section	 first	describes	 how	 the	 research	 was	 designed	 and	 the	 rational	 for	 using	 semi-structured	 interviews	 as	 methods	 for	 data	 collection;	 it	 then	 addresses	 the	challenges	 that	 arose	 and	 the	 techniques	 and	 processes	 of	 data	 analysis;	 and	finishes	with	notes	on	ethics	and	reflexivity.				
MAPPING	THE	IMPACT	OF	EPIGENETICS	IN	HEALTH	CARE	
Research design The	initial	and	primary	aim	of	this	project	was	to	map	the	impact	of	epigenetics	in	health	care.	This	aim	was	driven	by	the	need	to	accomplish	the	tasks	for	the	
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EPIGEN	 project	 assigned	 to	 me	 by	 the	 EPIGEN	 team.	 The	 objectives	 of	 this	research	were:		1)	To	identify	the	most	active	types	of	epigenetics	research	(basic,	translational,	clinical	research)		2)	To	identify	the	most	actively	studied	disease	areas	in	each	type	of	epigenetic	research		3)	 To	 identify	 the	 most	 active	 areas	 of	 application	 within	 clinical	 epigenetic	research		4)	To	identify	the	clinical	outputs	of	epigenetics		The	methods	used	in	this	part	of	the	research	project	include	qualitative	reading	of	 literature;	 systematic	 literature	 review;	 systematic	 review	 and	 qualitative	analysis	 of	 literature;	 and	 bibliometric	 analysis	 to	 track	 the	 record	 of	publications	 on	 epigenetics/epigenomics.	 Moreover,	 in	 order	 to	 position	 the	results	of	this	research	in	the	broader	picture	of	health	care	strategies	in	Europe,	the	European	Union	(EU)	Together	for	Health	Strategy	was	used	to	identify	the	interests	and	goals	 in	health	management	(EC	2007).	These	 interests	and	goals	were	 further	 investigated	 in	 the	 reports	 published	 by	 the	 World	 Health	Organisation	(WHO	2006;	2008;	2011a;	2011b;	2012;	2013a;	2013b;	2015).			All	 the	studies	 in	 this	part	of	 the	project	were	conducted	 twice	–	once	 in	2013	and	once	in	2014.	The	rationale	behind	repeating	the	studies	was	reproducibility	of	 the	 results	 obtained,	 hence,	 after	 the	 first	 round	of	 results	 in	 2013,	 another	round	of	studies	had	to	be	conducted	in	the	following	year.	The	results	collected	in	2013	were	presented	at	the	EPIGEN	annual	meetng	in	Rome,	February	2014.	
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The	 results	 collected	 in	 2014	 were	 presented	 at	 the	 EPIGEN	 International	Conference	 on	 “EPIGENomics	 and	 Health	 Care	 Policy:	 Challenges	 and	Opportunities”	in	Milan,	December	2014.	
	
PubMed generated systematic literature review 
Materials	and	methods	
The	data	area	used	in	pursuing	the	first	two	objectives	 from	the	 list	above	was	biomedical	literature.	The	database	used	in	these	queries	was	PuBMed.	PubMed	database	was	selected	because	my	colleagues	from	labs	at	the	European	Institute	of	 Oncology	 in	 Milan	 indicated	 it	 as	 the	 most	 commonly	 used	 database	 in	biomedical	 practice.	 Thus,	 the	 PubMed	 database	 seemed	 like	 the	most	 proper	choice	for	conducting	research	on	biomedical	literature.	A	quantitative	approach	to	data	collection	was	an	obvious	choice	for	pursuing	these	objectives.	In	social	studies	of	science,	quantitative	approaches	usually	entail	network	analysis	(e.g.,	Cambrosio	 et	 al	 2006;	 Navon	 and	 Schwed	 2012)	 whereby	 networks	 of	interactions	 among	 actors	 and	 groups	 can	be	 identified.	Applying	 this	method,	however,	 would	 not	 allow	 for	 teasing	 out	 the	 information	 sought	 after	 by	 the	specific	 tasks	 that	 required	 by	 the	 EPIGEN	 project.	 A	 combined	 quantitative-qualitative	 analytical	 strategy	 was	 proposed	 by	 Heur	 at	 al	 (2013)	 in	 their	examination	of	evidence	for	the	claim	of	‘ontological	turn’	in	STS.	In	this	article,	quantitative	analysis	of	the	social	science	and	humanities	 journals	and	a	subset	of	 STS	 literature	 were	 combined	 with	 bibliometric	 tools	 to	 analyse	 network	structures	in	the	social	and	knowledge	relationships	in	the	STS	subset,	and	with	qualitative	reading	of	this	literature.	Following	this	strategy	proposal	(Heur	at	al	
	 89	
2013),	 a	 combination	 of	 quantitative	 analysis	 with	 qualitative	 reading	 of	literature,	without	the	bibliometric	analysis	of	this	literature,	was	selected	as	the	protocol	to	be	followed	in	this	research.	 	The	bibliometric	analysis	was	skipped	in	 this	 research,	 as	 the	 specific	questions	asked	by	 the	EPIGEN	project	did	not	require	this	kind	of	analysis.			In	 conducting	 the	 systematic	 review,	 the	 following	 parameters	 of	 the	 PubMed	database	were	kept	constant	across	all	searches:	1) Text	availability	–	full	text	2) Species	–	humans	3) Languages	–	English	4) Article	type	–	reviews	and	systematic	reviews.		In	 the	 pilot	 phase	 of	 the	 study,	 the	 ‘article	 type’	 parameter	 of	 the	 PubMed	database	varied	and	it	was	set	to:	1)	all	types	of	articles;	2)	reviews;	3)	reviews	and	systematic	reviews;	and	4)	systematic	reviews.	The	‘reviews	and	systematic	reviews’	 was	 selected	 for	 further	 research	 as	 a	 representative	 enough	 of	 the	general	field	while	reducing	the	number	of	papers	to	be	subjected	to	qualitative	assessments.	A	 qualitative	 reading	 of	 papers	 produced	by	 ‘all	 types	 of	 articles’	search	would	 not	 be	manageable	 for	 one	 person.	 The	 specific	 combinations	 of	search	terms	that	were	used	for	in	this	systematic	review	are	shown	in	Table	1.	Moreover,	the	pilot	study	also	performed	the	searches	by	using	both	‘epigenetics’	and	 ‘epigenomics’	 as	 search	 terms.	 ‘Epigenetic’	 was	 selected	 as	 the	 more	exhaustive	and	relevant	term	for	further	studies.		
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			Type	of	research		Disease	area	
Epigenetics	 	Epigenetics,		Treatment	 	Epigenetics,		Treatment,		Clinical	trial	Cancer	 	 	 	Cardiovascular	diseases	(CVDs)	 	 	 	Neurodegenerative	diseases	(NDDs)	 	 	 	Autoimmune	diseases	(AIDs)	 	 	 	Diabetes	 	 	 	
	
Table	1:	A	grid	of	standardised	search	terms	used	in	the	systematic	review		
of	biomedical	literature		
	
Data	analysis	
Data	 analysis	 included	 recording	 and	 combining	 of	 the	 data	 collected	 into	different	 tables	 designed	 in	Microsoft	 Excel	 program;	 and	 then	 visualising	 the	results	using	Excel	tools.	The	overall	results	of	these	searches	are	shown	in	Table	2,	 while	 the	 graphs	 that	 visualise	 the	 results	 can	 be	 found	 in	 Chapter	 Four	 –	Beyond	The	Genome.	The	‘type	of	research’	area	was	processed	in	the	following	way:	
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1) The	 results	 of	 searches	 that	 contained	 a	 combination	 of	 terms	‘epigenetics’	 and	 ‘treatment’	 were	 taken	 as	 being	 representative	 of	‘translational	research’	in	epigenetics.	2) 	The	 results	 of	 searches	 that	 contained	 a	 combination	 of	 terms	‘epigenetics’,	 ‘treatment’	 and	 ‘clinical	 trial’	 were	 taken	 as	 being	representative	of	‘clinical	research’	in	epigenetics.	3) These	 results	 on	 ‘translational	 research’	 and	 clinical	 research’	 were	subtracted	from	the	results	of	searches	that	used	only	 	 ‘epigenetics’	as	a	search	term,	and	were	taken	as	being	representative	of	‘basic	research’	in	epigenetics.	 In	other	words,	of	all	 epigenetic	 research,	 the	part	 that	was	neither	 translational	 nor	 clinical	 was	 taken	 as	 being	 representative	 of	‘basic	research’	in	epigenetics.		
Key	words	 No.	of	papers	
Epigenetics	 2557	
Epigenetics,	treatment	 947	
Epigenetics,	treatment,	clinical	trial	 42	
Epigenetics,	CANCER	 1088	
Epigenetics,	treatment,	CANCER	 560	
Epigenetics,	treatment,	clinical	trial,	CANCER	 31	
Epigenetics,	CVDs	 163	
Epigenetics,	treatment,	CVDs	 80	
Epigenetics,	treatment,	clinical	trial,	CVDs	 4	
Epigenetics,	NDDs	 104	
Epigenetics,	treatment,	NDDs	 41	
Epigenetics,	treatment,	clinical	trial,	NDDs	 3	
Epigenetics,	AIDs	 106	
Epigenetics,	treatment,	AIDs	 36	
Epigenetics,	treatment,	clinical	trial,	AIDs	 2	
Epigenetics,	Diabetes	 40	
Epigenetics,	treatment,	Diabetes	 16	
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Epigenetics,	treatment,	clinical	trial,	Diabetes	 1	
	
Table	2:	Systematic	review	of	biomedical	literature		
Systematic review and qualitative analysis of the clinical research 
and application of epigenetics 
Materials	and	methods	
The	 ‘clinical	 research	 in	 cancer’	 results	 (produced	 by	 a	 combination	 of	‘epigenetics,	 ‘treatment’	 and	 clinical	 trial’	 as	 search	 terms)	 were	 qualitatively	analysed	 to	 identify	 the	 most	 targeted	 epigenome-modifying	 processes	 (or	mechanisms)	in	clinical	research.	The	rational	behind	conducting	this	qualitative	analysis	was	that	searching	for	‘epigenetics’	in	the	clinical	trials	repositories	(the	NIH	 National	 Cancer	 Institute,	 NCI	 and	 the	 European	 Union	 Clinical	 Trial	Register,	 EU-CT)	 did	 not	 yield	 any	 results.	 It	 is,	 however,	 known	 that	 several	epigenome-modifying	compounds	received	market	authorisation	and	many	are	being	clinically	tested.	Therefore,	generating	more	fine-grained	search	terms	was	necessary	 in	 order	 to	 perform	 further	 investigation	 of	 the	 areas	 of	 application	within	clinical	epigenetic	research.	Table	3	shows	the	results	of	 this	qualitative	analysis.		The	rational	for	focusing	on	cancer	was	two-fold.	First,	cancer	scored	as	the	most	studied	disease	area	in	all	types	of	research	presenting	thus	an	obvious	choice	as	a	 case	 study	 of	 further	 investigation.	 Second,	 the	 results	 of	 clinical	 trials	 (CT)	used	 specific	 names	 for	 compounds	 that	 were	 being	 tested,	 separately	 or	 in	combination	with	other	compounds,	and	not	the	mechanism	of	their	action.	
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Search	terms:	epigenetics,	treatment,	clinical	trial,	cancer		
Total	No.	of	papers	 31	
DNMT	related	papers	 5	
HDAC	related	papers	 8	
DNMT	and	HDAC	papers	 11	
Other	mechanisms	papers	 7	
	
Table	3:	The	most	targeted	mechanisms	of	epigenome-modification	in		
clinical	epigenetic	research		Moreover,	some	CTs	referred	to	epigenome-modifying	compounds	only	in	order	to	 discuss	 the	 compound	 that	 was	 actually	 tested	 in	 the	 trial	 at	 hand.	 A	qualitative	reading	of	all	the	clinical	trials	reported	in	the	results	was	therefore	required	 to	 confirm	 that	 the	 CTs	 reported	 in	 the	 results	 were	 actually	 being	conducted	on	an	epigenome-modifier.	Analyzing	 the	 results	of	 all	 clinical	 trials	on	epigenome-modifiers	for	all	types	of	diseases	was	a	task	beyond	the	abilities	of	one	person.	Thus,	even	though	it	itself	produced	a	substantial	number	of	CTs	to	be	 subjected	 for	qualitative	 reading,	 cancer	was	 selected	as	a	 case	 study	 for	identifying	the	most	active	areas	of	application	of	epigenetics	in	clinical	research.	Further	studies	conducted	 in	 the	NCI	and	 the	EU-CT	online	database	of	clinical	trials	 thus	used	 the	 following	 two	search	 terms:	1)	histone	deacetylase;	and	2)	methyltransferase.		In	a	pilot	study,	the	search	terms	used	where	 ‘histon	deacetylase	inhibitor’	and	‘methyltransferase	 inhibitors’,	 because	 their	 mechanism	 of	 action	 on	 the	epigenome	is	inhibition.	However,	the	combination	of	epigenetics-related	search	terms	 (histone	 deacetylase	 and	 methyltransferase)	 with	 the	 term’	 inhibitor’	
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trials	 containing	 a	 term	 ‘inhibitor’	 were	 reported	 in	 the	 list	 of	 results.	 The	qualitative	 reading	 of	 the	 results	 confirmed	 that	 this	 was,	 indeed,	 the	 case.	Therefore,	 the	search	was	repeated	with	using	only	terms	 ‘histone	deacetylase’	and	 ‘methyltransferase’	 as	 key	 words.	 Table	 4	 and	 Table	 5	 show	 the	 data	collections	 in	 these	searches,	 respectively,	which	were	submitted	 to	qualitative	reading	to	confirm	the	results	were	addressing	the	questions	asked.	The	results	that	 were	 generated	 were	 then	 used	 to	 compile	 a	 list	 of	 currently	 studied	epigenome-modifying	compounds.	Finally,	each	of	the	compounds	from	this	list	was	 searched	 for	 in	 the	US	Food	and	Drug	Administration	 (FDA)	database	and	the	 European	 Medicinal	 Agency	 (EMA)	 database	 to	 examine	 whether	 the	compound	 has	 already	 been	 approved	 and	 for	 what	 kid	 of	 application.	 The	results	of	this	study	are	shown	in	Table	10	in	Chapter	4.			
HISTONE	DEACETYLASE	
All	phases	of	CT	
Actively	
recruiting	 Not	recruiting	
Total	
No.	
All	CT	 174	 249	 423	
Treatment	 166	 235	 401	
Supportive	care	 4	 3	 7	
Screening	 1	 0	 1	
Prevention	 2	 2	 4	
Genetics	 0	 0	 0	
Diagnostic	 5	 2	 7	
Biomarker/laboratory	analysis	 76	 121	 197	
Tissue	collection/repository	 1	 2	 3	
Education/counselling/training	 0	 0	 0	
Behavioural	study	 0	 0	 0	
Natural	history/epidemiology	 1	 0	 1	
Health	services	research	 1	 0	 1	
	
Table	4:	On-going	clinical	trials	on	histone	deacetylases	as	targets	of		
epigenome	modifying	compounds	in	cancer	
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METHYLTRANSFERASE	
All	phases	of	CT	
Actively	recruiting	 Not	recruiting	 Total	No.	
All	CT	 45	 47	 92	
Treatment	 35	 45	 80	
Supportive	care	 3	 1	 4	
Screening	 0	 0	 0	
Prevention	 3	 1	 4	
Genetics	 0	 0	 0	
Diagnostic	 1	 1	 2	
Biomarker/laboratory	analysis	 28	 14	 42	
Tissue	collection/repository	 0	 0	 0	
Education/counselling/training	 1	 0	 1	
Behavioural	study	 1	 0	 1	
Natural	history/epidemiology	 1	 0	 1	
Health	services	research	 1	 0	 1	
	
Table	5:	On-going	clinical	trials	on	methyltransferases	as	targets	of		
epigenome	modifying	compounds	in	cancer	
	
Data	analysis	
Data	analysis	included	recording	and	combining	all	collected	data	into	different	tables	 designed	 in	 Microsoft	 Excel	 program;	 and	 then	 visualising	 the	 results	using	Excel	 tools.	The	results	of	 this	activity	are	shown	in	Table	4	and	Table	5,	while	the	graphs	that	visualise	the	results	can	be	found	shown	in	Chapter	Four	–	Beyond	The	Genome.	The	 type	of	application	 in	clinical	research	shown	 in	Table	4	and	Table	5	were	limited	by	the	parameters	for	‘type	of	trial’	set	by	the	NCI	database	itself.	Based	on	these	parameters,	type	of	application	in	clinical	research	in	cancer	include:	1)	all	types	of	CTs;	2)	treatment;	3)	supportive	care;	4)	screening;	5)	prevention;	6)	genetics;	 7)	 diagnostic;	 8)	 biomarker/laboratory	 analysis;	 9)	 tissue	
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collection/repository;	 10)	 education/counselling/training;	 11)	 behavioural	study;	12)	natural	history/epidemiology;	and	13)	health	services	research.	
	
Additional research task for the EPIGEN project 
Bibliometric	analysis	to	track	the	record	of	publications	on	
epigenetics/epigenomics	
This	 study	was	 conducted	as	 an	additional	 task	assigned	 to	me	by	 the	EPIGEN	team.	 The	 aim	 of	 this	 study	 was	 to	 examine	 the	 claims	 that	 there	 is	 an	exponential	increase	in	the	number	of	publications	carrying	‘epigenetics’	in	their	title	 (Haig	 2012),	 reaching	 several	 thousands,	 possibly	 even	 up	 to	 20	 000	 by	2011	depending	on	the	search	criteria	(Jirtle,	2012)	by	producing	a	new	method	to	 track	 the	 number	 of	 publications	 on	 epigenetics/epigenomics.	 The	working	hypothesis	 of	 the	 EPIGEN	 project	 was	 that	 while	 these	 claims	 are	 true,	 the	numbers	 are	 most	 likely	 exaggerated.	 The	 claim	 about	 the	 increase	 therefore	needed	 to	 be	 substantiated	 by	 numbers	 obtained	 through	 systematic	investigation	 that	 could	 then	 be	 shown	 to	 the	 decision-makers,	 which	 the	EPIGEN	 project	 and	 its	White	 paper	 aimed	 to	 reach.	 The	method	 used	 in	 this	analysis	was	thus	tailored	for	the	specific	purpose	of	 this	study.	The	study	was	first	 performed	 using	 PubMed	 as	 a	 source	 but	 was	 later	 refined	 by	 using	 the	webpages	 of	 selected	 biomedical	 journals	 as	 a	 source.	 The	 reason	 behind	 the	switch	 of	 sources	 is	 that	 PubMed	 reports	 results	 for	 the	 text	 deposited	 in	 it,	which	in	some	cases	means	only	the	abstract	of	papers	and	not	their	full	content.	Journals’	webpages,	although	denying	access	to	the	full	text	for	reading,	store	the	
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full	text	in	their	database.	Their	results	would	therefore	report	more	accurately	the	number	of	publications	that	contain	epigenetics/epigenomics.			
PubMed	 searches:	 The	 search	 terms	 used	 in	 probing	 this	 database	 were:	 1)	epigenetic;	 2)	 epigenomics;	 epigenetic/epigenomic;	 3)	 epigenetics,	epigenetics/epigenomics,	 4)	 epigenomic;	 epigenetics/epigenomics;	 and	 5)	epigenetics,	 epigenetics/epigenomics,	 epigenomics.	 The	 search	 parameters	 of	the	database	were	set	to	‘text	word’	and	‘English’.	The	searches	were	conducted	for	 the	 years	 2008,	 2009,	 2010,	 2011,	 2012,	 and	 2013	 (the	 year	 in	which	 the	study	 was	 conducted).	 The	 journals	 included	 in	 the	 searches	 were:	 Nature,	Nature	 Biotechnology,	 Nature	 Cell	 Biology,	 Nature	 Communication,	 Nature	Genetics,	 Nature	 Immunology,	 Nature	 Medicine,	 Nature	 Methods,	 Nature	Neuroscience,	 Nature	 Protocols,	 Nature	 Reviews	 [Cancer,	 Cardiology,	 Clinical	Oncology,	 Drug	 Discovery,	 Endocrinology,	 Gastroenterology	 &	 Hepatology,	Genetics,	 Immunology,	 Microbiology,	 Molecular	 Cell	 Biology,	 Nephrology,	Neurology,	 Neuroscience,	 Rheumatology,	 Urology];	 Science,	 Science	 Signalling,	Science	 Translational	 Medicine;	 Cell,	 American	 Journal	 of	 Human	 Genetics,	Biophysical	 Journal,	 Cancer	 Cell,	 Cell	 Host	 &	 Microbe,	 Cell	 Metabolism,	 Cell	Reports,	 Cell	 Stem	 Cell,	 Chemistry	 &	 Biology,	 Current	 Biology,	 Developmental	Cell,	 Immunity,	 Molecular	 Cell,	 Neuron,	 Stem	 Cell	 Reports,	 Structure;	 PLoS	Biology,	 PLoS	 computational	 Biology	 PLoS	 Genetics,	 PLoS	Medicine,	 PLoS	One;	EMBO,	 EMBO	 Reports,	 Blood,	 NEJM,	 The	 Lancet,	 The	 Lancet	 Diabetes	 &	Endocrinology,	 The	 Lancet	 Global	 Health,	 The	 Lancet	 Neurology,	 The	 Lancet	Oncology,	 The	 Lancet	 Respiratory	 Medicine;	 and	 British	 Medical	 Journal.	Additionally,	the	same	search	was	repeated	with	search	terms	‘genetic/genomic’	
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instead	of	‘epigenetic/epigenomic’	to	control	for	the	contamination	of	the	results	by	the	underlying		‘genetic/genomic’	part	in	‘epigenetic/epigenomic’	terms.	The	rational	behind	selecting	these	journals	and	a	five-year	span	was	that	these	journals	are	reported	as	the	top	65	scientific	journals	in	the	years	2012	based	on	their	5-year	impact	factor	by	ISI	Web	of	Knowledge	5-year	Journal	Impact	Factors	
list	of	Thompson	and	Reuters28;	
	
Journals’	 webpages	 searches:	 These	 searches	 were	 meant	 to	 prevent	 the	“information	 loss”	 that	was	experienced	 through	 the	PubMed	database	mining.	However,	 the	challenge	arose	 in	standardisation	of	search	 terms	that	would	be	used	across	webpages	of	all	journals	targeted	in	the	study.	This	challenge	arose	due	 to	 differences	 in	 options	 that	 different	 journals	 provide	 for	 search-fields	and/or	for	combining	search	terms.	Namely,	some	pages	of	some	journals’,	such	as	BMJ,	allow	 for	combining	of	 terms	 in	 the	same	search	but	report	 ‘no	results	found’	for	such	search;	while	when	searches	are	conducted	using	any	one	of	the	terms	from	this	combination,	the	results	appear.	Therefore,	in	order	to	conduct	a	systematic	 investigation,	 the	 searches	 had	 to	 be	 conducted	 in	 a	 term-by-term	fashion	 for	 each	 of	 the	 journals	 (or	 journal	 group,	 such	 as	 Nature	 Publishing	Group)	for	the	list:	1)	a	separate	search	for	the	term	‘epigenetics’;	2)	a	separate	search	for	the	term	‘epigenetic’;	3)	a	separate	search	for	the	term	‘epigenomics’;	and	4)	a	separate	search	for	the	term	‘epigenomic’.		
																																																								28	The	data	were	collected	under	conditions	of	free-access	to	the	database	of	WoK.	These	conditions	are	no	longer	available,	probably	due	to	some	recently	occurring	restrictions	to	website	access.	
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Data	analysis	
Each	of	the	four	separate	searches	was	conducted	for	each	of	the	journals	in	the	list	presented	above,	and	for	each	of	the	years	(2008-2013).	The	search	results	for	every	consecutive	page	that	appeared	were	opened	in	a	‘page	source’	option	of	 the	 browser;	 the	 text	 for	 every	 page	 was	 copied	 and	 saved	 into	 a	 word	document	 in	 a	 consecutive	manner.	The	 files	of	 each	of	 the	 search	 terms	were	then	 combined	 into	 a	 single	 file,	 and	 correspondingly	 so,	 for	 every	 journal	 in	every	 year.	 This	 activity	 produced	 thus	 a	 series	 of	 files	 like	 this:	Nature	 2008;	Nature	 2009;	 Nature	 2010;	 Nature	 2011;	 Nature	 2012;	 Nature	 2013;	 EMBO	2008;	EMBO	2009;	EMBO	2010;	EMBO	2011;	EMBO	2012;	EMBO	2013;	etc.	 for	each	of	the	journals	and	years.	All	together,	this	search	generated	sixty	data	files.		In	 order	 to	 control	 for	 the	 potential	 doubles	 in	 these	 results,	 I	 consulted	 a	colleague	 with	 highly	 developed	 computational	 skills,	 Dr.	 Pierre-Luc	 Germain,	about	how	 to	write	 a	 code	 in	Python	programming	 language	 that	would	 count	how	many	of	 the	 titles	 in	 each	of	 these	 sixty	 files	 are	unique.	This	 code	would	thus	help	in	eliminating	the	titles	that	could	appear	more	than	once	in	these	files,	when	both	‘epigenetics’	and	‘epigenomics’	would	appear	in	the	same	publication.	As	 the	 searches	 were	 conducted	 for	 each	 of	 these	 terms	 separately,	 such	publications	 would	 be	 counted	 twice	 without	 a	 script/code	 to	 control	 and	correct	for	this.	The	data	that	were	collected	were	then	inserted	into	a	Microsoft	Excel	table	and	visualised	into	graph	using	Excel	tools.		An	example	of	how	these	results	were	formatted	to	be	quantifiable	is	shown	in	Table	6	(for	the	years	2008	and	2012).		
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Journals	
2008	publications	 2012	publications	
Total	No.	 Script	No.	
Unique	No.	
(script	
derived)	
Total	No.	 Script	No.	
Unique	No.	
(script	
derived	
Nature(s)	 542	 540	 417	 989	 984	 734	
Science(s)	 71	 71	 61	 209	 209	 174	
Cell(s)	 415	 369	 331	 853	 715	 587	
PloS(s)	 500	 620	 234	 2768	 2768	 1277	
EMBO(s)	 76	 76	 61	 117	 117	 91	
Blood	 120	 120	 106	 218	 218	 184	
NEJM	 46	 46	 20	 40	 40	 19	
Lancet(s)	 26	 25	 24	 40	 40	 38	
JAMA	 38	 80	 20	 20	 80	 20	
BMJ(s)	 5	 5	 4	 10	 9	 8	
Total	number	 1839	 1952	 1278	 5264	 5180	 3132	
	
Table	6.	Bibliometric	analysis	to	track	the	record	of	publications	on		
epigenetics/epigenomics	
	
Additional materials and their analysis 
Qualitative	analysis	of	selected	life	sciences	literature			
The	 data	 used	 in	 this	 analysis	 are	 the	 collectively	 released	 results	 of	 the	 NIH	Roadmap	 Epigenomics	 project	 published	 in	 the	 special	 issue	 of	 the	 journal	
Nature	 in	 February	 2015.	 The	 rational	 behind	 focusing	 on	 the	 NIH	 Roadmap	Epigenomics	 results	 is	 two-fold.	 First,	 the	 quantitative-qualitative	 analyses	conducted	 for	 the	 EPIGEN	 project	 were	 not	 designed	 to	 address	 how	 is	‘environment’	 conceptualised	 in	 epigenetic	 research.	 Yet,	 environmental	epigenetics	 and	molecularisation	of	 the	environment	are	precisely	 the	areas	of	epigenetic	 research	 that	 gain	 most	 attention	 in	 different	 domains	 beyond	biomedicine.	 Conducting	 another	 qualitative-qualitative	 study	 with	 tailored	search	 terms	 and	methodology	 to	 address	 this	 was	 not	 plausible,	 due	 to	 time	
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constraints	of	the	PhD	programme	and	project.	Therefore,	a	small-scale	research	had	 to	 be	 selected	 instead.	 Second,	 within	 the	 five	 initiatives	 of	 the	 Roadmap	Epigenomics	 project,	 one	 includes	 research	 on	 responses	 to	 exposures	 like	physical,	chemical,	behavioural	and	social	factors.	Other	big	epigenetic	consortia	also	 state	 that	 understanding	 how	 environment	 influences	 human	 health	 and	populations	is	among	their	projects’	main	objectives.	Such	statements	are	made	on	 projects’	 description	 pages	 and	 as	 such	 are	 intended	 for	 the	 general	 and	interested	 public.	 The	 published	 data	 of	 these	 big	 consortia	 are,	 instead,	intended	for	the	research	community,	where	they	also	set	the	aims	and	norms	of	current	 and	 future	 research.	 Their	 analysis	 could	 therefore	 indicate	 to	 what	extent	 and	 how	 is	 environment	 actually	 conceptualised	 in	 wider	 research	community.	 Each	 of	 the	 papers	 was	 reviewed	 in	 search	 for:	 1)	 whether	 the	words	 ‘environment’	 or	 ‘environmental’	 occur	 and	 how	 often;	 and	 2)	 if	 the	research	makes	 at	 least	 a	 general	 reference	 to	 anything	 else	besides	 the	 intra-cellular	 components	 that	 could	be	 remotely	 related	 to	 the	extra-cellular,	 extra-organismal	factors.	
	
Qualitative	reading	of	documents	published	by	the	regional	and	global	
health	authorities	
The	first	European	Health	Strategy	“Together	for	Health”	was	used	to	identify:	1)	the	 challenges	 that	 the	 EU	 recognises	 as	 priorities	 to	 be	 addressed	 in	 the	upcoming	years;	2)	the	principles	on	which	the	health	strategy	for	the	future	is	grounded;	and	3)	the	values	that	drive	its	implementation.	The	rational	for	this	analysis	was	to	explore	how	the	impact	of	epigenetics	in	health	care,	mapped	in	
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this	 project,	 fits	with	 health	 challenges	 identified	 by	 European	 authorities	 and	strategies	 to	 address	 them.	 The	 health	 challenges	 reported	 in	 the	 EU	 health	strategy	were	further	explored	in	documents	published	by	the	WHO	and	include:	complex	 diseases	 and	 health	 divide,	 i.e.	 inequalities	 in	 health.	 Within	‘inequalities	 in	health’	 theme,	 the	 ‘social	determinants	of	health	 approach’	was	further	explored	for	two	reasons.	First,	poverty	was	reported	as	the	main	factor	that	 leads	 to	 poor	 health.	 Second,	 the	 case	 study	 of	 this	 project	 –	 the	psychological,	social	and	biological	determinants	of	ill	health	(pSoBid)	project	–	investigated	epigenetics	in	relation	to	socio-economic	status.			
Exploring	how	is	epigenetics	represented	in	the	public		
Occasional	 searches	 in	Google	were	 conducted	 and	 epigenetics-related	 content	on	these	pages	was	reviewed	for	what	type	of	studies	and	research	they	covered.	Additionally,	 biomedical	 journals	 were	 monitored	 for	 discussions	 regarding	media	representation	of	epigenetics.	
	
EXPLORING	HOW	EPIGENETICS	IS	MOBILIZED	ACROSS	DOMAINS	AND	
CONCEPTUALIZED	BY	DIFFERENT	ACTORS	IN	RESEARCH	AND	ACTION	
UPON	HEALTH		
Research design For	exploring	how	epigenetics	 is	mobilised	across	domains	and	conceptualised	by	 actors	 of	 diverse	 backgrounds	 in	 research	 and	 action	 upon	 health,	 the	
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research	focused	on	one	particular	case	–	the	psychological,	socila	and	biological	determinants	 of	 ill	 health	 (pSoBid)	 project	 in	 Glasgow.	 This	 interdisciplinary	project	conducted	a	research	on	the	associations	between	an	epigenetic	marker	and	socio-economic	status,	the	results	of	which	were	included	in	its	final	report	aimed	to	inform	and	deliver	policy	action	in	Glasgow.		The	research	questions	that	this	thesis	asked	include:		1)	How	is	epigenetics	mobilized	and	used	 in	an	 interdisciplinary	project	that	combines	biological	and	social	approach	to	health?		2)	 How	 do	 different	 actors	 conceptualize	 epigenetics	 within	 a	collaborative	 health	 endeavour	 aimed	 to	 bring	 about	 policy	 and	 action	upon	health?		The	methods	used	in	this	part	of	the	research	include	qualitative	reading	of	the	literature	published	on	the	pSoBid	cohorts	and	semi-structured	interviews	with	experts	from	the	pSoBid	project,	complemented	by	observational	studies.		
Interviews with professionals from the pSoBid project Semi-structured	 interviews	 as	 method	 of	 data	 collection	 were	 selected	 as	 the	most	suitable	 for	 this	part	of	 the	project	because	 they	provide	ample	space	 for	professionals	with	 different	 expertise	 involved	 in	 an	 interdisciplinary	 research	project	 to	express	 their	views	and	opinions.	Focus	groups	and	survey	research	would	be	 alternative	methods	 to	 capture	opinions	 and	perspective	of	 different	actors	but	they	require	a	much	larger	sample	of	people.	Given	the	stage	at	which	my	project	was	at	the	time	when	the	EPIGEN	project	was	finalising	its	activities,	
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it	was	 impractical,	 if	 not	 impossible,	 to	 gather	numerous	busy	professionals	 in	the	 same	 setting	 in	 order	 to	 organise	 focus	 groups.	 The	 initial	 idea	 to	 access	health	 professionals	 at	 the	 EPIGEN	 International	 Conference	 could	 not	 be	accomplished	 as	 they	 declined	 their	 invitations	 to	 come	 to	Milan.	 Considering	that	 this	 project	 was	 based	 in	 Italy,	 and	 that	 even	 the	 Italian	 epigenetic-epidemiologists	 are	mostly	based	 in	 the	UK,	 reaching	 the	 conditions	necessary	for	focus	groups	to	take	place	on	the	UK	soil	would	practically	be	impossible	to	accomplish.	 On	 the	 other	 hand,	 although	 open-ended	 questionnaires	 in	 survey	methods	 provide	 a	 space	 for	 participants	 to	 express	 their	 opinions	 and	experiences,	 the	 motives	 and	 meanings	 behind	 such	 responses	 cannot	 be	explored	as	 fully	as	 they	can	be	 in	semi-structured	 interviews.	Semi-structured	interviews	 were	 therefore	 selected	 as	 the	 most	 practical	 and	 effective	 way	 of	collecting	appropriate	data	for	this	part	of	the	project.			
Case	study	selection	
While	 providing	 cartography	 of	 epigenetics	 in	 healthcare,	 the	 project	 also	examined	 environmental	 epigenetics	 research,	 in	 particular,	 epidemiological	studies	 on	 the	 health-related	 effects	 of	 environmental	 and	 social	 factors	 via	epigenetics,	such	as:	a) Methylation	status	of	IGF2	gene	promoter	in	relation	to	nutritional	factors	in	the	Dutch	Famine	Birth	Cohort	Study	(Heijmans	et	al	2008);	b) Methylation	status	of	LINE-1/Alu	sequences	in	relation	to	air	pollution	in	the	Boston	area	Normative	Aging	Study	(Baccarelli	et	al	2009);	
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c) Methylation	status	of	F2RL3	locus	in	relation	to	smoking	in	the	European	Prospective	Investigation	into	Cancer	and	Nutrition	(Shenker	et	al	2013);	d) Methylation	 status	 of	 various	 gene	 promoters	 in	 relation	 to	 socio-economic	position	 (SEP)	 in	 the	British	1958	Birth	 cohort	 (Borghol	 et	 al	2012);	e) Global	methylation	content	 in	relation	 to	socio-economic	status	 (SES)	 in	the	pSoBid	cohort	(McGuinness	et	al	2012).		The	 last	 two	studies,	 the	McGuinness	et	al	2012	and	Borghol	et	al	2012,	study	the	same	social	factors	–	socio-economic	status	–	and	were	published	in	the	same	special	issue	of	the	International	Journal	of	Epidemiology	that	was	dedicated	to	the	prospects	of	epigenetics	in	and	for	epidemiology.	A	comparative	analysis	of	the	 two	 studies	 was	 therefore	 performed	 to	 examine	 whether	 any	 of	 the	 two	would	 be	 suitable	 for	 further	 analysis.	 The	 summary	 of	 this	 analysis	 that	 took	place	in	April	2014	is	presented	in	Table	7.		There	were	two	main	reasons	behind	choosing	the	McGuinness	study	for	further	exploration.	 First,	 the	 study	 was	 conducted	 on	 a	 cohort	 that	 was	 specifically	designed	 for	 studying	 the	 effects	 of	 socio-economic	 circumstances	 on	 health	(Velupillai	et	al	2008).	On	the	other	hand,	the	Borghol	study	was	conducted	on	a	birth	cohort.	Second,	 the	McGuinness	study	was	a	policy-related	study	–	 it	was	initiated	by	the	Glasgow	Centre	for	Population	Health	to	generate	guidelines	for	health	 policy	 in	 Glasgow.	 The	 Borghol	 study	 was	 an	 explorative	 one.	 As	 this	project	 was	 framed	 as	 ‘epigenetics	 and	 policy’,	 and	 sought	 to	 investigate	 how	epigenetics	 is	 currently	 employed	 in	 research	 and	 action	 upon	 health,	 the	McGuinness	 study	was	 selected	 for	 further	 exploration	 as	 a	 case	 study	 of	 this	thesis.		
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Table	7:	A	comparative	analysis	of	two	International	Journal	of		
Epidemiology	papers	on	the	association	between	socio-economic		
circumstances	and	epigenetic	differences		
(Borghol	et	al	2012	and	McGuinness	et	al	2012)		
Sampling		
The	interviews	were	conducted	 in	October	2014	in	Glasgow	with	support	 from	external	funding	body	–	the	COST	Action	IS1001	Bio-objects	and	their	boundaries:	
governing	 matters	 at	 the	 intersection	 of	 society,	 politics,	 and	 science,	 under	 its	Short	 Term	 Scientific	 Mission	 funding	 scheme.	 The	 allocated	 time	 for	 the	fieldwork	 in	 Glasgow	 was	 one	 working	 week.	 Bogner,	 Littig	 and	 Menz,	 (eds.	20009)	note	three	types	of	challenges	 in	 interviewing	experts:	sampling	 issues,	the	 specific	 access	 problems	 and	 the	 challenges	 of	 conducting	 interview.	 The	challenge	of	sampling	and	access	to	experts	in	this	study	arose	due	to	shortness	of	the	STSM	in	Glasgow,	which	could	not	be	extended	due	to	funding	limitation.	As	 a	 consequence,	 several	 of	 the	 pSoBid	 professionals	 were	 not	 available	 for	interviews	 during	 the	 designated	 week	 in	 October	 2014.	 Skype	 or	 phone	
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interviews	were	also	difficult	to	organise	due	to	their	busy	schedule.	In	order	to	conduct	the	STSM	under	the	COST	Action	IS1001,	a	person	from	the	University	of	Glasgow	had	 to	 accept	 to	 host	 it.	 The	 initial	 contact	was	 therefore	 established	with	the	principal	 investigator	of	 the	McGuinness	study	via	e-mail	 in	which	my	interest	in	their	work	and	the	aim	of	my	fieldwork	of	Glasgow	was	explained.	The	interviews	were	then	scheduled	with	nine	members	of	the	pSoBid	project,	based	on	their	availability	during	this	STSM,	while	ensuring	at	the	same	time	that	the	sample	of	people	reflected	the	diversity	of	disciplinary	expertise	 in	 the	pSoBid.	Assuring	that	the	sample	reflects	the	diversity	of	actors	with	respect	to	expertise	they	 bring	 into	 the	 project	 was	 of	 particular	 importance	 considering	 the	relatively	 small	 number	 of	 informants	 in	 this	 study.	 Four	 interviews	 were	organised	during	a	Skype	call	with	the	host	of	the	STSM,	while	another	four	were	arranged	via	e-mail.		A	 potential	 issue	 in	 receiving	 a	 positive	 answer	 by	 those	 pSoBid	 professionals	that	 were	 already	 accessed	 appeared	 to	 have	 been	 the	 language.	 Namely,	 the	informants	confessed	that	the	initial	Skype	calls	were	arranged	to	evaluate	if	my	command	 of	 English	 is	 good	 enough,	 as	 they	 held	 some	 concerns	 about	 being	interviewed	 by	 a	 non-native.	 Upon	 being	 assured	 that	 language	will	 not	 be	 an	obstacle	in	our	conversations,	they	felt	very	willing	and	comfortable	to	enter	into	discussions	and	also	engage	with	me	informally	during	my	stay	in	Glasgow.	The	issue	 of	 multi-lingualism	 in	 fieldwork	 is	 underexplored	 in	 literature,	 which	usually	 assumes	 a	monolingual	 research	 environment.	 Although	 this	 fieldwork	was	 conducted	 in	 a	monolingual	manner,	 it	 is	 important	 to	 keep	 in	mind	 that	language-related	 challenges	might	 arise	when	 the	 interviews	 are	 to	 take	 place	between	non-native	and	native	speakers,	be	it	English	or	in	any	other	language.	
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The	interviews	were	scheduled	with:	1) Head	of	 the	Laboratory	on	Biological	Aging	and	Epigenetics,	 Institute	of	Cancer	Sciences,	University	of	Glasgow	(member	1);		2) Head	of	the	Healthy	Working	Lives	Group,	Institute	of	Health	&	Wellbeing,	Public	Health,	University	of	Glasgow	(member	2);		3) Research	Associate	 in	 the	Healthy	Working	Lives	Group	working	on	 the	Biology	 of	 the	Workless,	 Institute	 of	 Health	 &	Wellbeing,	 Public	 Health	(member	3);		4) Research	Associate	 in	 the	 Scottish	 Observatory	 for	 Work	 and	 Health,	Institute	 of	 Health	 &	 Wellbeing,	 Public	 Health,	 University	 of	 Glasgow	(member	4);		5) Head	 of	 the	 Health	 Economics	 and	 Health	 Technology	 Assessment,	Institute	of	Health	&	Wellbeing,	University	of	Glasgow	(member	5);		6) Programme	 Manager	 in	 Public	 Health,	 Glasgow	 Centre	 for	 Population	Health	(member	6);		7) Programme	Leader	in	Neighbourhoods	and	Health,	and	Social	and	Spatial	Patterning	 of	 Health,	 Medical	 Research	 Council,	 University	 of	 Glasgow	(member	7);		8) Clinical	Lecturer	in	Public	Health,	University	of	Glasgow	(member	8).	All	interviewees	waived	anonymity.	9) Professor	of	Global	Health	and	former	Chief	Medical	Officer	for	Scotland		Unfortunately,	 the	 interview	with	the	 last	 informant	had	to	be	cancelled	due	to	this	informant’s	unanticipated	commitments.	The	final	sample	consisted	of	eight	pSoBid	 professionals.	 Six	 interviews	 lasted	 for	 approximately	 one	 hour,	 while	
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two	 lasted	 for	 about	 ninety	 minutes.	 In	 addition,	 informal	 engagement	 and	discussion	 took	place	with	3	of	 the	 informants	on	several	occasions	during	my	stay	in	Glasgow.	
	
Interview	Guide	
Preparatory	 research	 for	 the	 fieldwork	 in	 Glasgow	 included	 a	 review	 of	 all	publications	 produced	 on	 the	 pSoBid	 cohort;	 and	 activities	 and	projects	 of	 the	Glasgow	 Centre	 for	 Population	 health	 who	 initiated	 it;	 as	 well	 as	 getting	familiarised	with	other	work	of	the	professionals	involved	in	the	pSoBid	project	that	will	 be	 interviewed.	 These	 data	were	 then	 used	 in	 building	 the	 interview	guide.	 King	 and	 Horrocks’	 Interviews	 in	 Qualitative	 Research	 (2010)	 was	consulted	 for	 designing	 the	 interviews	 guide	 and	 for	 conducting	 data	 analysis.	This	book	provides	clear	and	easy	guidance	on	how	to	conduct	interviews	and	it	is	 an	 excellent	 resource	 for	 a	 novice	 in	 this	 type	 of	 research.	 Based	 on	 the	preparatory	research,	 two	main	themes	were	 interrogated	by	these	 interviews:	1)	the	cooperation	between	professionals	from	different	groups	and	of	different	background;	and	2)	the	evidential	value	of	epigenetic	data	in	population	studies	and	public	health	policy.		Several	additional	questions	within	these	two	broad	themes	were	also	examined:		-	How	did	the	actors	come	to	collaborate	in	the	first	place?	The	DNA	methylation	analysis	was	conducted	by	a	research	group	at	the	Institute	for	Cancer,	which	has	no	 formal	 affiliation	 with	 the	 GCPH	 who	 initiated	 the	 pSoBid	 project.	 It	 is,	however,	through	the	University	of	Glasgow	that	the	members	of	the	pSoBid	are	formally	connected,	as	shown	in	Chapter	Five	–	Behind	the	‘Glasgow	Effect’.	
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-	How	do	 actors	 of	 different	 professional/disciplinary	 background	 understand,	interpret,	 value	 and	 utilise	 epigenetic	 evidence;	 do	 these	 and	 to	 what	 extent	diverge	among	or	have	shared	meaning	between	the	actors?	-	What	is	the	perceived	status	of	epigenetic	evidence	in	public	health	compared	to	 other	 (non-molecular)	 types	 of	 evidence,	 i.e.	 data	 coming	 from	 social	epidemiology;	 and	 how	 is	 molecular	 evidence	 valued,	 in	 comparison	 with	evidence	 of	 non-molecular	 kind;	 and	 incorporated	 with	 evidence	 of	 non-molecular	kind?		-	 To	what	 extent	 is	 epigenetics	 through	 to	 influence	 the	ways	 in	which	 public	health	research	is	conducted	and	policy	strategies	are	devised?	-	How	is	in	utero/early	childhood	environment	justified,	evidentially,	as	a	source	of	adult	stage	epigenetic	differences	(methylation	levels),	which	were	correlated	with	SES	differences?	The	discussion	part	of	the	McGuinness	study	(McGuinness	et	 al	 2012)	 proposed	 that	 the	 effects	 experienced	 in	 utero	 and/or	 in	 early	childhood	 could	 be	 a	 possible	 explanation	 for	 the	 results	 they	 observed.	 In	addition,	such	explanation	was	picked	up	by	the	media,	who	publicized	the	study	findings	with	the	headlines	like	“Babies	born	into	poverty	are	damaged	forever	before	birth”	(The	Scotsman	201229)	and	leads	like	“New	research	into	DNA	has	shown	that	the	health	of	deprived	Glaswegians	could	be	impaired	before	they	are	even	born”	(BBC	News	201230).	The	questions	that	were	used	as	probes	within	these	two	broad	themes	include:	-	How	did	you	get	involved	in	the	project?	Can	you	tell	me	how	the	collaboration	between	you	and	other	members	started?																																																									
29 Available at: http://www.scotsman.com/news/babies-born-into-poverty-are-damaged-forever-before-
birth-1-2072713  
30 Available at: http://www.bbc.com/news/uk-scotland-glasgow-west-16680730 	
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-	 How	 do	 understand	 the	 work	 and	 results	 of	 other	 people	 with	 different	professional	background;	how	do	you	talk	with	each	other	about	it;	can	you	tell	me	about	any	difficulties	you	might	have	experienced	in	that?		-	Do	you	engage	also	with	the	public	in	Glasgow;	can	you	tell	me	how?	-	What	do	you	think	about	epigenetics	and	molecular	data?	Why	do	you	think	the	project	 collected	 also	 epigenetic	 data;	 do	 you	 think	 this	 was	 important?	 And	what	about	other	data,	is	this	something	entirely	new	and/or	more	important?		-	How	relevant,	if	at	all,	do	you	think	in	utero/early	childhood	environment	is	for	health	later	in	life?			The	 challenges	 in	 conducting	 interview	 can	 be	 in	 either	 over	 encouraging	 the	interviewee	to	structure	an	account	of	the	situation;	or	to	allow	the	interviewee	to	 introduce	 to	 a	 considerable	 account	 his	 own	 notion	 of	what	 they	 regard	 as	relevant	 instead	 of	 what	 the	 investigators	 regards	 as	 relevant	 (Dexter	2006/1969,	 p.18;	 cf.	 Bogner,	 Littig	 and	 Menz,	 eds.	 2009).	 Bogner,	 Littig	 and	Menz,	(eds.	2009)	thus	suggest	investigators	to	be	extremely	flexible	while	at	the	same	time	ensuring	to	present	themselves	as	competent	partners.	My	position	as	a	 junior	researcher	did	not	seem	to	pose	an	additional	challenge	 in	conducting	interviews	 with	 the	 pSoBid	 professionals	 because	 my	 background	 in	 science	made	all	 the	 informants	assured	of	my	 ‘general	 competence’.	The	 interviewees	did	not	perceive	me	as	‘inexperienced’	but	rather	as	‘a	fellow	expert	in	molecular	biology’	 or	 ‘an	 expert	 in	 a	 desirable	 area’	 (that	 is	 to	 say,	 molecular	 biology).	Beside	the	possible	challenge	that	my	status	of	a	non-native	speaker	could	have	had	on	 the	sampling	procedure,	 the	 local	dialect	of	Glasgow	was	at	 first	one	of	my	 concerns	 in	 preparing	 for	 these	 interviews,	 particularly	 because	 audio	
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recording	was	not	used	(see	below	in	the	Ethics	approvals,	risk	consideration	and	
reflexivity	 section).	 However,	 this	 did	 not	 pose	 an	 issue	 in	 this	 study	 as	 all	informants	use	formal	English	and	not	the	local	dialect.	Besides	my	educational	background,	 the	willingness	 on	 the	 side	 of	 the	 interviewees	 to	 discuss	 openly	and	freely	about	their	work	relied,	according	to	their	own	admission,	on	another	rather	surprising	factor	–	my	nationality,	i.e.	my	social/communal	background.	I	was	 thus	 perceived	 as	 a	 ‘like-minded’	 person	 who	 can	 understand	 and	appreciate	what	the	community	is	about	and	what	‘they	are	trying	to	achieve’	by	projects	like	the	pSoBid.		
	
Interview	setting	and	rapport	
All	 interviews	 took	 place	 in	 the	 offices	 of	 the	 informants.	 These	 included	 the	Glasgow	Centre	for	Population	Health	office,	Institute	for	Cancer	Sciences	lab	and	office,	 Medical	 Research	 Council	 office,	 and	 Glasgow	 Public	 Health	 Institute	 of	Health	and	Wellbeing	where	several	of	the	informants	hold	offices.			At	the	beginning	of	each	interview,	I	would	introduce	myself	and	my	project,	and	briefly	explain	why	I	am	interested	in	their	project	and	work;	as	well	as	what	I	am	interested	to	hear	about	from	them	in	that	interview:	1)	how	they	started	the	whole	 project;	 why;	 and	 how	 do	 they	 collaborate	 and	 2)	 what	 do	 they	 think	about	 the	 use	 of	 epigenetics	 in	 their	 projects,	 and	 epidemiological	 projects	 in	general,	and	why	they	think,	if	at	all,	it	is	important	in	such	projects.	The	rest	was	then	left	to	unfold	during	the	interview,	with	occasional	use	of	probes	to	stir	the	discussion.	Since	the	interviewees	waived	anonymity,	they	were	asked	after	the	
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interview	if	they	considered	anything	that	was	being	said	as	confidential	and	not	suitable	for	later	publishing.	They	were	also	told	they	will	receive	a	report,	which	had	to	be	submitted	to	the	funding	body	of	this	STSM,	that	was	produced	upon	the	analysis	of	the	data	collected	through	these	interviews.		
Observational component The	 original	 design	 of	 the	 STSM	 in	 Glasgow	 did	 not	 allow	 for	 participants	observation	or	ethnography,	as	these	would	entail	the	extended	involvement	in	the	social	life	of	the	pSoBid	professionals	(Bryman	2012)	while	the	STSM	could	last	 only	 for	 a	 week.	 However,	 informal	 engagement	 with	 several	 pSoBid	professionals	 provided	 critical	 insights	 into	 informants’	 understanding	 of	 their	role	 as	 both	 professionals	 and	 members	 of	 the	 community,	 and	 what	 the	communal,	local	bonds	and	identity	mean	to	Glaswegians.			The	observational	component	entailed:		1) Attendance	 at	 a	 football	match	 in	 Glasgow	 between	 Celtic	 FC	 and	 Saint	Partick	Thisle	FC,	which	included	the	‘traditional	walk’	to	the	Celtic	Park	Stadium	with	Celtic	fans	through	the	deprived	areas	of	Glasgow	2) Participating	 to	 post-match	 activities	 with	 Celtic	 fans	 in	 one	 of	 the	traditional	Celtic	FC	pubs	in	Glasgow	3) Attendance	 at	 a	 football	match	 in	Milan	 between	 Internazionale	 FC	 and	Celtic	FC	in	the	knock-out	phase	of	the	Europa	League,	in	the	visitors’	box	with	Celtic	fans	
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4) Participating	to	pre-match	activities	with	Celtic	fans	in	Milan	for	two	days,	including	city	walks	and	pub	hopping;	as	well	as	to	post-match	activities	with	Celtic	fans,	which	included	more	pub	hopping	
	
Data analysis Since	audio	recording	could	not	be	used	in	these	interviews	due	to	bureaucratic	impracticalities	 related	 to	 ethics	 approval	 (see	 below),	 the	 elaborate	 and	exhaustive	notes	were	taken	in	each	interview.	The	interviewees	themselves	did	not	feel	disturbed	by	my	taking	notes.	My	years-long	experience	in	taking	notes	in	 conversations	 with	 people	 in	 various	 settings	 I	 gained	 at	 my	 previous	 job	proved	a	valuable	asset	in	this	setting.		King	and	Horrocks’	guide	for	qualitative	researchers	 was	 consulted	 on	 how	 to	 get	 the	 best	 possible	 interview	 data	 by	taking	 notes	 (King	 and	 Horrocks	 2010).	 The	 notes	 were	 transcribed	 and	converted	into	electronic	format	by	myself	after	each	interview,	while	additional	comments	and	observations	were	also	noted	into	the	transcribed	text.		Data	analysis	 took	the	 form	of	 thematic	analysis	whereby	the	 focus	was	on	the	two	 themes	 set	 before	 the	 interviews	 –	 collaboration	 between	 actors	 and	 the	value	 of	 epigenetic	 data	 in	 research	 and	 policy	 –	 and	 what	 views,	 opinions	perspectives	were	elicited	by	in-depth	discussion.	Because	of	the	small	number	of	informants	who	at	the	same	time	waived	anonymity,	the	analysis	also	focused	on	 to	what	 extent	 and	 how	 does	 disciplinary	 and/or	 professional	 background	influence	perceptions	about	epigenetic	data;	does	junior/senior	level	within	the	project	play	a	role	and	how;	how	informants	spoke	about	other	informants	and	their	 work;	 and	 how	 informants	 perceived	 their	 own	 role	 in	 their	 discipline,	
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within	the	project	and	in	future	projects.	Another	theme	emerged	from	the	data	–	 communal	 identity	 and	 membership.	 This	 concept	 first	 emerged	 during	 the	interviews	but	it	was	only	after	observational	component	was	included	into	the	data	that	the	communal	identity	and	membership	emerged	as	a	theme	that	cuts	across	 all	 the	 others.	 A	 preliminary	 analysis	 of	 the	 data	 had	 to	 be	 completed	within	 four	 weeks	 after	 the	 STSM	 and	 shaped	 into	 a	 report,	 as	 the	 external	funding	 body	 required	 such	 a	 report	 for	 the	 final	 approval	 of	 this	 work.	 This	report	was	also	sent	to	all	the	interviewees.		Observational	 studies	 were	 conducted	 through	 informal	 engagement	 with	pSoBid	 researchers,	 which	 unintentionally	 included	 engagement	 with	 also	pSoBid	 participants.	 This	 took	 the	 form	 of	 attending	 football	 matches	 and	engaging	 in	 football	 supporting	 activities	 of	 the	 Celtic	 Football	 Club	 (FC)	 in	Glasgow,	during	the	STSM,	and	later	in	Milan.	The	observational	data	on	football-related	 activities	 were	 included	 into	 data	 analysis	 as	 they	 provided	 not	 only	additional	source	of	information	that	helped	identify	the	communal	identity	and	membership	as	a	third	theme,	but	the	only	possible	way	of	gauging	the	meaning	of	this	theme	for	the	professionals	involved	in	the	pSoBid	project.			
Ethics approvals, risk considerations and reflexivity Obtaining	ethical	approval	for	this	study	from	home	institutions	–	the	European	Institute	 of	 Oncology	 (IEO)	 and	 the	 University	 of	 Milan	 (UoM)	 –	 was	 neither	required	 nor	 was	 it	 possible.	 These	 institutions	 only	 processed	 application	regarding	 their	 own	 personnel	 (IEO)	 or	 for	 the	 studies	 conducted	 in	 Italy	
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(UoM)31.	 The	 issue	 therefore	 was	 whether	 ethics	 approvals	 should	 be	 sought	from	 the	 host	 institution	 –	 the	 University	 of	 Glasgow	 (UoG),	 and	 all	 other	institutions	 with	 which	 the	 informants	 are	 affiliated	 –	 Institute	 of	 Cancer	Sciences,	 Glasgow	 Centre	 for	 Population	 Health,	 Institute	 of	 Health	 and	Wellbeing	 and	 Medical	 Research	 Council.	 Such	 process	 would	 be	 long	 and	cumbersome,	while	the	time	of	the	fieldwork	could	not	have	been	moved	due	to	the	 external	 funding	 body	 limitations	 –	 the	 fieldwork	 could	 have	 only	 been	approved	in	August	2014,	while	it	had	to	be	completed	by	December	2014.	As	a	solution	for	these	conflicting	requirements,	an	agreement	was	reached	with	my	STSM	host	and	other	informants	whereby	they	would	waive	anonymity	but	that	audio	 recording	 would	 not	 be	 used	 during	 these	 interviews.	 This	 study	exemplifies	how	plurality	of	regulatory	frameworks	and	procedures	with	respect	to	 approvals	 can	 appear	 as	 a	 potential	 source	 of	 difficulties	 for	 trans-national	and	multi-cultural	 fieldwork.	These	difficulties	have	to	be	tackled	and	managed	on	a	case-by-case	basis,	and	this	requires	a	lot	of	flexibility	not	just	on	the	side	of	the	researcher	but	also	on	the	side	of	the	prospective	informants.			The	data	collected	 for	 the	 first	aim	of	 this	project	come	from	published	and/or	publicly	 available	 sources	 and	 hence	 raises	 no	 ethical	 concerns.	 The	 data	collected	 through	 interviews	 were	 obtained	 with	 the	 consent	 from	 all	informants.	 The	 informants’	 role	 as	 group	 leaders/representatives	 were	disclosed,	but	none	of	the	informants	were	named	in	any	public	presentation	of	
																																																								31	In	July	2015,	the	University	of	Milan	Ethics	Committee	extended	its	competencies	to	studies	taking	place	outside	of	Italy	and	now	considers	such	applications	for	research	outside	of	Italy.	This	change	is	a	result	of	joint	work	by	myself,	Luca	Marelli	and	Giuseppe	Testa		
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the	 data.	 In	 addition,	 the	 results	 of	 how	 the	 data	 collected	 through	 interviews	and	observational	 study	were	used	 in	my	 thesis	were	presented	 to	each	of	 the	informant	in	the	form	of	a	written	report.	All	informants	expressed	no	concerns	or	complaint	over	how	their	work,	views	and	perspectives	were	presented	in	the	report.	The	observational	study	data	pose	no	ethical	concerns	or	risk	either,	as	all	 the	 participants	 remained	 known	only	 to	 the	 extent	 that	 they	 are	 Celtic	 FC	supporters.		This	 research	 was	 eventually	 approached	 from	 an	 interpretivist	 position	whereby	 multiple	 versions	 of	 reality	 are	 possible.	 However,	 the	 philosophical	assumptions	that	underlie	this	research	are	those	of	critical	empiricism,	as	found	in	King	and	Horrocks:		 »Behaviour	 and	 experiences	 are	 seen	 to	 be	 ‘generated	 by’	 underlying	structures	 such	 as	 biological,	 economic	 or	 social	 structures».	 (King	 and	Horrocks	2010,	p.	9):		Accordingly,	 the	 methodological	 approach	 employed	 is	 that	 of	 contextualism	rather	 than	 of	 full-blown	 constructivism.	 Given	 the	 original	 structuring	 of	 this	research	through	the	objectives	set	up	by	the	EPIGEN	project,	the	only	possible	methodological	approach	in	this	project	was	that	of	methodological	pragmatism	(Tashakkori	and	Teddlie	2010,	eds.).		Besides	 empirical	 reflexivity,	 Willig	 (2001)	 distinguishes	 also	 personal	reflexivity,	 whereby	 contingencies	 of	 our	 experiences	 and	 life	 influence	 the	process	of	 research	 in	 all	 its	 stages	 (Willig	 2001).	 In	 this	 respect,	my	previous	
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involvement	 with	 non-governmental	 organisation	 where	 I	 worked	 with	vulnerable	groups	of	people	living	in	or	coming	from	the	conditions	of	extreme	poverty	might	have	played	a	contributing	 factor	 in	choosing	 to	 focus	on	health	inequalities	 rather	 than	 on	 innovation	 practices	 in	 biotechnology.	 Accordingly,	the	 aspirations	 and	 deontological	 claims	 to	 remedy	 to	 the	 long-suffered	injustices	 of	 Glaswegian	 community	 expressed	 by	 my	 interviewees	 resonated	with	my	own	aspirations	and	expectations	of	what	science	should	be	about	and	for.	 The	 project’s	 exploration	 of	 solidarity	 also	 reflects	 my	 own	 interest	 in	solidary	 practices.	 I	 believe,	 however,	 that	 these	 considerations	worked	 to	 the	project’s	best	interest	and	not	against	it.			
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CHAPTER	FOUR	–	BEYOND	THE	GENOME	
	
INTRODUCTION	
This	 chapter	 presents	 empirical	 data	 gathered	 through	 combined	 qualitative-quantitative	 strategy	 developed	within	 this	 project	 to	 present	 the	most	 active	areas	 of	 epigenetic	 research,	 clinical	 application	 and	 clinical	 outputs.	 It	 also	presents	data	on	how	‘environment’	is	conceptualised/addressed	in	epigenomic	practice;	 and	 on	 environmental	 epigenetics	 research	 and	 its	 commercial	application.	 The	 chapter	 finds	 that	 the	 most	 actvevly	 studied	 diseases	 in	epigenetic	 research	 reflect	 the	 diseases	 reported	 by	 the	 WHO	 as	 major	contributors	 to	 the	 burden	 of	 disease	 in	 both	 ‘developed’	 and	 ‘developing’	countries	and	regions	of	the	world.	The	chapter	also	finds	that	epigenetics	goes	‘beyond	the	genome’	insofar	as	what	lies	beyond	can	be	converted	into	genome-friendly,	 code-compatible	 manner	 that	 is	 to	 say	 into	 digital	 representations	(Meloni	and	Testa	2014).					
THE	IMPACT	OF	EPIGENETICS	ON	HEALTH	CARE	
The	methods	used	in	this	part	of	the	research	project	include	systematic	review	and	 qualitative	 reading	 of	 biomedical	 literature	 gathered	 through	 PubMed	database;	 systematic	 review	 and	 qualitative	 analysis	 of	 cancer	 clinical	 trials	gathered	 through	 the	National	 Cancer	 Institute	 (NCI)	 and	 the	 European	Union	Clinical	Trial	(EU-CT)	registers.	The	analysis	 took	the	 form	of	compiling	 lists	of	
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the	results	in	Microsoft	Excel	files	and	visualising	the	data	using	Microsoft	Excel	tools.			The	 search	 terms	 used	 to	 capture	 translational	 and	 clinical	 research	 were	‘epigenetics,	 treatment’	 and	 ‘epigenetics,	 treatment,	 clinical	 trial’	 respectively.	Additional	key	words	were	used	in	combination	with	each	of	these	search	terms	to	 determine	 the	 most	 actively	 studied	 disease	 areas	 included:	 cancer;	cardiovascular	 diseases;	 neurodegenerative	 diseases;	 autoimmune	 diseases;	type	2	diabetes.	The	results	of	these	searches	are	shown	in	Figure	1.		
	
Figure	1	-	Types	of	research	within	the	field	of	epigenetics.		
Source:	PubMed	2014		The	 ‘treatment’	 part	 of	 the	 pie	 in	 Figure	 1	 represents	 translational	 research;	‘clinical	 trial’	 part	 represents	 clinical	 research;	 while	 ‘other’	 section	 of	 the	 pie	represents	 ‘basic	 research’.	 The	 ‘basic	 research’	 section	 was	 calculated	 by	subtracting	the	results	on	‘translational	research’	and	clinical	research’	from	the	results	 of	 ‘total	 epigenetics’,	 i.e.	 it	 is	 represented	 by	 the	 part	 of	 all	 epigenetic	
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research	that	is	neither	translational	nor	clinical.	Basic	research	was	identified	as	the	most	active	type	of	research	within	the	field	of	epigenetics	in	general	(68%,	the	top	left	graph	of	Figure	1),	as	well	as	in	epigenetic	studies	of	the	five	selected	disease	areas	(other	graphs	in	Figure	1).	A	significantly	smaller	size	of	the	area	representing	 clinical	 research	 (1-3%)	 is	 expected	 to	 occur	 in	 all	 biomedical	sciences,	not	 just	 the	emerging	ones	 like	 epigenetics.	This	 should	especially	be	kept	 in	 mind	 in	 light	 of	 the	 results	 of	 how	 much	 is	 translational	 research	represented	within	all	epigenetics	research	–	between	30%	and	40%.			The	 search	 terms	 used	 in	 identifying	 the	 most	 actively	 studied	 diseases	 were	selected	upon	general	review	and	qualitative	reading	of	biomedical	literature	on	epigenetic	research.	Figure	2	show	results	of	the	searches	related	to	identifying	the	 most	 actively	 studied	 disease	 areas	 in	 basic,	 translational	 and	 clinical	epigenetic	research.			
	
Figure	2	-	The	most	actively	studied	disease	areas	in	epigenetic	research.		
Source:	PubMed	2014	
	 125	
	Cancer	was	identified	as	the	most	actively	studied	disease	area	within	the	field	of	epigenetics	in	general	(47%,	the	top	left	graph	in	Figure	2),	as	well	as	in	all	types	of	 epigenetic	 research	 (other	 graphs	 in	 Figure	 2).	 In	 clinical	 research	 in	particular,	cancer	dominated	the	results	with	the	score	of	71%	(the	bottom	right	graph	in	Figure	2).	These	diseases	were	reported	by	the	WHO,	with	the	exception	of	autoimmune	diseases,	as	the	major	contributors	to	burden	of	disease	in	both	‘developed’	 and	 ‘developing’	 countries	 and	 regions	 of	 the	 world	 (WHO	 2008).	Moreover,	cancer,	neurodegenerative	diseases	and	autoimmune	diseases	are	the	diseases	 studied	 within	 the	 NIH	 Roadmap	 Epigenomics	 project	 (Epigenomics	Roadmap	Project	2015).			The	 thirty	 one	 papers	 obtained	 in	 a	 search	 that	 used	 ‘epigenetics,	 treatment,	clinical	 trial,	 cancer’	 as	 search	 terms	were	 submitted	 to	 qualitative	 reading	 to	identify	which	epigenome-modifying	mechanisms	are	 the	most	 studied	ones	 in	clinical	research.	The	results	of	this	study	are	shown	in	Table	3	in	Chapter	Three	–	 Research	 Design	 and	 Methods.	 The	 following	 searches	 conducted	 in	 the	databases	on	clinical	trials	did	not	yield	any	results	when	‘epigenetics’	was	used	as	the	key	word.	More	fine-grained	terms	were	therefore	necessary	 in	order	to	conduct	 such	 studies.	 Cancer	 as	 a	 case	 study	was,	 on	 the	 other	 hand,	 selected	because	it	scored	the	highest	in	all	the	performed	searches,	reaching	71%	in	the	clinical	research	(Figure	2,	the	bottom	right	graph).	The	results	of	the	qualitative	reading	 of	 cancer	 clinical	 research	 are	 shown	 in	 Figure	 3.	 The	 most	 actively	studied	 targets	 in	 epigenetic	 therapies	 in	 cancer	 are	 DNA	 methyltrasnferases	
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(DNMT)	and	histone	deacetylases	(HDAC),	or	a	combination	of	both	(DNMT	and	HDAC).	Section	‘other’	in	Figure	3	represents	uncategorised	targets.				
	
Figure	3	-	Targets	of	epigenetic	therapies	in	cancer.	Source:	PubMed	2014		These	 results	 therefore	 formulated	 search	 terms	 for	 a	 study	 on	 clinical	applications	of	epigenetics.	A	study	about	on-going	clinical	trials	at	the	National	Cancer	 Institute	 (NCI)32	was	 conducted	 to	 examine	 the	 types	 of	 cancer	 care	(treatment,	 prevention,	 diagnosis,	 etc.)	 for	 which	 the	 targets	 of	 epigenetic	therapy	are	currently	in	clinical	testing.	The	results	for	histone	deacetylases	and	methyltranspherases	are	shown	in	Tables	8	and	9	respectively	in	Chapter	Two	–	Methods.		These	clinical	 trials	reported	 in	 the	results	of	 these	searches	were	subjected	to	qualitative	 analysis	 to	 confirm	 that	 the	 compounds	 they	 test	 for	 do,	 indeed,	
																																																								32	Available	at	http://www.cancer.gov/clinicaltrials		(Last	accessed	on	12.12.2016.)	
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target	 the	 epigenome.	 Treatment	 and	 biomarker/laboratory	 analysis33	are	 the	dominant	 areas	 of	 cancer	 care	 for	 both	 HDAC	 inhibitors	 (HDACi)	 and	 DNMT	inhibitors	 (DNMTi),	 but	 several	 trials	 are	 conducted	 in	 the	 areas	of	 supportive	care	 and	 diagnosis,	 as	 well	 as	 prevention.	 According	 to	 the	 results	 obtained	through	NCI	database,	thirty-six	epigenome-modifying	compounds	are	currently	tested	 in	 cancer,	 and	most	 of	 them	 target	 histone	 deacetylation.	Most	 of	 these	epigenome-modifying	 compounds	 are	 in	 the	 first	 two	phases	of	 clinical	 testing	Figure	 4),	which	 are	 conducted	 for	 testing	 the	 safety	 of	 a	 drug	 and	 not	 for	 its	efficacy	in	treatment	
	
Figure	4	-	The	phases	of	clinical	trials	of	currently	tested		
epigenome-modifying	compounds	in	cancer.		
Source:	NCI	2014		The	epigenome-modifying	compounds	 that	are	currently	 tested	 in	 five	of	more	clinical	trials	(CTs)	are	shown	in	Table	8.			
																																																								33	The	NCI	database	has	embedded,	non-modifiable	categories	within	search	criteria.	Biomarker/laboratory	analysis	category	is	in	most	cases	combined	with	treatment	category	as	a	‘type	of	trial’	
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	 Generic	name	 No	of	CTs	
1	 Vorinostat	 123	
2	 Panobinostat	 89	
3	 Romidepsin	 39	
4	 Temozolomide	 28	
5	 Valproate	 27	
6	 Belinostat	 18	
7	 Entinostat	 17	
8	 HDACi	general	 12	
9	 Decitabine	 9	
10	 SGI-110	 8	
11	 DNMTi	general	 6	
12	 Ricolinostat	 5	
13	 Pracinostat	 5	
14	 Azacitidine	 5	
	
Table	8:	The	most	actively	tested	epigenome	modifying	compounds	in		
cancer	clinical	trials.	Source:	NCI	2014		The	search	on	epigenome-modifying	compounds	that	target	histone	deacetylases	and	 DNA	 methyltranspherases	 was	 then	 conducted	 using	 also	 the	 EU	 clinical	trial	register	(EU-CTR)	database.		The	results	of	this	search	are	shown	in	Table	9.				
	 Generic	name	 No	of	CTs	
1	 Temozolomide	 115	
2	 Azacitidine	 53	
3	 Valproate	 39	
4	 Mercaptopurine	 38	
5	 Decitabine	 25	
6	 Panobinostat	 22	
7	 Vorinostat	 17	
8	 Romidepsin	 7	
9	 Belinostat	 6	
10	 Givinostat	 6	
	
Table	9:	The	most	actively	tested	epigenome	modifying	compounds.		
Source:	EU-CTR	
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The	compounds	identified	in	these	studies	were	then	searched	for	in	the	US	Food	and	 Drugs	 Administration	 	 (FDA)	 and	 the	 European	 Medicines	 Agency	 (EMA)	databases	 to	 check	 which	 of	 them,	 if	 any,	 have	 previously	 received	 market	authorisation;	 under	which	market	 name;	 and	 for	what	 condition.	 	 The	 list	 of	epigenome-modifying	 compounds	 that	 are	 received	market	 authorisation	 until	August	2014	is	shown	in	Table	10.	The	FDA	authorised	nine	such	epidrugs,	while	the	 EMA	 authorised	 five	were.	 In	 addition,	 Panobinostat	 and	 Tecadinaline	 are	two	 HDAC	 inhibitors	 that	 are	 in	 phase	 three	 of	 clinical	 testing,	 which	 aims	 to	demonstrate	 the	 drug’s	 efficacy	 in	 disease	 treatment.	 Moreover,	 a	 companies	that	 offer	 a	 range	 of	 in	 vitro	 tests	 for	 several	 epigenetic	 markers	 in	 cancer	treatment,	 e.g.	 Oncomethylome	 Sciences,	 Epigenomics	 AG,	 Sequenom,	 Exact	Sciences	are	emerging;	and	one	such	test	received	market	authorisation	from	the	FDA	 in	2014	 (a	 combined	 four	methylation	markers	 test	 for	 early	detection	of	colon	cancers	by	the	Exact	Sciences	company).	
	Most	 of	 these	 drugs	 have	 reached	 the	market	 in	 the	 last	 10	 years,	 but	 several	received	market	authorisation	before	the	year	2000,	i.e.	prior	to	the	beginning	of	the	‘exponential	rise’	in	publications	on	epigenetics	(Haig	2012;	Jirtle	2012).	One	such	 drug	 is	 on	 the	 market	 since	 as	 early	 as	 1953,	 when	 the	 FDA	 approved	market	 authorisation	 request	 to	 the	 TEVA	 Pharmaceutical	 Private	 Limited	Company	 for	 Purinethol.	 As	 it	 happens	 in	 general	 with	 drug	 approval	applications	 filed	 for	 different	 markets,	 which	 operate	 in	 different	 regulatory	frameworks,	 an	 epigenome-modifying	 compound	 Istodax	 (romidepsin)	 of	 the	Celgene	Europe	Ltd.	Company	received	market	authorisation	by	the	US	Food	and	
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Drug	 Administration	 in	 2009,	 while	 the	 European	 Medicines	 Agency	 rejected	their	application	twice	in	201234.			
Generic	name	 App	 Condition*	 Market	name	
Valproate	 FDA	
anticonvulsion	
Depakote-ER-
CR/Depakene/Stavzor/Depacon	
Vorinostat/SAHA	 FDA	 CTCL	 Zolinza	
Romidepsin	 FDA	 CTCL,	PTCL	 Istodax	
Belinostat	 FDA	 PTCL	 BELEODAQ	
Sodium	
phenylbutyrate	
FDA	
EMA	
UCD	 Buphenyl/SODIUM	
PHENYLBUTYRATE/Ammonapse/Ph
eburane	
Temozolomide	 FDA	EMA	
GBM	
Temodar/Temodal/Temomedac/Te
mozolomide-Hexal/Hospira-
Sandoz-Sun-Teva	
Mercaptopurine	 FDA	EMA	
ALL	 MERCAPTOPURINE/PURINETHOL/P
URIXAN	/Xaluprine	
Decitabine	 FDA	EMA	
MDS/AML	 Dacogen/Decitabine	
5-azacytidine	 FDA	EMA	
MDS	 Vidaza/Azacitidine	
	
Table	10:	The	list	of	epigenome-modifying	compounds	(epidrugs)			
currently	approved	by	FDA	and/or	EMA.		
Source:	FDA	2014;	EMA	2014;	NCI		2014;	EU-CTR	2014		
*CTCL	–	cutaneous	T-cell	lymphoma;	PTCL	–	peripheral	T-cell	lymphoma;		
UCD	–	urea	cycle	disorder;	GBM	–	glioblastoma;	ALL	–	acute	lymphoblastic		
leukemia;	AML	–	acute	myeloidic	leukemia;	MDS	–	myelodysplastic		
syndromes																																																											34	Available	at:	http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002122/smops/Negative/human_smop_000407.jsp&mid=WC0b01ac058001d127	(Last	accessed	on	12.12.2016.)	
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THE	‘ENVIRONMENT’	IN	EPIGENOMIC	SCIENCE		
With	the	advent	and	rapid	development	of	sequencing-based	technologies,	much	of	today’s	science	of	epigenetics	is	concerned	with	producing	genome-wide	maps	of	 various	 DNA	 and	 chromatin	 modification,	 as	 well	 as	 chromatin	 structures	across	 the	whole	 genome.	 This	 science	 of	 genome-wide	mapping	 of	 epigenetic	modifications	goes	by	the	name	‘epigenomics’.	In	the	last	couple	of	years,	many	national	and	supranational	epigenomic	projects	and/or	consortia	were	initiated	with	 the	 aim	 of	 producing	 high-resolution	 reference	 epigenomes	 for	 different	cell	 types.	 Results	 of	 one	 such	 project,	 the	NIH	Roadmap	Epigenomics	 project,	were	collectively	published	 in	a	special	 issue	of	 the	 journal	Nature	 in	February	2015	 (Nature	 2015).	 The	 NIH	 Roadmap	 Epigenomic	 project	 was	 initiated	 in	2010	and	consisted	of	five	research	initiatives.	One	such	initiative	was	on	human	health	and	disease,	which	supported	also	the	research	on	responses	to	exposures	such	as	physical,	chemical,	behavioral,	and	social	 factors35.	The	eight	threads	in	which	 its	Nature	papers	were	published	 include:	 annotation	of	 the	non-coding	genome;	relationship	between	different	epigenomic	marks;	epigenomic	changes	during	 differentiation	 and	 development;	 regulatory	 models:	 networks,	 motifs,	modules,	sequence	drivers	and	predictive	models;	interpreting	variation:	GWAS,	cancer,	 genotype,	 evolution	 and	 allelic;	 epigenomic	 changes	 in	human	diseases	and	during	cancer	progression;	brain	epigenomics;	and	computational	tools	and	methods.	 None	 of	 the	 twenty-one	 publications	 produced	 by	 the	 project	 was	concerned	with	 responses	 to	 environmental	 factors.	Only	one	paper	mentioned	environmental	exposures	and	it	did	so	in	its	introduction	-	Sexual	dimorphism	in																																																									35	Form	more	information	see	http://www.roadmapepigenomics.org/overview/epigenomics-human-health	(Last	accessed	on	12.12.2016.)	
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epigenomic	responses	of	stem	cells	to	extreme	fetal	growth	(Delahaye	et	al.	2015).	One	paper	mentions	the	environment	as	something	to	control	against	(Lowdon	
et	al.	2015).	Another	paper	mentions	 it	 in	 the	discussion	part	as	a	 side-note	of	how	the	results	presented	relate	to	the	general	picture	of	the	Alzheimer	disease	model	 (Gjoneska	 et	 al.	 2015).	 Other	 papers	 that	 do	 contain	 just	 the	 word	‘environment’,	 the	word	 is	 found	 in	 the	 references	or	 in	 the	acknowledgments.	The	 reference	 in	 almost	 all	 cases	 being	 the	 Genome-wide	 chromatin	 state	
transitions	 associated	with	 developmental	 and	 environmental	 cues	 by	 Zhu	 et	 al.	2015.	The	 acknowledgment	was	 always	 the	 same	 and	 referred	 to	 the	National	Institute	 of	 Environmental	Health	 Sciences.	 In	most	 of	 these	 papers	 the	words	‘environment’	 and	 ‘environmental’	 are	 entirely	 absent.	 The	 papers,	 however,	employ	all	the	expressions	from	genomic	vocabulary,	e.g.	functional	annotations,	datasets,	 regulatory	networks,	mapping,	etc.	The	 lack	 (or	complete	absence)	of	‘environment-related	 discourse	 and,	 correspondingly,	 the	 dominance	 of	‘genomic’	 (or	 ‘-omic’	 in	 general)	 discourse	 suggest	 that	 the	 environment	 in	epigenomic	 science	 and	practice	 is	 being	 taken	 into	 consideration	 insofar	 as	 it	could	 be	 represented	 in	 a	 ‘genome-friendly,	 code-compatible’,	 that	 is	 to	 say,	digital	manner	(Maloni	and	Testa	2014).		At	 the	 same	 time,	 in	 the	 big	 and	 growing	 field	 of	 epigenetics	 a	 small	 corner	 is	concerned	 with	 molecular	 relationship	 between	 factors	 such	 as	 chemicals,	smoking,	 diet,	 exercise,	 etc.,	 and	 health-related	 conditions	 like	 elevated	 blood	pressure,	 anxiety,	 obesity,	 etc.	 in	 a	 causal,	mechanistic	manner	 (Landecker	 and	Panofsky	2013).	Factors	like	child	neglect	(i.e.	parental	care,	Weaver	et	al.	2004),	poverty	 (i.e.	 socio-economic	 circumstances,	McGuinness	et	 al.	 2012;	Borghol	 et	
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al.	2012)	or	substance	abuse	(i.e.	drug	addiction,	Renthal	and	Nestler	2008),	are	the	subject	of	study	for	a	 few	of	 them.	The	pioneering	experiments	 in	this	area	have	 been	 produced	 by	 an	 interdisciplinary	 team	 of	 scientists	 at	 the	 McGill	University	 in	 Montreal.	 A	 study	 conducted	 on	 a	 rat	 model	 of	 maternal	 care	showed	 that	 having	 attentive	 or	 inattentive	mothers	 caused	 differences	 in	 the	methylation	 status	of	 two	genes	 in	 the	brain	of	 the	pups:	1)	 the	glucocorticoid	receptor	 gene,	 which	 has	 a	 role	 in	 stress	 responses,	 and	 2)	 the	 oestrogen	receptor	gene,	which	has	a	role	in	parental	behaviour.	The	study	was	published	in	 the	 journal	Nature	 Neuroscience	 under	 the	 title	 Epigenetic	 programming	 by	
maternal	behaviour	 (Weaver	et	al	2004).	 	This	study	has	paved	the	way	for	the	establishment	 of	 research	 fields	 that	 connect	 epigenetics	 to	 the	 research	programmes	of	other	disciplines	such	as	environmental	epigenetics,	behavioural	epigenetics,	 social	epigenetics	and	nutritional	epigenetics.	However,	 the	results	of	such	studies	and	the	scientists	that	conduct	them	are	received	rather	critically	and	with	a	high	dose	of	skepticism	within	the	wider	field	(Pickersgill	2016).	My	own	 experience	 of	 four	 years	 of	 working	 in	 a	 research	 institution,	 which	required	 doing	 bench	 work	 for	 a	 year,	 attending	 two	 lab	 meetings	 and	 one	seminar	 per	 week,	 presenting	 scientific	 publications	 of	 this	 kind	 (e.g.	Padmanabhan	et	al	2013)	at	journal	clubs,	and	presenting	my	own	data	to	the	lab	and	 Institute	 colleagues	 as	 well	 as	 at	 the	 annual	 meetings	 of	 the	 EPIGEN	consortium,	 confirms	 such	 general	 attitude	 of	 suspicion	 and	 cynicism	 among	fellow	epigeneticists	regarding	environmental	epigenetics	research	and	results.	Despite	 representing	 such	 small	 corner	 of	 the	 field,	 or	 perhaps	 because	 of	 it,	these	 studies	 gain	 the	 most	 attention	 outside	 of	 the	 field,	 including	 in	 social	studies	 of	 science.	 Accordingly,	 several	 companies	 that	 seek	 to	 provide	 their	
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products	and	services	with	scientific	legitimacy	have	recognized	its	commercial	potential,	which	is	discussed	in	the	following	section.		
COMMERCIAL	APPLICATION	OF	EPIGENETICS	IN	NON-MEDICAL	
SECTORS	
Drawing	on	 results	 of	 experiments	with	 agouti	mice,	which	demonstrated	 that	diet	 is	 responsible	 for	 phenotypic	 differences	 (Waterland	 and	 Jirtle	 2013)	 and	studies	 in	 humans	 that	 suggest	 that	 diet	 of	 parents	 affects	 growth	 and	metabolism	 in	 children	 (Tobi	 et	 al.	 2014),	 nutrition	 industry	 has	 endorsed	epigenetics	 in	 its	 science-based	 justifications	of	 their	products’	 health	benefits.	For	 example,	 Reliv	 International	 Company	 released	 ‘the	 epigenetic	 superfood’	product	 called	 LunaRich36.	 This	 product	 is	 based	 on	 a	 naturally	 occurring	 soy	peptide	 called	 lunasin,	 for	 which	 the	 company	 claims	 to	 be	 ‘the	 first	 dietary	ingredient	identified	to	affect	gene	expression	and	promote	optimal	health	at	the	epigenetic	 level’.	 According	 the	 LunaRich	 advert,	 lunasin	 is	 one	 of	 the	 most	heavily	researched	and	scientifically	supported	nutritional	compounds	available	today,	with	over	30	research	institutions,	20	funding	sources,	and	80	published	papers	behind	it.	The	adverts	go	on	to	explain	what	epigenetics	and	epigenome	is,	 emphasizing	 that	 ‘while	 you	 can’t	 change	 your	 DNA	 blueprint,	 you	 can	influence	 the	way	 that	 DNA	 expresses	 itself.’	 Considering	 its	 numerous	 health	benefits	 –	 cholesterol	 management,	 inflammation	 reduction,	 antioxidant	benefits,	 improved	 immunity,	 and	 cellular	 health	 –	 the	 take-home	 message	directed	 at	 prospective	 customers	 is	 that	 “with	 lunasin,	 you	 really	 can	 take																																																									36	Available	at:	https://reliv.com/lunarich	(Last	accessed	on	12.12.2016.)	
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control	of	your	health».37	Other	companies	have	gone	even	further	and	endorsed	epigenetics	 as	 their	 future	 investment.	 Nestlé,	 one	 of	 the	 most	 valuable	companies	 in	 the	 world	 (Forbes	 reports	 Nestlé	 as	 33rd	 on	 its	World’s	 Biggest	Public	 Companies	 list,	 with	 an	 estimated	 worth	 value	 of	 $235.7	 billion38	US	dollars	 –	 over	 30	 billion	more	 that	 the	 biggest	 pharmaceutical	 companies	 like	Pfizer	and	Novartis)	 recently	announced	 that	 they	would	contribute	22	million	Swiss	 Franks	 to	 a	 six-year	 research	 project	 into	 maternal	 nutrition	 and	epigenetics	 –	 ‘the	 science	 of	 how	 eating	 behaviours	 and	 other	 environmental	factors	 can	 affect	 your	 genes,	 health	 and	 that	 of	 your	 offspring,	 for	 future	generations	to	come’.	At	the	time	when	this	company	is	fighting	allegations	using	of	child	labour	in	Ivory	Coast	farms39,	Nestlé	has	announced	a	partnership	with	an	international	alliance	of	researchers	at	institutions	in	Southampton,	Auckland	and	Singapore,	who	make	up	the	EpiGen	Consortium,	and	that	being	involved	in	‘such	 cutting-edge	 research	 in	 such	 a	 vital	 and	 exciting	 field’	 will	 enable	 the	company	to	“create	products	that	have	a	proven,	positive	impact	on	the	health	of	mothers	 and	 their	 children.	 Ultimately,	 being	 a	 leading	 Nutrition,	 Health	 and	Wellness	company	is	about	improving	the	quality	of	peoples’	lives”40.			In	 a	 similar	 fashion,	 epigenetics	 has	 landed	 itself	 a	 top	 spot	 on	 the	 long	 list	 of	science-based	 approaches	 to	 cosmetics	 and	 the	marketing	 of	 its	 products.	 For	example,	 a	 journal	 called	 Cosmetics	 &	 Toiletries:	 Science	 Applied	 published	 an																																																									37	Available	at:	https://reliv.com/lunasin-and-epigenetics	(Last	accessed	on	12.12.2016.)	38	Available	at:	http://www.forbes.com/companies/nestle/	(Last	accessed	on	12.12.2016.)	39	Available	at:	https://www.theguardian.com/global-development-professionals-network/2015/sep/02/child-labour-on-nestle-farms-chocolate-giants-problems-continue	(Last	accessed	on	12.12.2016.)	40	Available	at:	http://www.nestle.com/media/newsandfeatures/nestle-research-epigenetics	(Last	accessed	on	12.12.2016.)	
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article	 Epigenetics	 and	 Aging:	 A	 New	 Player	 in	 Skin	 Care41,	 with	 references	 to	many	 papers	 published	 in	 prominent	 scientific	 journals,	 like	 PLoS	 Genetics	(Gronniger	et	al.	2010),	Cell	(Rando	and	Chang	2012)	and	Nature	Genetics	(Wang	et	 al.	 2008).	 Accordingly,	 several	 cosmetic	 companies	 have	 marketed,	 or	announced	 intentions	 to	market	 ‘epigenetics-inspired’	products.	An	example	of	such	a	product	is	Re-Nutrive	Ultimate	Lift	Age-correcting	creme	by	Estée	Lauder,	a	 discovery	 inspired	 by	 the	 field	 of	 epigenetics.	 The	 Estée	 Lauder’s	 advert	 for	Australian	market	stated	that	 its	company’s	 is	 further	advancing	its	 ‘decades	of	scientific	expertise	and	innovation’,	to	help	you	repair,	recharge	and	restore	your	skin’s	energized,	radiant	appearance42.	Other	examples	of	epigenetics	as	a	 ‘new	paradigm’	in	whatever	the	companies’	business	is	about,	include	also	healing	and	other	forms	of	alternative	medicine.	Epigenetics	Healing	Centre	offers	services	of	functional	 medicine,	 hyperbarics,	 nutritional	 counseling,	 and	 prenatal	 care.43	Another	company,	which	claimed	to	have	been	a	‘proud	supporter	of	Team	GB’	at	the	2016	Olympic	Games,	offers	various	products	and	services,	all	in	this	way	or	another	related	to	or	with	epigenetics	-	hence	the	company’s	name,	Epigenetics	Limited.44			In	 recent	 years,	 the	 epigenetic	 effects	 of	 meditation	 have	 not	 only	 been	investigated	but	some	studies	have,	in	fact,	been	published	(Kaliman	et	al.	2013).																																																									41	Available	at:	N.K.	Konstantinov,	C.J.	Ulff-Møller,	S.	Dimitrov	and	H.I.	Maibach,	Epigenetics	and	Aging:	A	New	Player	in	Skin	Care,	Cosm	&	Toil	130(9)	32-37	(Nov/Dec	2015)	-	See	more	at:	http://www.cosmeticsandtoiletries.com/research/biology/Epigenetics-and-Aging-A-New-Player-in-Skin-Care-352273491.html#sthash.o5n5VJNc.dpuf	(Last	accessed	on	12.12.2016.)	42	Available	at:	http://www.esteelauder.co.th/media/boutiques/re-nutriv/2/life-re-newing-molecules.html#!/re-nutriv/1	(Last	accessed	on	12.12.2016.)	43	Available	at:	http://drgoodbinder.com/services/	(Last	accessed	on	12.12.2016.)	44	Available	at:	http://www.epigenetics-international.com	(Last	accessed	on	12.12.2016.)	
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But	in	some	cases,	epigenetics	healing	has	been	taken	to	mean	that	no	treatment	is	 necessary	 as	 we	 can	 heal	 ourselves	 and	 now	 epigenetics	 proves	 it,	 as	 it	(finally)	 ‘explains	how	energy	healing	techniques	work’.	 In	reviewing	follow-up	stories	 of	 the	 2010	 Time	 magazine	 cover	 that	 appeared	 on	 various	 media	channels,	the	search	results	led	to	a	webpages	discussing	a	popular	book	called	
The	 Genie	 in	 Your	 Genes:	 Epigenetic	Medicine	 and	 the	 New	 Biology	 of	 Intention	(Church	 2007).	 This	 book	 contains	 references	 to	 many	 epigenetic	 studies	 but	upon	describing	them,	the	text	would	subtly	slide	into	a	different	interpretation	of	 the	 results	 of	 these	 studies,	 presenting	 them	 as	 explanations	 of	 the	mechanisms	 by	 which	 meditation	 and	 positive	 thoughts	 operate,	 as	 well	 as	confirmations	of	holistic	and	energy	healing.	By	April	2014,	 this	book	 received	81	comments	on	Amazon	and	 the	overall	 rating	of	4.5	stars.	For	a	comparison,	‘non-alternative-healing’	books	on	epigenetics	received	two	or	three,	at	the	best.	Of	 those	 81	 people	 commenting	 on	 the	 book,	 only	 one	 former	 researcher	 and	teacher	 at	 the	 time,	 and	 one	 doctor-gynecologist,	 bothered	 to	 object	 to	 the	overwhelmingly	positive	reviews.	They	did	so,	according	to	their	own	admission,	because	they	had	to	face	a	student	and	a	patient	who	refused	medical	treatments	after	reading	this	book.	The	rest	of	the	comments	were	overwhelmingly	positive	and	 welcoming	 of	 the	 new	 age	 ear	 of	 epigenetics,	 rating	 this	 book	 with	 the	maximum	of	5	stars	in	64	out	or	81	cases.			
TRACKING	THE	NUMBER	OF	PUBLICATIONS	ON	EPIGENETICS	
The	purpose	of	a	study	to	track	the	number	of	publications	on	epigenetics	was	to	verify	the	claims	that	publications	on	epigenetics	record	an	exponential	increase	
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in	 the	 last	 decade	 (Haig	 2012;	 Jirtle	 2012).	 This	 was	 understood	 within	 the	EPIGEN	 project	 as	 particularly	 important	 in	 order	 to	 provide	 a	 quantifiable	report	 on	 every	 aspect	 of	 the	 ‘expected	 impact	 of	 epigenetics	 on	 health	 care’.	Data	 from	 two	 independent	 searches	 conducted	 for	 the	 period	 2008-2013	confirm	 that	 there	 is,	 indeed,	 an	 increase	 in	 the	 number	 of	 publications	 on	epigenetics	in	the	specified	period,	as	shown	in	Figure	5.	However,	the	curve	is	far	 less	 steep	 than	 the	 one	 reported	 by	Haig	 (2012)	 and	 the	 absolute	 number	reached	 for	 every	 year	 is	 far	 below	 those	 anticipated	 by	 Jirtle	 (2012),	 which	reached	 several	 thousands	 and	were	 forecasted	 for	 up	 to	 20,000	 for	 the	 year	2011.	 	
	
Figure	5	-	The	number	of	publications	on	epigenetics/epigenomics		
per	year	for	the	period	2008-2013		
Source:	webpages	of	the	top	biomedical	journals	according	to	ISI		
Web	of	Knowledge	5-year	Impact	Factor	2012		
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On	 the	 other	 hand,	 Figure	 6	 shows	 results	 of	 the	 second	 search,	 which	 was,	instead,	a	small-scale	comparative	investigation	into	the	number	of	publications	on	epigenetics	and	genetics.	Since	this	search	was	aimed	at	probing	if,	in	fact,	the	increase	 in	 the	 number	 of	 publications	 can	 be	 detected	 in	 the	 fields	 of	 both	genetics	 and	 epigenetics,	 the	 search	 was	 done	 with	 less	 precision	 than	 the	previous	one.	Instead	of	journal’s	webpages,	PubMed	was	used	as	a	source.	The	absolute	numbers	in	the	Figure	6	are	therefore	not	representative	of	the	actual	numbers,	 but	 are	 not	 of	 not	 of	 great	 importance	 because	 the	 focus	 is	 on	 the	relative	ratio	between	the	two	fields.	Interestingly,	the	genetics/genomics	curve	in	 the	 graph	 shows	 an	 even	 greater	 increase	 in	 the	 number	 of	 publication	per	year,	i.e.	it	is	steeper,	than	the	epigenetic/epigenomic	one.	
	
Figure	6	-	The	number	of	publications	on	genetics	(top	curve)	and		
epigenetics	(bottom	curve)	per	year	for	the	period	2008-2013.		
Source:	PubMed	2013		These	results	suggest	the	increase	in	the	number	of	publications	on	epigenetics	is	concurrent	with	the	increase	in	the	number	of	publications	on	genetics.	Similar	
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case	 might	 be,	 and	 probably	 is,	 with	 other	 fields	 in	 the	 life	 sciences.	 The	consortia-like	 projects	 are	 being	 established	 for	 other	 research	 fields	 beside	epigenetics,	 such	as	proteomics45,	 cancer46,	 or	 immunology47,	 to	 list	 a	 few.	The	same	 applies	 to	 the	 establishment	 of	 new	 scientific	 journals.	 Increase	 in	 the	number	 of	 publication	 on	 epigenetics	 should	 thus	 only	 indicate	 that	 more	scientific	papers	are	being	published	as	technological	power	increases	and	funds	are	flowing	into	science.			
CONCLUSIONS	
This	 research	 was	 initiated	 in	 order	 to	 map	 and	 measure	 the	 impact	 of	epigenetics	 on	 health	 care.	 The	 results	 show	 that	 epigenetics	 is	 actively	employed	 not	 only	 in	 basic	 research	 but	 also	 in	 translational	 and	 clinical	research.	 Moreover,	 epigenetic	 research	 outputs	 like	 epigenome-modifying	compounds	 already	 have	 clinical	 impact.	 Numerous	 drugs	 with	 epigenetic	mechanism	of	action	have	already	been	used	in	treating	diverse	types	of	cancer	–	glioblastomas,	 leukemias,	 lymphomas,	 etc.	 Some	 drugs	 that	 have	 been	authorised	many	decades	have	now	been	shown	to	have	epigenetic	mechanism	of	action	such	as	TEVA’s	Purinethol.	Accordingly,	the	disease	areas	that	are	most	actively	 studied	 in	 epigenetic	 research,	 and	 where	 epigenetics	 is	 expected	 to	make	 the	 greatest	 impact,	 are	 precisely	 those	 areas	 that	 the	 public	 health																																																									45	For	example,	Human	Proteome	Project,	available	at:	http://www.thehpp.org	(Last	accessed	on	12.12.2016.)	46	For	example,	Cancer	Stem	Cell	Consortium,	available	at:	https://ccrod.cancer.gov/confluence/display/NCICSCC/Home	(Last	accessed	on	12.12.2016.)	47	For	example,	Human	Immunology	Project	Consortium,	available	at:	http://www.thehpp.org	(Last	accessed	on	12.12.2016.)	
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agencies	 like	 the	WHO	 and	 the	 political	 bodies	 like	 the	 EU	 identify	 as	 posing	major	challenges	to	the	health	of	the	population		(WHO	2008;	20012;	EC	2007).	In	addition,	these	diseases	have	long	been	known,	or	have	been	suspected,	to	be	under	 the	 influence	of	 factors	other	 than	genetics.	 In	order	words,	 factors	 that	are	 not	 the	 DNA	 sequence	 itself	 –	 which	 could	 be	 considered	 a	 ‘genomic	paradigm’	 in	 the	 understanding	 of	 health	 –	 but	 by	 factors	 that	 are	beyond	 the	genome	such	as	life	styles	related,	environmental	and	social	factors.		The	 big	 epigenetics	 consortia	 that	 have	 been	 established	 in	 recent	 years	 as	follow	up	projects	of	Human	Genome	Project	(HGP)	and	the	Encyclopedia	of	the	DNA	elements	project	seem	to	affirm	that	beyond	the	genome	can	go	all	the	way	to	 the	 social	 and	 environmental	 factors.	 	 The	 International	 Human	 Epigenom	Consortium	 (IHEC),	 for	 example,	 states	 that	 their	 long	 terms	 objective	 is	 to	understand	 ‘the	extent	 to	which	the	epigenome	has	shaped	human	populations	over	 generations	 and	 in	 response	 to	 the	 environment’48.	 Similarly,	 the	 NIH	Roadmap	 Epigenomics	 states	 that	 their	 Epigenomics	 of	 Human	 Health	 and	
Disease	 Initiative	 will	 support	 research	 on	 also	 response	 to	 exposures	 such	as	physical,	 chemical,	 behavioral,	 and	 social	 factors 49 .	 However,	 upon	 closer	inspection,	 most	 of	 their	 published	 data	 do	 not	 even	 contain	 the	 word	‘environment’.	 These	 publications,	 instead,	 employ	 all	 expressions	 from	 the	genomic	 vocabulary,	 e.g.	 functional	 annotations,	 datasets,	 regulatory	networks,	mapping,	etc.	The	lack	(or	complete	absence)	of	‘environmental’	discourse’	and,	correspondingly,	 the	 dominance	 of	 ‘genomic’	 (or	 ‘-omic’	 in	 general)	 discourse	suggest	that	the	environment	in	epigenomics	–	the	dominant	practice	of	today’s																																																									48	Form	more	information	see	http://ihec-epigenomes.org/about/objectives/	(Last	accessed	on	12.12.2016.)	49	Form	more	information	see	http://www.roadmapepigenomics.org/overview/epigenomics-human-health	(Last	accessed	on	12.12.2016.)	
	 142	
epigenetic	science	–	is	conceptualised	insofar	as	it	is	and	could	be	converted	into	genome-friendly	and	code-compatible	digital	representations	(Maloni	and	Testa	2014).		On	 the	 other	 hand,	 a	 small	 corner	 of	 the	 field	 is	 concerned	 with	 the	 causal	relationship	between	factors	such	as	chemicals,	smoking,	diet,	exercise,	etc.,	and	health-related	 conditions	 like	 elevated	 blood	 pressure,	 anxiety,	 obesity,	 and	 it	goes	by	the	name	environmental	epigenetics.	Yet,	the	results	of	such	studies	are	received	 rather	 critically	 and	with	 a	 high	 dose	 of	 skepticism	within	 the	wider	field	 (Pickersgill	 2016).	 My	 own	 experience	 of	 working	 for	 four	 years	 in	 a	research	 institution	 confirms	 such	 general	 attitude	 of	 suspicion	 and	 cynicism	among	 fellow	 epigeneticists	 regarding	 environmental	 epigenetics	 research	 and	scientists	that	conduct	it.	It	is	precisely	such	studies,	on	the	other	hand,	that	gain	the	most	attention	outside	the	field,	in	epidemiology,	popular	culture,	humanities	and	social	studies	of	science,	as	well	as	in	non-medical	commercial	sectors.		Accordingly,	 the	 enthusiasm	 for	 epigenetics	 in	 the	 wider	 society	 has	 not	 only	been	 recognized	 but	 also	 exploited	 by	 the	 very	 same	 epigeneticists	 who	 hold	environmental	 epigenetic	 research	 and	 results	 to	 be	 suspicious	 (Pickersgill	2016).	 It	 has	 been	 previously	 shown	 that	 scientists	 tend	 to	 enthusiastically	overstate	 the	 potential	 of	 their	 research	 field	 in	 order	 to	 create	 and	 meet	expectation	 in	related	communities	of	practice,	 funding	agencies	and	the	wider	public,	and	perpetuate	dynamism	and	momentum	(Brown	and	Michael	2003).	In	this	 respect,	 the	 expectations	 of	 epigenetics	 seems	 to	 operate	 o	 two	 levels:	 1)	epigenetics	 goes	 ‘beyond	 the	 genome’	 but	 only	 insofar	 as	 it	 converts	 the	environmental,	 the	 social,	 the	biographical	 –	 into	 ‘a	genome-friendly	and	code-compatible	 (Meloni	 and	 Testa	 (2014);	 and	 2)	 epigenetics	 shows	 how	 the	
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contingencies	 of	 life	 –	 what	 we	 eat,	 pollution	 or	 stress	 –	 affect	 how	 genes	operate.	 In	 other	 words,	 how	 the	 environment,	 biography	 and	milieu	 become	molecularly	embodied	(Landecker	2011;	Niewhoener	2011).		The	 discourse	 on	 genome-compatible	 digitization	 of	 what	 lies	 beyond	 the	genome	resonates	better	with	 the	wider	research	community	but	has	not	been	taken	 up	 beyond	 the	 life	 sciences.	 The	 discourse	 on	 molecularisation	 of	 the	environment,	 on	 the	 other	 hand,	 has	 been	 marginalized	 within	 the	 research	community	but	resonates	well	with	wider	society,	including	social	inequalities	in	health	 paradigm.	 This	 research	 further	 focuses	 on	 one	 project	 on	 social	inequalities	 of	 health	 in	 Glasgow,	 which	 investigated	 the	 association	 between	socio-economic	 status	 and	 an	 epigenetic	 marker	 (among	 other	 factors),	 and	group	 of	 people	 gathered	 around	 this	 project	 –	 the	 psychological,	 social	 and	biological	determinants	of	ill	health	in	Glasgow	(the	pSoBid	project).				
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CHAPTER	FIVE	–	BEHIND	THE	‘GLASGOW	EFFECT’	
INTRODUCTION	
This	 chapter	 presents	 on	 empirical	 data	 collected	 through	 semi-structured	interviews	 and	 observational	 studies	 to	 discuss	 how	 molecularisation	 of	 the	environment	(Landecker	2011;	Niewhoener	2011)	is	employed	in	research	and	health	policy.	 It	discusses	collaboration	among	actors	of	diverse	background	 in	the	pSoBid	study;	epigenetic	data	as	‘evidence’	in	research	and	policy	action;	and	communal	 identity	 and	 membership	 as	 the	 driving	 engine	 behind	 the	 pSoBid	collective	endeavour.	The	chapter	finds	that	it	is	thanks	to	its	molecularization	of	the	 environment	 and	 therefore	 its	 purported	 objectivity,	 that	 epigenetics	 is	bestowed	the	potential	for	actionable	public	health	knowledge	within	the	pSoBid	project.	 In	 addition,	 the	 chapter	 also	 finds	 that	 it	 is	 the	 solidary	 practice	 that	governs	 the	 interdisciplinary	 collaborative	 endeavour	 in	 Glasgow	 that	 is	 the	pSoBid	project.				
BACKGROUND	–	‘EPIGENOMIC	SIGNATURE	OF	POVERTY’	IN	GLASGOW	
The	McGuinness	 study,	published	 in	 the	 International	 Journal	of	Epidemiology,	reported	 that	 socioeconomic	 status	 (SES)	 is	 associated	 with	 epigenetic	differences	in	a	cohort	of	research	subjects	called	“pSoBid”	–	psychological,	social	and	 biological	 determinants	 of	 ill	 health	 (McGuinness	 et	 al.	 2012).	 The	 study	found	 that	 the	 most	 economically	 deprived	 subjects	 had,	 in	 their	 peripheral	
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blood,	17%	less	DNA	methylation	globally50	than	the	affluent	subjects,	and	that	manual	 workers	 had	 24%	 less	 DNA	 methylation	 content	 than	 non-manual	workers.	 Associations	 were	 also	 found	 between	 DNA	 methylation	 levels	 and	previously	established	biomarkers	of	cardiovascular	diseases	and	inflammation,	such	as	fibrinogen	and	interleukin	6.		This	 research	 focuses	on	 the	McGuinness	 study	and	 the	 city	of	Glasgow	where	the	study	took	place	for	several	reasons.	First	and	foremost,	 the	cohort	used	in	the	study	was	designed	from	the	beginning	to	study	socio-economic	differences	in	 relation	 to	 health	 outcomes	 (Velupillai	 et	 al.	 2008),	 thereby	 providing	empirical	 ground	 for	 exploring	 how	 epigenetics	 is	 recruited	 as	 evidence	 in	studies	 on	 social	 inequalities	 in	 health.	 Second,	 the	 study	 was	 triggered	 in	response	 to	 health	 inequalities	 in	 Glasgow	 illustrated	 by	 the	 difference	 of	 26	years	 in	 the	 average	 life	 expectancy	 between	 Glaswegians	 from	 the	 most	deprived	and	the	most	affluent	area	(WHO	2008).	More	specifically,	these	stark	health	disparities	 could	not	be	explained	by	 conventional	 risk	 factors,	 as	other	post-industrial	 cities	 with	 similar	 socio-economic	 profiles,	 like	 Manchester	 or	Liverpool,	do	not	 show	such	a	 steep	gradient	 in	health.	The	health	 figures	 that	had	“earned”	the	city	of	Glasgow	the	reputation	of	‘the	sick	man	of	Europe’	also	defined	the	contours	of	a	true	unknown	within	the	well-rehearsed	framework	of	the	social	determinants	of	health;	and	led	to	the	naming	of	such	phenomenon	as	
the	Glasgow	effect	 (WHO	 2011).	 Third,	 the	 pSoBid	 cohort,	 and	 accordingly	 the	McGuinness	 study,	 were	 initiated	 by	 a	 local	 health	 organisation,	 the	 Glasgow	Centre	 for	 Population	 Health	 (GCPH),	 and	 gathered	 people	 of	 various	
																																																								
50 DNA methylation levels are an epigenetic mark that is, according to the authors of the study, 
‘reflective of changes in gene expression linked to disease’. 
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backgrounds	 –	 from	 social	 epidemiology	 and	 occupational	 health,	 to	biochemistry,	 genetics,	 biological	 aging	 and	 epigenetics,	 to	 psychology,	 and	neuroscience	–	to	work	together	and	collectively	gathering	the	data	and	propose	action	to	address	the	prevailing	heath	inequalities	in	Glasgow.	Finally,	the	results	of	 all	 studies,	 including	 the	McGuinness	 study,	were	collectively	presented	 in	a	report,	 which	 its	 proponents	 offered	 as	 a	 guide	 for	 Glasgow's	 public	 health	policies	(GCPH	2013).			
Materials	and	methods	
The	empirical	investigation	of	the	McGuinness	study,	the	pSoBid	cohort	and	the	city	 of	 Glasgow	 –	 to	 which	 I	 will	 refer	 collectively	 to	 as	 ‘the	 Glasgow	 case’	 in	further	text	–	included:		a	review	of	publications	produced	on	the	pSoBid	cohort,	and	 activities	 and	 projects	 of	 the	 GCPH	 who	 initiated	 it	 and	 semi-structured	interviews	conducted	in	Glasgow	with	eight	professionals	involved	in	the	pSoBid	project.	Additionally,	two	observational	studies	–	one	in	Glasgow,	other	Milan	–	were	included	into	the	analysis	of	the	Glasgow	case,	after	it	became	evident	that	football	 supporting	 in	 Glasgow,	 and	 the	 social	 activities	 related	 to	 football	supporting,	 provide	 an	 important,	 if	 not	 a	 decisive	 insight,	 into	 the	 relations	among	researchers	and	participants	of	the	pSoBid	study,	and	among	Glaswegians	in	general.		The	two	main	themes	interrogated	by	the	semi-structured	interviews	include:	1)	how	do	different	agents	cooperate	to	bring	about	healthcare	policy;	and	2)	what	is	 the	 evidential	 value	 of	 epigenetic	 data	 in	 public	 health.	 Several	 additional	questions	within	these	two	broad	themes	were	also	examined:	how	actors	from	
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different	 professional/disciplinary	 background	 came	 to	 collaborate	 in	 the	 first	place;	how	these	actors	understand,	interpret,	value	and	use	epigenetic	evidence;	how	 is	 epigenetic	 evidence	used	and	understood	 in	 comparison	 to	other	 (non-molecular)	 types	 of	 evidence	 in	 public	 health	 (i.e.	 data	 coming	 from	 social	epidemiology).	 For	 details	 on	 how	 the	 Interview	 Guide	 was	 designed	 and	interviews	 conducted,	 see	 Chapter	Three	 –	Research	Design	 and	Methods.	 The	initial	 coding	 in	 thematic	 analysis	 suggested	 that	 communal	 identity	 and	membership	 is	 a	 theme	 that	 cuts	 across	 all	 others.	 The	 full	 significance	 of	 the	communal	 identity	 and	 membership	 in	 Glasgow	 was	 recognised	 upon	complementing	 the	 interview	 data	 with	 observations	 made	 during	 social	activities	initiated	by	football	supporting.			
COLLABORATION	AMONG	ACTORS	OF	DIVERSE	BACKGROUND		
Despite	the	diversity	of	expertise	in	the	pSoBid	project,	all	interviewed	members	expressed	 a	 shared	 perspective	 on	 how	 their	 collaborative	 endeavour	 was	established,	and	how	‘health’	is	understood	within	the	endeavour.	The	common	response	to	the	question	of	how	collaboration	between	the	team	members	began	was	 that	 the	 interviewees	were	 initially	 exposed	 to	 each	other’s	work	 through	talks	 and	 seminars	 organised	 by	 the	 institution	 to	 which	 all	 the	 interviewees	belong	 –	 the	University	 of	 Glasgow.	 This	 exposure	was	 perceived	 as	 providing	them	with	 an	 opportunity	 to	 exchange	 ideas,	 involve	more	 colleagues	 and	 co-workers	in	the	process,	and	develop	a	common	vision	that	would	eventually	be	formalised	through	shared	projects.		
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Two	main	components	can	thus	be	distinguished	as	having	played	a	role	in	the	establishment	 of	 this	 collaborative	 platform:	 institutional	 and	 personal	component.	 Institutional	 facilities	 were	 understood	 as	 providing	 geographical	proximity	of	(most)	researchers	involved	in	the	project	and	hence	as	facilitating	an	 informal	engagement	between	different	professionals.	At	 the	same	time,	 the	home	institution	(the	University	of	Glasgow)	is	perceived	as	facilitating	people’s	exposure	 to	 each	 other’s	 work	 in	 a	 more	 formal	 way,	 by	 organising	 different	social	events	and	seminars.	On	the	other	hand,	people’s	personal	character	and	willingness	 to	 take	 part	 in	 a	 long-lasting	 project	 that	 gathers	 people	 of	 very	different	disciplinary	backgrounds	emerged	as	additional	and	major	facilitator	of	the	 pSoBid	 project.	 Several	 interviewees	 pointed	 out	 that	 the	 pSoBid	 project	depended	 also	 on	 people	 who	 are	 neither	 constitutive	 collaborators	 nor	institutional	affiliates	but	whose	engagement	was	nonetheless	essential	 for	 the	project.		One	such	example	 is	 the	pSoBid	cohort	research	participants.	 In	particular,	 the	participants	 from	 the	most	deprived	community	and	spanning	 the	25-35	years	age	 range,	were	 difficult	 to	 recruit	 in	 the	 first	 place.	 In	 this	 case,	 the	 personal	character	of	 the	 individuals	 involved	in	the	project,	and	their	capacity	to	 ‘bring	people	together’	from	the	local	communities	was	indicated	as	the	‘engine	behind’	the	 successful	 implementation	 of	 the	 project.	 Another	 such	 example	 of	 non-constitutive	 members	 playing	 an	 essential	 role	 in	 the	 implementation	 of	 the	pSoBid,	are	officials	from	the	local	authorities.	Although	the	local	authorities	as	a	body	represent	a	constitutive	member	for	projects’	implementation,	the	officials	hold	elected	positions.	The	ways	in	which	the	research	project	was	presented	to	the	 current	 officials	 from	 the	 local	 authorities	 was	 therefore	 critical	 for	 a	
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successful	 implementation	 of	 the	 project.	 Communication	 skills	 and	 personal	‘engagement	 with	 local	 authority	 officials’	 were	 singled	 out	 as	 making	 the	difference	between	positive	and	negative	answer	to	perform	a	certain	study,	as	exemplified	by	the	following	statement:		 “Member	 951	had	 done	 an	 amazing	 job	 to	 translate	 messages	 of	 the	research	 to	 wider	 audience	 including	 policy-makers.	 He	 has	 been	involved	 from	 the	 beginning	 in	 the	 pSoBid,	 the	 [Glasgow]	 Centre	 [for	Population	Health],	and	knows	epigenetics	and	biological	basis	 [of	aging	and	health	outcomes]”	(Member	6).			The	 interviews	 revealed	 also	 a	 shared	perspective	 on	 two	 added	 values	 at	 the	basis	of	their	collaboration.	First,	the	interviewees	pointed	to	the	existence	of	a	community	 problem,	 i.e.	 the	 steep	 health	 inequalities	 that	 map	 onto	 social	inequalities	between	Glaswegian	communities,	which	they	defined	as	“the	glue”,	or	“a	unifying	thrust”	under	which	people	joined	forces	to	address	this	problem.	Second,	 all	 interviewees	 emphasized	 that	 a	 holistic	 approach	 to	 the	 process	 of	aging	 and	 health	 in	 necessary	 to	 be	 adopted	 in	 order	 to	 tackle	 the	 underlying	factors	across	all	aspects	of	people’s	lives	that	affect	healthy	aging.			In	 order	 to	 fully	 appreciate	 how	 Glasgow’s	 community	 problem	 constituted	 a	major	 driver	 for	 the	 establishment	 of	 collaboration	 in	 Glasgow,	 the	 unique	historical	background	and	current	political	situation	of	 its	citizens	need	also	 to	be	taken	into	account.	The	Irish	ancestry	of	many	Glaswegians,	and	most	notably																																																									
51 The interview that was scheduled with Member 9 had to be cancelled.  
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those	 living	 in	 the	 deprived	 parts	 of	 the	 city,	 contributes	 to	 a	 strong	 sense	 of	'immigrant	 community'	 in	 relation	 to	 their	 national	 identity	 and	 sense	 of	belonging	to	the	United	Kingdom.	One	of	the	 interviewees	pointed	out	how	the	following	 statement	 by	 former	 conservative	 London	 Mayor	 set	 a	 furious	reaction:	“a	pound	spent	in	Croydon	[South	London]	is	far	more	of	value	to	the	country	than	a	pound	spent	in	Strathclyde	[in	the	Glasgow	area]”52.		Glasgow’s	public	attitude	 towards	 the	central	government	was	reflected	by	 the	electoral	 results	 of	 the	 Scottish	 Independence	 Referendum	 in	 2014,	 when	 the	majority	of	Glaswegians	voted	for	independence.	According	to	the	interviewees,	the	distance	between	 the	community	of	Glaswegians	and	 the	central	politics	of	the	 UK	 resulted	 in	 huge	 public	 support	 of	 local	 initiatives,	 such	 as	 the	 pSoBid	project,	and	other	related	projects	such	as	GCPH’s	Glasgow	Indicators	project	or	Medical	 Research	 Council’s	 the	 West	 of	 Scotland	 Twenty-07	 study.	 The	communal	 identity	 and	 membership	 of	 Glaswegians	 had,	 in	 fact,	 a	 significant	impact	 on	 the	 recruitment	 of	 participants	 for	 the	 pSoBid	 study.	 Recruiting	 the	participants	was,	of	course,	crucial	for	initiating	the	study	in	the	first	place.			 	“It	was...[shaking	head].	Member	10	and	I	had	to	talk	to	the	guys	before	and	after	games,	in	the	pub...”	(Member	1)		The	‘games’	this	statement	is	referring	to	are	the	matches	of	Celtic	football	club	(FC).	The	recruitment	of	participants	from	the	deprived	area	was	conducted,	 in	part,	 at	 the	 Celtic	 Park	 football	 stadium.	 As	 the	 matter	 of	 fact,	 the	 topic	 of	recruitment	during	the	fieldwork	in	Glasgow	was	first	discussed	in	an	 informal																																																									
52 See: https://www.youtube.com/watch?v=CjFboRwGiqc (Last accessed: 09/09/2016). 
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conversation	 that	 took	place	on	 the	road	 from	Dalmarnock	railway	station	and	Celtic	Park	football	stadium.	Walking	the	road	from	Dalmarnock	station	to	Celtic	Park,	 I	was	 told	 that	 this	was	 the	deprived	area	 from	which	the	participants	of	the	 pSoBid	 came.	 Walking	 through	 this	 area	 of	 Glasgow	 is	 generally	 not	recommended.	 The	 housing	 projects	 have	 improved	 the	 infrastructure	 of	 the	area	in	the	past	several	years,	but	their	effects	are	slow	to	detect	–	the	health	has	improved	 too	 little	 compare	 to	 what	 the	 decision-makers	 consider	 is	 worth	further	investment.	This	was	pointed	by	several	 interviewees	as	the	main	issue	in	 delivering	 long-term	 health	 interventions	 and	 why	 initiating	 collaborative	projects	 that	 collect	 as	 much	 evidence	 as	 possible,	 like	 the	 pSoBid,	 is	 of	 the	utmost	importance	for	the	community.	On	the	match	nights,	however,	the	area	is	safe	as	everyone	is	walking	together	to	reach	the	Celtic	Park,	chatting	and	singing	the	 club	 songs	 –	 people	 from	 Calton,	 the	 deprived	 area,	 professionals	 like	member	1	and	2	(who	happens	to	live	in	the	affluent	area	of	Lanzie),	and	many	other	 Glaswegians.	 It	 was	 this	 ‘local’	 and	 ‘inside	 experience’	 of	 football	supporting	activities	in	Glasgow	that,	in	fact,	provided	a	deeper	appreciation	and	understanding	 of	 the	 interviewees’	 insistence	 on	 the	 community	 and	 its	problems	as	the	‘glue’	of	their	endeavour.		A	couple	of	months	 later,	 in	Milan,	 I	 joined	 the	Celtic	 supporters,	 including	 the	pSoBid	researchers,	for	another	game,	this	time	at	the	San	Siro	stadium	in	Milan	–	 Celtic’s	 match	 against	 Internazionale	 in	 the	 Europa	 League.	 What	 has	 been	observed	 about	 the	 Celtic	 supporting	 Glaswegians,	 from	 the	 activities	 that	preceded	and	followed	the	match,	to	the	match	itself,	seemed	to	be	reflecting	the	description	about	the	community	expressed	by	one	of	the	interviewees:	“We	are	very	 tribal”	 (Member	 1).	 Moreover,	 the	 Irish	 ancestry	 and	 the	 present-day	
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inclination	 to	 everything-Irish,	 painted	 everything	 at	 the	 San	 Siro	 stadium	and	across	 the	 city	 of	 Milan	 into	 green	 and	 clovers,	 while	 the	 flag	 of	 Ireland	 was	hoisted	on	each	 step.	A	 remark	 that	not	 a	 single	Scottish	 flag	was	present	was	met	with	a	“we	are	an	Irish	Club”	response	from	several	of	the	supporters.	These	observations	 and	 ‘lived	 experience’	 of	 what	 the	 Celtic	 represents	 for	 the	Glaswegian	community	beyond	just	being	a	football	club,	lead	to	the	revisiting	of	the	data	collected	through	the	semi-structured	interviews	in	Glasgow	and	to	the	inclusion	of	these	observational	data	into	the	analysis	of	the	Glasgow	case.		What	might	 seem	 as	 a	 trivial	 detail	 at	 first	 glance	 –	 a	 sport	 club	membership	shared	by	both	study	participants	and	researchers	–	played	instead	an	important	role	 in	 the	 development	 of	 the	 pSoBid	 project,	 and	 hence	 constituted	 an	important	 resource	 for	 the	 analysis	 of	 Glasgow.	 In	 other	 words,	 beyond	 the	simple	fact	that	the	deprived	community	and	(the	more	affluent)	researchers	are	gathered	 around	 the	 same	 football	 team,	 lie	 in	 fact	 the	norms	 and	 values	 that,	made	 possible	 the	 assemblage	 of	 the	 collaborative	 approach	 of	 the	 pSoBid	project	to	the	local	health	conditions	of	Glasgow.	The	local	‘morality’	of	Glasgow	manifested	itself	in	a	sense	of	belonging	to	a	football	team	and	in	its	supporters’	relation	 to	 the	 rest	 of	 the	 country	 and	 provided	 a	 fertile	 terrain	 for	 aligning	 a	moral	 investment	 into	 the	 long-standing	 injustices	 affecting	 Glasgow	 citizens	with	a	number	of	sentiments	and	aspirations.	These	sentiments	and	aspirations	were	 expressed	 as	 deontological	 claims	 of	 professionals	 from	 the	 pSoBid	 to	provide	 knowledgeable	 representations	 of	 such	 injustices	 that	 would	 bring	about	political	action,	and	as	an	expression	of	 trust	 in	and	commitment	 to	 this	research	 on	 the	 side	 of	 research	 participants.	 It	 is	 the	 particular	 social	 and	political	character	of	the	context	of	Glasgow	–	characterised	by	historical	legacy	
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of	 migration	 and	 political	 conflicts,	 as	 well	 as	 the	 current	 distinct	 identity	 in	relation	 to	 the	 rest	 of	 the	 UK	 –	 that	 catalysed	 and	 shaped	 this	 kind	 of	collaborative	research	practice	around	epigenetics.		Collaboration	in	Glasgow	is	thus	grounded	in	specific	relationships	–	local	bonds	–	 between	 the	 members	 of	 this	 community	 and	 can,	 accordingly,	 be	characterised	as	 ‘shared	practices	 that	reflect	a	collective	commitment	 to	carry	some	 costs	 to	 assist	 others’	 (Prainsack	 and	 Buyx	 2011).	 In	 other	 words,	 the	collaborative	in	the	case	of	Glasgow	can	be	considered	a	solidaristic	endeavour.	The	costs	of	assisting	others	can	be	reflected	as	career-related	for	researchers,	as	they	agree	 to	give	addressing	 the	communal	problem	a	higher	priority	 in	 their	work;	 the	 cost	 of	 inconvenience	 in	 providing	 biological	 samples	 for	 research	participants;	 and	 financial	 cost	 of	 supporting	 publicly	 funded	 projects	 and	initiatives	 like	 the	pSoBid	 for	 the	Glaswegian	citizens	 in	general.	Moreover,	 the	practices	entailed	in	the	pSoBid	project	are	enacted	on	different	levels:	personal,	communal	 and	 contractual	 (Prainsack	 and	 Buyx	 2012).	 The	 personal	 level	 is	exemplified	 by	 the	 collaboration	 between	 the	 members	 of	 the	 pSoBid	 team.	Solidarity	 is	 thus	 enacted	 among	 the	 researchers	 as	 they	 carry	 time-	 and	resource-related	costs	for	pursuing	a	collective	commitment	to	interdisciplinary,	collaborative	 research	 rather	 than	 to	 their	 own.	 The	 communal	 level	 is	exemplified	by	the	recruitment	of	participants,	which	was	facilitated	by	the	fact	that	 both	 researchers	 and	 participants	 belonging	 to	 specific	 community	 –	 the	community	of	Celtic	FC	supporters.	Moreover,	 communal	 solidarity	 is	 reflected	also	in	community’s	support,	 including	in	funding,	to	the	local	health	initiatives	like	 the	 pSoBid,	 Finally,	 the	 contractual/legal	 level	 is	 exemplified	 by	 the	 very	establishment	 of	 the	 Glasgow	Centre	 for	 Population	Health	 (GCPH).	 The	 GCPH	
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represents	 a	 contractual	 commitment	 to	 take	 action	 on	 health	 inequalities	 in	Glasgow	between	the	Scottish	Government,	 the	National	Health	Service	Greater	Glasgow	and	Clyde,	the	Glasgow	City	Council	and	the	University	of	Glasgow.	The	practices	engendered	by	a	distinct	context	of	Glasgow,	grounded	in	and	brought	about	 by	 social	 relations	 among	Glaswegians	 –	 as	 researchers,	 participants,	 or	simply	citizens	–	thus	reflect	a	shared	commitment	to	carry	costs	to	assist	others.	In	 other	 words,	 they	 are	 solidaristic.	 The	 Glasgow	 case	 thus	 represents	 an	empirical	example	of	the	initiation	and	implementation	of	a	collaborative	health	project	through	solidarity.		
EPIGENETIC	DATA	IN	HEALTH	RESEARCH	AND	POLICY	ACTION		
The	role	of	epigenetic	knowledge	 in	 capturing	and	 intervening	upon	 the	socio-political	aspects	of	the	‘Glasgow	effect’	emerges	from	the	interviewees’	diverging	responses	 to	 questions	 regarding	 the	 status	 of	 epigenetic	 evidence	 in	 social	action	and	public	policy	(compared	to	other,	non-molecular	 types	of	evidence),	and	 the	 extent	 to	which	 epigenetics	 is	 expected	 to	 influence,	 or	 perhaps	 even	change,	 research	 on	 socially-affected	 health	 phenomena	 and	 policy	 strategies	that	may	be	devised	based	on	such	knowledge.			All	interviewees	emphasized	that	adopting	a	holistic	approach	to	the	process	of	aging	and	health	is	necessary	in	order	to	tackle	the	underlying	factors	across	all	aspects	 of	 people’s	 lives	 that	 affect	 healthy	 aging.	 Epigenetic	 data	 was	 here	understood	as	providing	an	additional	layer	of	information,	contributing	thus	to	a	 deeper	 understanding	 of	 the	 interconnectedness	 between	 factors	 that	influence	health	and	aging,	and	opening	additional	possibilities	for	intervention.	
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However,	 the	 interviewees	 perception	 about	 the	 value	 of	 epigenetic	 evidence,	compared	 to	 the	 already	 available	 evidence	 gathered	 through	 the	 means	 of	classical	epidemiology,	i.e.	non-molecular	data,	differed	in	relation	to	whom	was	such	evidence	presented.		With	 respect	 to	 health	 research,	 epigenetics	 was	 mostly	 understood	 as	 an	additional	measure	reflecting	allostatic	load,	or	as	‘bio-dosimeter’	(McGuiness	et	al	 2012;	 Landecker	 and	 Panofsky	 2013).	 As	 the	 geophysical	 and	 demographic	maps	 of	 Glasgow	 are	 already	 available,	 together	 with	 historical	 data	 about	population	 migration	 and	 settlements,	 the	 demonstration	 of	 environmental	effects	on	health	is	sought	also	on	the	molecular	level,	measured	within	the	body.	Epigenetic	 data	 is	 thus	 understood	 as	 making	 a	 contribution	 to	 research	 and	action	upon	health	insofar	as	it	can	be	easily	converted	into	the	current	standard	measure	in	epidemiological	research	–	the	quality	adjusted	life	years	(QUALYs).			 “There	 is	no	hierarchy	of	evidence	 ...	no	special	status	 for	any	particular	type	of	data...	 It	can	happen	that	one	type	of	evidence	suggests	different	and/or	 contradictory	 conclusions	 [and]	 epigenetic	 data	 can	 influence	hypothesis	 generation	 to	 great	 extent	 and	 the	methodological	 set-up	 of	population	health	research”	(Member	5)		The	representative	of	the	GCPH	pointed	out	that	before	the	pSoBid	study,	there	was	no	such	‘all	encompassing’	effort	present	in	population	research	in	Glasgow	and	 that	 adding	 the	 ‘biological	 component’	 into	 the	 investigation	 of	 the	determinants	 of	 ill	 health	 ‘definitely	 provides	 deeper	 insight	 into	 factors	 that	
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contribute	to	ill	health’.	As	for	the	influence	of	this	data	to	the	ways	population	research	is	being	conducted,	the	same	interviewer	stated:		 “I	 don’t	 think	 it	 [epigenetic	 data]	 is	 more	 important.	 	 The	 [Glasgow]	Centre	[for	Population	Health]	 is	definitely	taking	the	biological	element	into	consideration	[but]	it	is	not	separately	included	in	the	agenda	of	the	Centre	 [and]	our	 research	will	 continue	 to	use	 the	 traditional	 approach.	But	the	biological	level	will	be	kept	in	mind	for	future	projects”	(Member	6).			These	data	suggest	that	the	collaboration	with	the	pSobid	that	relied	on	both	the	biological,	i.e.	epigentic	data,	and	data	collected	through	the	methods	of	classical	epidemiology,	was	not	characterised	as	 redrawing	 the	boundaries	between	 the	disciplines.	Similarly,	the	collaboration	was	not	understood	as	providing	a	whole	new	conceptualisation	of	social	phenomena	to	affect	political	decision-making	in	public	 health.	 Rather,	 epigenetics	 is	 understood	 as	 a	 potential	 resource	 in	overcoming	 some	 disciplinary	 limitations	 that	 people	 are	 faced,	 a	 boundary	concept	(Star	and	Griesemer	1989).	The	head	of	the	lab	expressed	this	attitude	while	pointing	out	 that	everything	 they	do	 in	 the	 lab	has	a	 strong	translational	emphasis	and	must	be	applicable	to	real	population	as	well.			 “Things	often	work	in	the	lab,	but	then	are	not	so	good	when	they	‘leave’	the	 lab	 and	 are	 supposed	 to	 ‘meet’	 the	 real	 populations.	 [Our]	 work	 is	directed	 towards	 validation	 and	 application	 of	 biomarkers	 of	 aging	 we	
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identified	in	the	lab	in	clinical	populations	and	epidemiological	cohorts.	”	(Member	1)		On	the	side	of	social	epidemiology	and	public	health,	this	was	expressed	in	terms	of	the	influence	that	utilization	of	epigenetics	can	have	on	‘scalability	of	research’	and	‘study	design’.	The	head	of	the	Healthy	Working	Lives	group	pointed	out	that	in	 order	 to	make	 the	 data	 reliable,	 the	 classical	 population	 studies	 have	 to	 be	large-scale,	with	big	samples,	over	longer	periods	of	time.	Studies	collecting	the	data	on	molecular	level,	like	epigenetic	studies,	can	significantly	reduce	the	size	of	 the	 sample	 necessary	 to	 conduct	 a	 study,	 and	 the	 time	 needed	 to	 obtain	reliable	evidence	and	to	devise	and	implement	intervention	strategies.		The	molecular	 approach	 in	 epidemiology	 is	 thus	 understood	 not	 as	 overriding	the	 classical	 epidemiological	 approach	but	 as	making	 a	 difference	 in	 providing	support	 for	 some	 existing	 health	 strategies	 over	 the	 others.	 Epigenetic	 data	 is	thus	 considered	 as	 a	 practical,	 advantageous	 tool	 in	 discriminating	 between	more	 effective	 and	 less	 effective	 interventions	 at	 more	 early	 stages	 of	 their	implementation,	which	can	also	be	used	for	long	term	monitoring	to	validate	the	success	of	health	interventions.		 “You	test	for	more	hypotheses	at	the	same	time...	Epidemiological	studies	are	large-scale,	takes	long	to	get	results	and	know	if	you	are	successful...	here	[in	the	lab]	you	test	on	a	small	sample,	get	results	faster...	it	reduces	time,	size	and	cost”.		(Member	2)		
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The	 representative	 of	 the	 GCPH,	 reflected	 upon	 the	 pSoBid	 collaborative	endeavour	 as	 potentially	 opening	 up	 different	 disciplines	 to	 the	 tools	 and	approaches	of	the	other:		 “A	 collaborative	 and	multifactorial	 approach	 can	 open	 up	 a	 horizon	 for	policy	makers	to	take	into	account	this	new	form	of	evidence,	but	also	for	[lab]	 scientists	 to	 reach	 out	 to	 the	 field	 of	 population	 health	 and	 policy	[making]	with	their	own	research	data”.		Yet,	the	potential	of	the	new,	molecular,	was	recognized	mostly	in	relation	to	its	purported	 objectivity.	Molecular	 type	 of	 data	 is	 therefore	 recognized	 as	 ‘silver	bullet’,	or	a	‘sought	for’	type	of	evidence	in	fostering	political	action	upon	health	and	social	inequalities	in	health	in	Glasgow.			 “I	 was	 looking	 for	 a	 way	 to	 approach	 policy	 people,	 make	 them	 more	interested	[in	the	work	I	was	doing]...	they	are	sceptical	about	small	scale	results	[in	epidemiological	research]	but	say	that	the	population	is	too	big	to	make	such	studies	and	interventions”	(Member	2)		In	 this	 respect,	 epigenetics	 could	 be	 considered	 as	 a	 novel	 lens,	 the	molecular	and	hence	 objective	 conduit	 (Landecker	 and	Panofsky	2013)	 that	 lets	 decision	makers	see	things	for	what	they	really	are,	all	the	more	so	when	they	are	buried	‘under	the	skin’,	thereby	escaping	the	eye	of	everyman	(Jasanoff	1998).		
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“[It]	is	considered	more	objective...	surveys	are	still	considered	to	be	‘soft	version’	 of	 the	 data,	 too	 subjective...	 [this]	 is	 physical.	 Decision-makers	can	see,	directly,	how	things	get	under	the	skin.”	(Member	7)		Epigenetics	is	thus	understood	as	an	instrumentally	effective,	policy-tied	kind	of	knowledge	that	could	foster	socio-political	change	in	a	non-distant	future	largely	by	virtue	of	 its	purported	objectivity.	The	potential	 for	political	action	assigned	to	 epigenetics	 therefore	 stems	 from	 its	 translation	 of	 the	 social	 environments	(e.g.	 class,	 biography,	 community	 membership)	 at	 the	 basis	 of	 “the	 Glasgow	effect”,	 into	 a	 different	 kind	 of	 material	 objectivity,	 whose	 molecular	representation	is	deemed	to	offer	better	leverage	for	socio-political	change.		The	mobilization	 of	 epigenetics	 in	 the	 collaborative	 health	 endeavour	 in	 Glasgow	points	 therefore	 to	 a	 moment	 of	 intertwined	 epistemic	 and	 normative	 self-reflexivity.	 It	 is	 the	 political	 aspirations	 that	 inform	 policy-relevant	 health	research	 and	 thereby	 recruit	 a	 specific	 kind	 of	 knowledge,	 along	 with	 its	practitioners,	in	light	of	its	promised	potential	for	health-related	policy-making.		
CONCLUSIONS	
The	 empirical	 data	 presented	 a	 case	 of	 how	 the	 community	 issues	 related	 to	inequalities	among	and	local	bonds	between	Glaswegians	played	a	pivotal	role	in	assembling	 the	 collective	 endeavour	 of	 the	 pSoBid	 project;	 and	 how	 the	interdisciplinary	 context	 of	 the	 Glasgow	 case	 curved	 a	 space	 for	 epigenetic	evidence	in	a	research	agenda	aimed	at	social	policy	change.		
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It	 is,	 indeed,	 from	 the	problematic	 socio-political	 background	 that	 yielded	 “the	Glasgow	 effect”	 that	 the	 epistemic	 dialogue	 among	 the	 disciplines	 around	epigenetics	 emerged.	 A	 shared	 historical	 legacy	 of	 migration	 and	 political	conflicts,	as	well	as	the	current	immigrant	and	distinct	identity	in	relation	to	the	rest	of	the	UK,	that	characterize	the	context	of	Glasgow,	appear	to	be	the	driving	engine	of	health	endeavours	like	the	pSoBid.	Within	such	a	context,	epigenetics	emerges	 as	 an	 epistemic,	 techno-scientific	 articulation	 of	 the	 local	 morality	shared	 by	 the	 Glaswegians	 as	 supporters	 of	 a	 football	 team,	 researchers,	 or	simply	 citizens,	which	 the	 statements	 like	 	 ‘we	 are	 very	 tribal’	 epitomize.	 	 The	local	‘morality’	of	Glasgow	manifested	itself	as	belonging	to	a	football	team,	and	in	 its	 supporters’	 relation	 to	 the	 rest	 of	 the	 country	 (as	 many	 of	 them	 are	descendants	of	 Irish	settlers	 from	the	19th	century	onwards),	provided	a	 fertile	terrain	for	aligning	a	moral	investment	into	the	long-standing	injustices	affecting	Glasgow	citizens	with	a	number	of	sentiments	and	aspirations.	The	sentiments	of	being	 first	 and	 foremost	 Glaswegians	 translated	 into	 deontological	 claims	 of	professionals	 from	 the	 pSoBid	 to	 provide	 knowledgeable	 (molecular)	representations	 of	 such	 injustices	 for	 policy-makers.	 From	 their	 perspective,	leveraging	 the	 virtue	 of	 the	 purported	 objectivity	 afforded	by	 epigenetics	 is	 to	contribute	to	a	socio-political	change	in	a	non-distant	future,	which	could	finally	remedy	 to	 the	past	 injustices	 affecting	 their	 fellow	supporters	 and	 citizens.	On	the	 side	 of	 the	 latter,	 Celtic’s	 membership	 and	 belonging	 to	 its	 community	 of	supporters	translated	into	an	expression	of	trust	in	–	and	a	commitment	to	–	this	research,	 which	 made	 possible	 the	 recruitment	 of	 a	 sufficient	 number	 of	participants	to	these	studies	from	the	more	deprived	communities.			
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A	‘molecular	heuristic’	of	the	social	and	material	causes	in	Glasgow	thus	seems	to	be	propelled	and	shaped	by	the	aspirations	to	remedy	the	infamous	title	of	“the	sick	man	 of	 Europe”	 and	 a	moral	 enterprise	 that	 emerges	 from	 it.	 In	 such	 an	enterprise,	 the	 Glaswegian	 biologies	 enable	 temporary	 joint	 epistemic	 work	(Niewhoener	2015)	and	the	construction	of	mixed	epistemic	categories	(Meloni	2015)	 among	 researchers	 gather	 around	 the	 pSoBid,	 in	 their	 endeavour	 to	address	 the	 environmental	 and	 social	 determinants	 of	 health.	 Differently	 from	the	 understanding	 that	 epigenetics	 is	 used	 for	 assigning	 responsibility	 for	 the	bodily	 effects	 to	 the	 individuals	 who	 fail	 to	 comply	 with	 environmental	advisories	instead	for	socio-political	action	on	pre-existing	inequalities	in	health	(Mansfield	 2012),	 the	 openness	 to	 the	 environment	 and	 the	 molecular	representation	 of	 its	 effects	 on	 individual	 health	 are	 in	 the	 case	 of	 Glasgow	regarded	 as	 a	potential	 “game-changer”	 for	 the	 resolution	of	 the	 long-standing	inequalities	 that	 characterize	 the	 health	 of	 Glaswegians,	 including	 and	particularly	on	the	level	of	political	action.	The	potential	for	political	innovation	assigned	 to	 epigenetics	 stems	 precisely	 from	 its	 translation	 of	 the	 social	environments	(e.g.	class,	biography,	community	membership)	at	the	basis	of	“the	Glasgow	 effect”,	 into	 a	 different	 kind	 of	 material	 objectivity,	 whose	 molecular	representation	is	deemed	to	offer	better	leverage	for	socio-political	change.		The	mobilization	of	epigenetics	in	the	collaborative	health	endeavour	in	Glasgow	thus	points	therefore	to	a	moment	of	intertwined	epistemic	and	normative	self-reflexivity.	The	recognition	of	the	instrumental	role	of	epigenetics	in	the	case	at	hand	 does	 not	 however	 diminish	 its	 heuristic	 potential.	 The	 research	 around	epigenetics	currently	embeds	diverging	representations	of	biological	phenomena	(e.g.	 an	 additional	 layer	 of	 evidence,	 a	 type	 of	 material	 objectivity,	 etc.),	 and	
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allows	 distinct	 types	 of	 joint	 epistemic	 works	 (Niewhoener	 2015)	 within	 the	community	 of	 natural	 scientists,	 epidemiologists,	 sociologists,	 anthropologists,	psychologists,	etc.	However,	rather	than	testifying	to	thicker	conceptualisations	linking	biology	and	culture	(Niewöhner	2015),	the	case	of	Glasgow	highlights	the	very	 concrete	 ways	 in	 which	 the	 epigenetic	 factual	 discourse	 can	 come	 to	operate	 that	 analogi-digital	 translation	 of	 material	 (food,	 occupational	exposures,	toxins,	pesticides)	as	well	as	social	(chronic	stress,	social	status,	early	life	adversity,	parental	behaviours)	environments	into	the	language	of	epigenetic	markings	 (Meloni	 and	Testa	 2014).	 The	 epidemiological	 uptake	 of	 epigenetics,	however,	 occurs	 insofar	 as	 its	 data	 can	 be	 made	 compatible	 with	 their	 own	standard	 of	 coding	 –	 the	 QUALY,	 through	 its	 translation	 into	 genome-friendly	form.	 Regardless	 of	 whether	 it	 is	 genome-friendly	 or	 QUALY-based,	 the	instrumental	 value	 of	 epigenetics	 arises	 through	 its	 provision	 of	 a	decontextualized	 snapshot	 of	 molecular	 endpoints	 that	 sample	 the	 social	 and	environmental	turmoil	of	human	existence	(Lock	2015).	In	doing	so,	it	thus	turns	the	 understanding	 of	 complex	 cultural	 and	 social	 practices	 into	 molecularly	accountable	interacting	substances	that	get	under	our	skin	(see	Landecker	2011,	Landecker	 and	 Panofsky	 2013).	 It	 is	 thanks	 to	 its	 molecularization	 of	 the	environment	 that	 epigenetics	 is	 bestowed	 the	 potential	 for	 actionable	 public	health	knowledge.		At	 the	 same	 time,	 the	 case	 of	 Glasgow	 represents	 also	 an	 example	 of	 how	successful	implementation	of	a	collective	endeavour	rests	upon	the	local	bonding	and	social	relations	between	researchers	and	participants	who	both	are	first	and	foremost	 fellow	 citizens.	 The	 case	 of	 Glasgow	 thus	 provides	 an	 empirical	example	of	solidarity	as	grounding	principle	of	research	and	for	bringing	about	
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political	action	upon	health.		The	context	of	Glasgow	is,	indeed,	a	rather	specific	one.	 The	 norms	 and	 values	 that	 made	 possible	 the	 assemblage	 of	 health	endeavour	 like	 the	pSoBid	might,	 in	 fact,	be	endemic	 to	Glasgow.	 In	 this	 sense,	the	applicability	of	 a	 solidarity-based	 research	and	action	upon	health	 in	 some	other	 contexts	 might	 prove	 to	 be	 challenging.	 Nevertheless,	 the	 Glasgow	 case	indicates	that	‘increasing	our	sensitivity	to	the	particular	details	of	the	pain	and	humiliation	 of	 other,	 unfamiliar	 sorts	 of	 people...	 makes	 it	 more	 difficult	 to	marginalize	people	different	from	ourselves’	(Rorty	1989,	p.	xvi).	Accordingly,	as	the	 case	 of	 Glasgow	 suggests,	 if	 not	 on	 the	 global	 level,	 it	 certainly	 can	 propel	political	action	in	local	communities.			
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CHAPTER	SIX	–	CONCLUSIONS			This	 project	 was	 an	 empirical	 invesriation	 of	 epigenetics	 and	 its	 societal	implications.	Starting	from	a	mapping	of	the	field	activity,	this	research	has	first	shown	 that	 epigenetics	 is	 most	 actively	 studied	 in	 cancer,	 cardiovascular	diseases,	 neurodegenerative	 diseases,	 autoimmune	 diseases	 and	 diabetes.	Epigenetics	 is	 actively	 employed	 not	 only	 in	 basic	 research	 but	 also	 in	translational	 and	 clinical	 research.	Moreover,	 numerous	 drugs	with	 epigenetic	mechanism	 of	 action	 are	 in	 use	 for	 treating	 diverse	 types	 of	 cancer	 –	glioblastomas,	 leukemias,	 lymphomas,	 etc.,	 while	 many	 epigenome-modifying	compounds	are	currently	being	tested	in	cancer	and	other	diseases.	In	aiming	to	answer	to	the	research	questions	of	what	are	the	most	active	types	of	epigenetic	research;	 what	 are	 the	 most	 actively	 studied	 disease	 areas,	 areas	 of	 clinical	application	and	what	are	the	research	outputs	of	epigenetic	research,	the	thesis	found	 that	 the	 disease	 areas	most	 actively	 studied	 in	 epigenetic	 research,	 and	where	 its	 clinical	 application	 is	most	 detectable,	 are	 precisely	 those	 areas	 that	the	 public	 health	 agencies	 like	 the	 WHO	 and	 the	 political	 bodies	 like	 the	 EU	
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identify	as	posing	major	challenges	to	the	health	of	the	population		(WHO	2008;	20012;	EU	2007).		At	 the	 same	 time,	 these	 diseases	 have	 long	 been	 known	 to	 be,	 or	 at	 least	suspected	to	be,	influence	by	environmental,	social	and	life	style	related	factors.	In	 line	 with	 this,	 the	 big	 epigenetics	 consortia	 that	 have	 been	 established	 in	recent	years	state	among	their	objectives	the	understanding	of	how	epigenome	has	 shaped	 human	 populations	 over	 generations	 and	 in	 response	 to	 the	environment,	 and	 how	 exposures	 such	 as	 physical,	 chemical,	 behavioral,	 and	social	 factors	 influence	 gene	 expression	 and	 health.	 However,	 most	 of	 their	published	 data	 do	 not	 even	 contain	 the	 word	 ‘environment’,	 Instead,	 the	expressions	 employed	 are	 exclusively	 those	 from	 genomic	 vocabulary,	 e.g.	functional	annotations,	datasets,	regulatory	networks,	mapping,	etc.,	 suggesting	thus	 that	 the	 environment	 in	 epigenomics	 –	 the	 dominants	 practice	 of	 today’s	epigenetic	science	–	 is	being	taken	into	consideration	insofar	as	 it	 is,	and	could	be,	 converted	 into	 ‘genome-friendly	 and	 code-compatible’	 digital	 readouts	(Maloni	and	Testa	2014).			A	much	small	 corner	of	 the	 field	 that	 is	concerned	with	 the	causal	 relationship	between	 factors	 such	 as	 chemicals,	 smoking,	 diet,	 exercise,	 etc.,	 and	 health-related	conditions	like	elevated	blood	pressure,	anxiety,	obesity,	and	goes	by	the	name	 environmental	 epigenetics.	 The	 experimental	 formulization	 of	environment	in	environmental	epigenetics	generates	concept	of	the	environment	as	being	moleculairzed.	Molecularisation	of	the	environment,	accordingly,	is	the	aspect	 of	 epigenetics	 that	 resonates	 well	 with	 wider	 society’s	 aspirations	 of	‘taking	 control	 of	 your	 health’	 (Reliv	 International)	 and	 ‘your	DNA	 is	 not	 your	
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destiny’	(Cloud	2010;	Spector	2012),	as	well	as	with	social	inequalities	in	health	paradigm	(McGuinness	et	al	2012)	and	hopes	of	new	engagement	between	 the	social	and	the	biological	sciences	(Landecker	and	Panofsky	2013;	Meloni	2015;	Niewhoener	2015).	It	is	precisely	this	small	subfield	in	epigenetic	research	that	has	been	gaining	attention	 in	diverse	domains	beyond	biomedicine,	despite,	or	perhaps	 even	 because,	 its	 results	 are	 disputed	 within	 biomedical	 research	community.		Focusing	on	one	interdisciplinary	project	based	in	Glasgow	–	a	city	characterized	by	stark	health	and	social	inequalities,	where	epigenetics	has	been	employed	to	measure	and	instruct	relevant	social	programs	to	target	these	inequalities	–	this	research	has	further	shown	that	it	is	the	community	issues	related	to	inequalities	among,	 and	 the	 local	bonds	between,	Glaswegians	 that	played	a	pivotal	 role	 in	assembling	the	collective	endeavour	of	 this	 interdisciplinary	project.	Moreover,	it	 is	precisely	from	the	problematic	socio-political	background	that	yielded	“the	Glasgow	 effect”,	 that	 the	 epistemic	 dialogue	 among	 the	 disciplines	 within	 the	project	 emerged.	 Within	 such	 a	 context,	 epigenetics	 emerges	 as	 an	 epistemic,	techno-scientific	articulation	of	the	local	morality	shared	by	the	Glaswegians	as	supporters	of	a	football	team,	researchers,	or	simply	citizens,	to	remedy	for	the	perceived	 long-standing	 injustices	 that	 community	 had	 endured.	 In	 aiming	 to	answer	 to	 the	 research	 questions	 of	 how	 is	 epigenetics	 mobilized	 and	conceptualized	by	actors	of	diverse	backgrounds	involved	in	an	interdisciplinary	collaborative	project,	this	thesis	found	that	within	such	one	project	–	the	pSoBid	project	–	that	aimed	to	measure	and	instruct	relevant	social	programs	to	target	health	 and	 social	 inequalities,	 epigenetics	 is	 perceived	 to	 be	 an	 instrumentally	
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effective,	 policy-friendly	 evidentiary	 resource	 that	 could	 foster	 socio-political	change	in	a	non-distant	future.	Accordingly,	it	is	thanks	to	its	molecularization	of	the	 environment	 and	 therefore	 its	 purported	 objectivity,	 that	 epigenetics	 is	bestowed	the	potential	for	actionable	public	health	knowledge.			The	expectations	of	epigenetics	seem	to	operate	on	two	levels.	First,	epigenomics	is	expected	to	deliver	where	its	–omic	predecessor	genomics	has	faild	to	do	so.	However,	 epigenomics	 goes	 ‘beyond	 the	 genome’	 only	 insofar	 as	 the	environmental,	 the	 social,	 the	 biographical	 –	 the	 ‘analogical	 vastness	 of	 the	environmental	 signals’	 –	 can	 be	 converted	 into	 ‘genome-friendly	 and	 code-compatible	digital	representation’	(Meloni	and	Testa	(2014).	Differently	than	in	the	 life	 sciences	 and	 biomedicine,	 this	 ‘code-compatibility’	 in	 epidemiology	 is	predicated	upon	the	conversion	of	epigenetic	data	into	the	standard	code	used	in	epidemiological	research	–	the	QUALYs.			The	 instrumental	 value	 of	 epigeneticist	 thus	 arises	 through	 its	 provision	 of	 a	decontextualized	 snapshot	 of	 molecular	 endpoints	 that	 sample	 the	 social	 and	environmental	turmoil	of	human	existence	(Lock	2015).	In	doing	so,	it	turns	the	understanding	 of	 complex	 cultural	 and	 social	 practices	 into	 molecularly	accountable	 interacting	 substances	 that	 get	 under	 our	 skin	 (Landecker	 2011,	Landecker	and	Panofsky	2013).	In	relation	to	this,	epigenetics	is	expected	to	also	provide	 insight	 into	 how	 the	 contingencies	 of	 life	 –	 what	 we	 eat,	 pollution	 or	stress	 –	 affect	 how	 genes	 operate.	 In	 other	 words,	 how	 the	 environment,	biography	 and	 milieu	 are	 molecularly	 embedded	 to	 produce	 bodily	 outcomes	body	(Landecker	2011;	Niewhoener	2011;	Mansfield	2012;	Meloni	2015).		
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The	research	around	epigenetics	currently	embeds	diverging	representations	of	biological	 phenomena	 (e.g.	 an	 additional	 layer	 of	 evidence,	 a	 type	 of	 material	objectivity,	etc.),	and	allows	distinct	types	of	joint	epistemic	works	(Niewhoener	2015)	within	 the	community	of	natural	 scientists,	epidemiologists,	 sociologists,	anthropologists,	 psychologists,	 etc.	 However,	 rather	 than	 testifying	 to	 thicker	conceptualisations	 linking	 biology	 and	 culture	 (Niewöhner	 2015),	 the	 case	 of	Glasgow	 highlights	 the	 very	 concrete	 ways	 in	 which	 the	 epigenetic	 factual	discourse	can	come	to	operate	the	translation	of	the	material	(food,	occupational	exposures,	toxins,	pesticides)	as	well	as	social	(chronic	stress,	social	status,	early	life	adversity,	parental	behaviours)	environments	into	the	language	of	epigenetic	markings	 (Meloni	 and	 Testa	 2014).	 Moreover,	 differently	 from	 the	understanding	that	epigenetics	is	used	for	assigning	responsibility	for	the	bodily	effects	 to	 the	 individuals	 who	 fail	 to	 comply	 with	 environmental	 advisories,	instead	 for	 socio-political	 action	 on	 the	 pre-existing	 inequalities	 in	 health	(Mansfield	 2012),	 the	 openness	 to	 the	 environment	 and	 the	 molecular	representation	 of	 its	 effects	 on	 individual	 health	 are	 in	 the	 case	 of	 Glasgow	regarded	 as	 a	 potential	 “game-changer”	 for	 resolution	 of	 the	 long-standing	inequalities	 that	 characterize	 the	 health	 of	 Glaswegians,	 particularly	 so	 on	 the	level	of	political	action.		This	 thesis	 shows	 that	 in	 the	 case	 of	 Glasgow,	 the	 potential	 for	 political	innovation	 assigned	 to	 epigenetics	 stems	 from	 its	 translation	 of	 the	 social	environments	(e.g.	class,	biography,	community	membership)	at	the	basis	of	the	“Glasgow	 effect”,	 into	 a	 different	 kind	 of	material	 objectivity,	whose	molecular	representation	 is	 deemed	 to	 offer	 better	 leverage	 for	 socio-political	 change.	 In 
this respect, the Glasgow study exemplifies a more general trend in population studies 
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towards the collection of biological samples and increasingly sophisticated 
biomarkers analysis. Emergence	 of	 such	 a	 trend	 coincides	 with	 increasingly	voiced	 complaints	 about	 the	 lack	 of	 political	 commitment	 and	 action	 to	 tackle	social	 determinants	 of	 health	 despite	 the	 vast	 amount	 of	 evidence	 collected	 in	previous	years	by	means	of	classical	epidemiology.	The	recent	“Review	of	social	determinants	and	 the	health	divide	 in	 the	WHO	European	Region:	 final	 report”	(WHO	2012)	was,	in	fact,	portrayed	as	“a	‘wake-up’	call	to	action	among	political	and	 professional	 leaders”	 by	 the	 WHO	 Regional	 Director	 for	 Europe	 (page	 v,	
Forward).	 The	 Review	 followed	 up	 on	 the	 final	 report	 (WHO	 2008)	 of	 the	Commission	on	social	determinants	of	health	established	in	2005	after	decades	of	research	into	social	determinants	of	health,	that	was	launched	on	the	bases	of	calls	 for	 action	 expressed	 in	 the	WHO	 Declaration	 of	 Alma	 Ata	 Declaration	 in	1978	and	the	Ottawa	Charter	for	Health	Promotion	in	1986.	Finding	the	evidence	of	molecular	embodiment	of	social	factors	such	SES	and	poverty	thus	features	as	a	potential	game-changer	in	the	policy-making	arena	in	general.			This	 thesis	 delivers	 an	 empirically	 grounded	 contribution	 to	 explorations	 of	epigenetics.	 In	 pursuing	 its	 first	 aim	 –	 mapping	 the	 impact	 of	 epigenetics	 on	health	 care	 –	 this	 thesis	 makes	 a	 methodological	 contribution	 to	 empirical	investigations	 of	 emerging	 fields	 of	 the	 life	 sciences.	 The	 thesis	 delivers	 a	combinatory	 qualitative-quantitative	method	 for	 systematic	 scoping	 of	 data	 to	produce	 a	map	 of	 the	most	 active	 areas	 of	 research	 and	 clinical	 application	 of	epigenetics.	 Furthermore,	 by	 focusing	 on	 the	 case	 of	 Glasgow,	 a	 city	characterized	by	stark	health	and	social	inequalities,	where	epigenetics	has	been	employed	 in	a	 interdisciplinary	project	 to	measure	and	 instruct	 relevant	 social	
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programs	 to	 target	 these	 inequalities,	 this	 thesis	 contributes	 a	 critical	 insight	into	how	is	epigenetics	is	currently	employed	–	in	collaboration	between	actors	of	diverse	 backgrounds;	 and	 in	 policy	 efforts	 and	 action	 upon	 health.	 It	 thus	contributes	 to	 discussions	 about	 epigenetics	 and	 molecularization	 of	 the	environment,	 biography	 and	 milieu	 (Landecker	 2011;	 Niewöhner	 2011;	Mansfield	2012)	by	adding	an	understanding	of	epigenetics	as	an	instrumentally	effective,	 policy-appropriate	 evidentiary	 resource	 that	 could	 prove	 a	 “game-changer”	for	the	resolution	of	the	long-standing	inequalities	that	characterize	the	health	of	Glaswegians.		The	 thesis	 also	 contributes	 to	discussions	 about	 the	 governance	of	 research.	 It	delivers	an	empirical	 example	of	how	solidarity	practice	 lied	at	 the	basis	of	 an	interdisciplinary	 collaborative	 research	 project	 and	 operated	 to	 bring	 about	political	action	in	local	communities.	Solidarity	has	previously	been	discussed	as	a	practice	of	citizens	towards	research	biobanks	whereby	citizens	should	accept	a	 small	 cost	 of	 sample	 donation	 as	 their	 trust	 in	 and	 commitment	 to	 research	that	 in	the	future	could	benefit	 the	whole	of	society	(Prainack	and	Buyx	2013);	and	towards	other	citizens	in	accepting	that	those	who	suffer	from	the	so-called	‘life-style	 related	diseases’	 –	 like	 smoking	 induced	 lung	 cancer	–	 should	not	be	denied	access	public	health	services	on	the	bases	of	their	solidarity	with	people	who	do	not	‘practice’	such	‘unhealthy	life	styels’	(Buyx	and	Prainsack	2012).	This	thesis	 has	 shown	 that	 solidarity	 practice	 need	 operate	 also	 on	 the	 side	 of	scientists	 towards	 the	citizens	and	community	 they	belong	 to.	 In	discussion	on	public	‘unease	with’	and	‘lack	of	trust	in’	science	(EC	2007),	the	thesis	shifts	the	focus	 away	 from	 ‘democratization	 of	 expertise’	 and	 ‘citizen	 science’	 standards	and	 questions	 of	 legitimacy	 and	 extension	 (Collins	 and	 Evans	 2002)	 and	
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representation	 (Brown	 2009).	 The	 thesis,	 instead,	 suggests	 that	 it	 is	 the	 local	bonds	between	of	citizens	of	Glasgow,	where	scientists	are	at	the	same	time	first	and	 foremost	 citizen	 of	 their	 local	 community,	which	 played	 a	 decisive	 role	 in	initiation	 and	 implementation	 of	 an	 interdisciplinary	 collaborative	 research	project.	Thus,	 this	 thesis	 invites	 further	explorations	of	solidarity	practices	and	the	role	of	‘scientist	as	citizens’	in	discussions	about	the	governance	of	research.			Finally,	being	grounded	in	a	programme	of	interdisciplinary	character,	this	thesis	is	 uniquely	positioned	 to	make	 a	 trans-disciplinary	 reflection	upon	epigenetics	and	 its	 societal	 implications.	 Hence,	 this	 thesis	 stands	 as	 a	 piece	 of	interdisciplinary	scholarship	that	found	its	place	within	the	field	of	STS	–	a	field	that	 has	 long	 been	 openly	 friendly	 to	 such	 contributions.	 The	 interdisciplinary	character	 of	 the	 thesis	 is	 reflected	 in	 the	 aims	 it	 set	 to	 achieve,	 methods	 it	employed	and	disciplines	it	relied	on,	and	presents	its	greatest	strength.		On	 the	 other	 hand,	 it	 presents	 also	 the	 source	 of	 its	 limitations.	 First,	 the	 two	aims	it	pursued	in	parallel	are	not	 incompatible	but	there	 is	a	tension	between	them	 in	 terms	 of	 both	 empirical	 methods	 and	 theoretical	 assumptions	 that	informed	 them.	This	 thesis	did	not	attempt	 to	solve	 them	but	rather	embraced	them	 as	 valuable	 insights	 to	 and	 reflections	 of	 how	 epigenetics	 has	 come	 to	inhabit	 different	 social	 worlds	 and	 different	 fragments	 of	 social	 reality.	 With	respect	 to	 this,	 however,	 the	 thesis	 does	 bring	 to	 the	 fore	 the	 difficulties	with	which	 projects	 responsible	 to	 simultaneously	 contribute	 to	 different	communities	 face.	 In	 the	 case	 of	 this	 project,	 it	 is	 the	 biomedical	 research	community,	 as	 exemplified	by	 its	 research	 activities	 conducted	 for	 the	EPIGEN	project;	 and	 humanities	 and	 social	 sciences,	 as	 exemplified	 by	 this	 research	
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activities	 conducted	within	 the	 program	 of	 Foundations	 and	 Ethics	 of	 the	 Life	Sciences	 and	 Their	 Ethical	 Consequences.	 Accordingly,	 the	 experimental	character	 of	 this	 thesis	 represents	 an	 important	 exploratory	 contribution	 to	interdisciplinarity	as	mode	of	inquiry.	Second,	 and	 in	 relation	 to	 the	 first,	 this	 thesis	 was	 faced	 with	 bureaucratic	impracticalities	in	sampling	procedure	and	funding	limitations	for	the	fieldwork	in	 Glasgow,	 which	 was	 reflected	 in	 the	 small	 sample	 of	 people	 who	 were	interviewed.	Although	 this	 in	no	way	affected	 the	quality	of	 the	data	 collected,	accessing	 a	 greater	number	of	 people	would	have	 certainly	been	beneficial	 for	the	thesis.	Moreover,	the	project	focused	on	one	distinct	local	context.	Although	the	 specificities	 of	 Glasgow	 represented	 an	 interesting	 object	 of	 inquiry,	investigating	 how	 they	 relat	 to	 the	 more	 general	 practice	 of	 epigenetics	 in	research	on	social	inequalities	in	health	would	have	also	been	beneficial	for	this	thesis.	Accordingly,	one	way	in	which	the	research	informed	by	this	thesis	can	be	directed	 in	 the	 future	 is	precisely	 to	explore	normative	and	epistemic	 tensions	and	 junctures	 that	 arise	 from	 understanding	 of	 the	 human	 body	 as	 both	universal	and	 locally	embedded.	A	 recently	established	 “Epigenetics	and	Stress	Network”	 (EpiStressNet 53 )	 gathers	 researchers	 of	 diverse	 background	 and	various	 institutions	 across	 the	 UK	 and	 Europe	 (including	 some	 pSoBid	researchers)	 to	 ‘elucidate	 the	 biological	 impact	 of	 social	 and	 behavioural	stressors’.	An	observational	study	of	meetings,	supplemented	by	interviews	with	various	partnerts	in	the	network,	would	indeed	provide	an	ideal	terrain	for	the	exploration	 ‘joint	 epistemic	 work’	 (Niewöhner	 2015)	 and	 ‘mixed	 epistemic	categories’	 (Meloni	 2015)	 as	 well	 as	 normative	 concerns	 brought	 about	 by																																																									53	Available	at:	https://www.sheffield.ac.uk/epistressnet		(Last	accessed	on	12.12.2016)	
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molecularisation	 of	 the	 environment,	 biography	 and	 milieu	 (Landecker	 2011;	Niewöhner	2011;	Mansfield	2012).	Additionally,	after	an	initial	exchange	of	ideas	at	the	PhD	training	School	in	York,	Anna	 Lydia	 Svalastog	 (Østfold	 University	 College,	 Norway)	 and	 I	 explored	‘gender	 as	 cause	 and	 effect’	 in	 the	 science	 of	 epigenetics	 and	 discussed	 the	importance	of	gender	analysis	for	research	design	and	interdisciplinary	dialogue	in	science	and	public	debate	(data	presented	at	the	Symposium	Body	Discourses	/	Body	Politics	and	Agency:	What's	Left	of	the	Body,	Vienna,	5-7	February	2015).	Due	 to	 necessity	 of	 prioretizing	 between	 my	 already	 numerious	 project	commitments,	 this	 promising	 terrain	 for	 investigation	 had	 to	 be	 left	 aside	 for	some	future	projects.	Hence,	another	way	in	which	the	follow	up	research	of	this	project	 can	be	 taken	 is	 to	 further	 investigate	of	how	gender	 is	 (not)	 informing	research	design	and	interdisciplinary	dialogue	in	science	and	public	debate.	Finally,	 in	an	essay	 required	 for	 completing	 the	PhD	course	 in	 ”Foundations	of	Probability	and	Statistical	Inference”,	I	discussed	how	stability	vs.	reversibility	of	epigenetic	 marks	 would	 (re)configure	 the	 understanding	 of	 ’risk’	 in	epidemiological	 research,	 depending	 on	 the	 choice	 of	 statistical	 inference	 –	frequentist	 (‘objective’;	 based	 on	 a	 series	 of	 repetitions;	 fixed)	 or	 Bayesian	(‘subjective’;	 based	 on	 degrees	 of	 belief;	 dynamic).	 As	 my	 interest	 in	 the	philosophical	foundations	of	science	has	always	been	strong,	further	exploration	of	the	conceptual	issues	in	epigenetic	data	collection	and	analysis	in	population	studies,	 and	 their	 social	 dimension,	 would	 be	 another	 potential	 direction	 of	future	research	on	epigenetics	and	policy.			
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